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Abstract 
Guillain-Barre’ syndrome (GBS) is a rare disease that affects the peripheral nervous 
system.  It is autoimmune in nature and generally presents with areflexia and paresthesias that 
can lead to total paralysis.  Guillain-Barre’ syndrome, with the eradication of polio, is now the 
leading cause of flaccid paralysis in the United States.  This condition produces significant 
mortality and morbidity challenging the entire healthcare team, but particularly nurses.  Guillain-
Barre’ syndrome is not understood well by nurses.  Patients who have experienced a moderate to 
severe case of Guillain-Barre’ syndrome have reported that nursing care was inconsistent.  
Patients have disclosed that nurses do not have the knowledge related to the special needs of 
GBS patients.  Because of this lack of knowledge, patients experience unnecessary discomfort 
and/or stress.     
Research to better understand the impact of an acute episode of Guillain-Barre’ syndrome 
and the care required during hospitalization is crucial in order to educate caregivers and enhance 
the patient’s care experience.  The purpose of this study was to gain a richer understanding of the 
patient’s recalled experience of an acute episode of moderate to severe Guillain-Barre’ 
syndrome.  A qualitative descriptive design was utilized to answer three research questions.  
Orem’s self care deficit theory of nursing was utilized to inform this research study.  Data were 
collected through semi-structured interviews with 14 participants.  The sample included 10 
females and four males from 19 to 79 years old from eight different states.  Inductive content 
analysis was utilized to analyze the data to establish themes.     
Five major themes were identified:  physical manifestations of GBS, attitudes and 
emotions, knowledge and awareness, the value of peer contact, and care concepts.  These themes 
would suggest that healthcare team members, including nurses, do not have an understanding of 
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the special needs of Guillain-Barre’ syndrome patients.  Additional work and research is needed 
to enhance the patient’s experience with moderate to severe Guillain-Barre’ syndrome.  
Implications are evident in the areas of practice, educational preparation of healthcare staff, 
health policy and future research. 
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 Chapter One:  Background  
Introduction 
Guillain-Barre’ syndrome (GBS) is a rare disease that affects the peripheral nervous 
system.  It is autoimmune in nature and generally presents with areflexia and paresthesias that 
can lead to total paralysis.  Moderate to severe cases of Guillain-Barre’ syndrome result in 
significant long-term functional impairments in patients.  The functional impairments that 
accompany Guillain-Barre’ syndrome can lead to permanent disability (Frenzen, 2008).  Table 1 
describes the permanent disability percentages by age category resulting from Guillain-Barre’ 
syndrome (Frenzen, 2008). 
Table 1 
Permanent Disability by Age 
Age Range Percent of GBS Patients 
Permanently Disabled 
 
95% Confidence Interval 
18-34 12.1% 10.4% - 13.7% 
35-64 22.0% 20.8% - 23.2% 
>65 48.8% 47.1% - 50.5% 
Note.  Adapted from “Economic cost of guillain-barre’ syndrome in the United States”, by P. 
Frenzen, 2008, Neurology, 71, 21-27. 
 
Guillain-Barre’ syndrome, with the eradication of polio, is now the leading cause of 
flaccid paralysis in the United States (Chalela, 2001; Napgal et al., 1999).  During the acute 
episode, Guillain-Barre’ syndrome can lead to total paralysis requiring hospitalization for 
mechanical ventilatory support.   This condition produces significant mortality and morbidity 
(Hartung et al., 2001) challenging the entire healthcare team, but particularly nurses (Haldeman 
& Zulkosky, 2005; Murray, 1993; Sulton, 2002; Walsh, 2006).  Research is needed to better 
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understand the impact that an acute episode of Guillain-Barre’ syndrome has on patients and the 
care that is required during hospitalization in order to educate caregivers and enhance the 
patient’s care experience.  
General Information on Rare Diseases 
The National Institutes of Health (2014) defines a rare disease, also known as an orphan 
disease, as a disease that impacts less than 200,000 Americans concurrently.  Rare disease is a 
term that represents a heterogeneous set of illnesses that can impact any of the body’s systems 
(Schieppati, Henter, Daina, & Aperia, 2008).  When considered cumulatively, rare 
diseases in the United States are not so rare (Wastfelt, Fadeel, & Henter, 2006).  The Office of 
Rare Disease Research (ORDR), part of the National Institutes of Health’s (NIH) National 
Center for Advancing Translational Sciences (NCATS), reports that there are approximately 
6800 rare diseases in the United States (National Institutes of Health, 2014).  Rare diseases 
include such commonly known conditions as Crohn’s Disease, Cystic Fibrosis, Duchenne 
Muscular Dystrophy, Huntington’s Disease, Tourette’s syndrome and Guillain-Barre’ syndrome, 
just to name a few.   
Considering each rare disease individually, one might think that the reach of these 
illnesses is limited; however, when combining all of the known rare diseases together, more than 
30 million Americans are directly impacted and living with a diagnosed rare disease (National 
Institutes of Health, 2014).  This means that nearly one in ten people, almost ten percent of the 
U.S. population, have a rare disease (National Organization for Rare Disorders, 2014).  When 
considering the population of Europe, an additional 30 million individuals are affected (Wastfelt 
et al., 2006).  With these figures, rare diseases are not so rare and are becoming less rare.  
Wastfelt et al. (2006) reported that nearly 250 new rare diseases are identified annually.  The 
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increase in rare disease identification is in part due to advances in medical and diagnostic 
abilities and sophistication in the understanding of pathophysiological processes leading to 
diseases being placed into more narrowly defined categories (Wastfelt et al., 2006).   The 
identification of rare diseases is anticipated to continue to increase because of these advances. 
Rare diseases, and the impact that these illnesses have on patients, families, and 
caregivers is an important topic to better understand.  Diseases that are classified as rare can be 
life-threatening and cause long-term residual issues (Wastfelt et al., 2006).  Patients, and family 
members, can experience a significant impact on quality of life related to rare diseases and their 
sequelae (Wastfelt et al., 2006).    
Rare Disease Awareness and Issues 
Rare diseases, such as Guillain-Barre’ syndrome, pose special challenges for patients, 
their support systems, and providers making these illnesses a critical public health concern 
(National Institutes of Health, 2014; Schieppati et al., 2008).  The focus on rare diseases, and the 
public’s awareness of these illnesses in general, seemed to change in the mid to late 1980’s.  This 
change was driven by Congress in 1985 when the National Commission on Orphan Diseases was 
created and then the subsequent report from this Commission that was produced in 1989 (U.S. 
Department of Health and Human Services, 1989).  This 106-page report detailed the issues that 
patients, physicians, and others faced when encountering a rare disease.   
For patients and families, these issues included:  (a) difficulty obtaining information 
about treatment; (b) a lack of awareness of research advances and availability of clinical trials; 
(c) lack of information on the sequelae related to their rare disease and the subsequent impact on 
work and school; (d) the significant financial burdens created by cost of treatment (if a treatment 
was available for their specific illness) as well as the loss of income; and (e) not being aware of 
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the availability of resources such as support groups.  The lack of information and education that 
patients reported was also a concern for providers.  Physicians caring for patients with rare 
illnesses revealed that they did not have the educational resources to share with patients and were 
conservative in diagnosis and treatment secondary to their lack of knowledge on rare diseases.  
Providers desire more information regarding rare diseases in order to provide better care.   
The report highlighted that patient advocacy organizations, and the associated support 
groups, could contribute to the educational needs of patients and providers.  Patient advocacy 
groups revealed that developing and distributing educational information and providing 
educational sessions to patients and families had become a primary function.  Because of the 
work of patient advocacy/support groups, the public’s awareness regarding rare diseases has 
increased (Schieppati et al., 2008).   
Schieppati et al. (2008) revealed that patients impacted by a rare disease are faced with 
care that is inadequate, both from a health and social perspective.  Because of this, advocacy 
groups are seeing their purpose as not only including increasing the public’s awareness of rare 
diseases and the subsequent impact on patients and families but also to focus on enhancing care 
and benefits that patients with a rare disease receive (Schieppati et al., 2008).  The Guillain-
Barre’ Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy Foundation 
International supports research efforts related to care enhancements for Guillain-Barre’ 
syndrome patients.  Nursing plays a significant role in the provision of care to patients with rare 
diseases including Guillain-Barre’ syndrome.  Issues specifically related to the provision of 
nursing care for patients with a rare disease were not addressed in the Commission’s report 
making this a research priority for future study. 
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 In addition to the National Commission’s 1989 report, and the work of disease specific 
patient advocacy groups (such as the Guillain-Barre’ Syndrome/Chronic Inflammatory 
Demyelinating Polyneuropathy Foundation International), the National Organization for Rare 
Disorders (NORD) also is increasing the public’s awareness of rare diseases.  The National 
Organization for Rare Disorders sponsors a Rare Disease Day the last day of February of each 
year.  Rare Disease Day was founded in Europe in 2008 by the European Rare Disease 
Organization (EURORDIS) and initiated in 2009 in the United States by NORD.  The purpose of 
Rare Disease Day is to connect patients, families, caregivers, medical centers, and patient 
organizations and to gain more attention, including media coverage, for rare diseases and the 
complications that patients’ experience.  
Guillain-Barre’ Syndrome as a Rare Disease 
Guillain-Barre’ syndrome impacts more than 5,000 patients annually with an incidence of 
1.1 to 1.8 cases per 100,000 individuals (McGrogan, Madle, Seaman, and de Vries, 2009).  
Guillain-Barre’ syndrome is a disorder that is considered to be an acute, typically monophasic, 
immune-mediated illness (Walgaard et al., 2011).  Guillain-Barre’ syndrome is accompanied by 
a variable clinical course (Walgaard et al., 2011).  Patients can experience mild symptoms, 
requiring patients to have assistance with ambulation, to severe symptoms including tetraplegia, 
requiring patients to be intubated and mechanically ventilated (Nagpal et al., 1999).  The severity 
of illness, and associated sequelae, are related to the variant of Guillain-Barre’ syndrome.  A 
detailed discussion of the pathophysiology of Guillain-Barre’ syndrome and its variants is 
covered in Chapter Two.  Frenzen (2008) reports that up to 30 percent of patients affected with 
this illness will have a case severe enough to require mechanical ventilatory support.  Patients 
who reach this level of severity are unable to communicate their needs, verbally or nonverbally, 
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secondary to paralysis as well as their requirement of intubation and ventilation for survival.  
Patients are cognitively aware of their surroundings and the happenings within their surroundings 
during sedation vacations and when the patient has stabilized to a point where they no longer 
require sedation as previously required secondary to mechanical ventilation.  In addition, since 
GBS patients requiring mechanical ventilator support typically experience tetraparesis, sedating 
the patient to prevent endotracheal tube dislodgement is not always necessary.  Generally, 
individuals diagnosed with GBS retain cognitive functioning (DeCort, 2011).  Despite being 
cognitively aware of their environment, patients are not able to communicate effectively, or in 
severe cases, not at all.  It is essential to better understand the patients experience during 
hospitalization with moderate to severe Guillain-Barre’ syndrome so care enhancements in 
nursing and supportive care can be realized. 
In addition to the communication challenges, patients who have experienced a moderate 
to severe case of Guillain-Barre’ syndrome have reported that nursing care was inconsistent 
(DeCort, 2011).  Guillain-Barre’ syndrome is not well understood by nurses (Murray, 2010).  
Patients have disclosed that nurses do not have an awareness of the unique care needs of GBS 
patients which contributes to stress and discomfort that is not necessary for patients to endure 
(DeCort, 2011)  Patients reported that:  (a) nursing staff did not understand that paralyzed 
patients could experience pain (GBS patients experience severe pain), (b) nursing staff did not 
offer meal assistance to a partially paralyzed patient because they believed the patient should 
feed themselves, (c) nurses did not understand the proper use of bed side rails, (d) nurses did not 
provide needed assistance with toileting, and (e) staff did not properly communicate when 
providing assistance with activities of daily living (Murray, 2010).   
7 
 
A Professor at the University of Auckland (New Zealand) discussed the special needs of 
GBS patients and their support systems including:  (a) the patient’s right to information, (b) the 
right to an effective communication method, (c) the duty of care, (d) provider and staff 
competence, and (e) the importance of compassion (DeCort, 2011).  A call to action was made 
for GBS patients to share their nursing care experiences (DeCort, 2011).  GBS patients are unlike 
any other patient (DeCort, 2011) and research is needed specifically with this population so that 
care enhancements can be made.     
Although research has examined the long term impact of Guillain-Barre syndrome, 
including functional impairments, there is little information about the patient experience during a 
hospitalization with moderate to severe Guillain-Barre’ syndrome and the subsequent translation 
of this information into knowledge for care enhancements.  A few patients have described their 
experience in the way of personal accounts (Bowes, 1984; Henschel, 1978; Rice, 1977; Shearn & 
Shearn, 1986), and there are also published case studies (Walsh, 2006).  Additional information 
related to the patient experience from personal accounts and case studies is covered in Chapter 
Two.   
Forsberg, Ahlstrom, and Holmqvist (2008) described patients’ experiences during the 
initial phase of Guillain-Barre’ syndrome.  The study included 35 participants, utilized an 
interview guide and qualitative content analysis.  Subjects in the Forsberg et al. (2008) study 
included those that presented with mild, moderate, and severe cases of Guillain-Barre’ 
syndrome.  The analysis revealed the following four themes:  (a) fear and insecurity in a 
vulnerable situation, (b) distinct hopeful improvement, (c) alarmingly slow recovery, and (d) 
strange bodily and mental situations.  There were 18 subthemes identified (Table 2; Forsberg et 
al., 2008); however, this is only one study and more research is needed.   
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Table 2 
Themes and Subthemes Identified in one Guillain-Barre’ Syndrome Study 
Theme Subtheme 
Fear and insecurity in a vulnerable situation Fear of getting worse 
 Frightening to lose body functions 
 Helplessness and shame 
 Life-threatening state of health 
 Feeling isolated because of limited  
     communication 
 Insecurity when being moved to another ward 
 
Distinct, hopeful improvement Reassured by rapid and steady improvement 
 Distinct turning point was a relief 
 Increasing independency inspired joy and 
     hope 
 
Alarmingly slow recovery Prolonged time before start of recovery 
     caused doubt 
 Growing awareness of having a serious 
     disease 
 Fear of residual deficits 
 
Strange bodily and mental sensations The body felt unreal 
 Hurt by pain 
 Annoying numbness 
 Feelings of exhaustion 
 Increased mucous and unpleasant suctioning 
 Scary hallucinations 
 
Note.  Adapted from “Falling ill with guillain-barre’ syndrome: Patients’ experiences during 
the initial phase,” by A. Forsberg, G. Ahlstrom, & L. Holmqvist, 2008, Scandinavian Journal 
of Caring Sciences, 22, 220-226. 
 
Because of the lack of research in this area, and the findings in the Forsberg et al. (2008) 
study (that also included those patients presenting with a mild case of Guillain-Barre’ syndrome), 
more research is needed to better understand the patient’s recalled experience with moderate to 
severe Guillain-Barre’ syndrome with the anticipation of disseminating the findings so that care 
can be enhanced by providing additional education to caregivers.   
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Increased Awareness of Guillain-Barre’ Syndrome 
 Guillain-Barre’ syndrome became better known to the general United States public in 
1976 during an increased incidence of GBS that was thought to be associated with the 
administration of influenza vaccination against the swine-type influenza A (H1N1) virus (Haber, 
Sejvar, Mikaeloff, and DeStefano, 2009).   More than 45 million individuals from across the 
United States were vaccinated against H1N1 during the months of October to December 1976 
(Haber et al., 2009).  During this time period, the number of Guillain-Barre’ syndrome cases 
increased (500 cases reported) as well as mortality related to GBS (25 deaths) (Haber et al., 
2009).  Haber et al. (2009) revealed that the increase in GBS morbidity and mortality was 
thought to be associated with the H1N1 immunization program.  The increased incidence of GBS 
between October and December 1976, one additional case of GBS per 100,000 vaccinated 
individuals, led to the discontinuation of the H1N1 immunization program in January 1977 
(Haber et al., 2009).  It was reported at that time that additional research was needed regarding 
the investigation of any link between the immunization and a potential increased risk of GBS 
(Haber et al., 2009).   
The events of 1976 caused an increased level of fear in the general population related to 
this illness.  The Institute of Medicine (IOM) reported that they accepted the notion of a cause 
and effect relationship between the influenza vaccination program in 1976 and the increase 
number of adult cases of Guillain-Barre’ syndrome (Haber et al.).  This connection between 
immunization and GBS resulted in some individuals electing not to receive influenza 
vaccination.  GBS patients reported having anxiety and fear regarding a relapse if vaccinated 
(Bowes, 1984).  Further research by the Institute of Medicine revealed that there was not enough 
evidence after the 1976 issue to accept or reject the idea that influenza vaccination caused GBS 
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(Haber et al., 2009).    It is essential to clarify misconceptions about GBS, such as concerns with 
vaccination, in order to decrease fear and anxiety in patients.  Fear and anxiety can impact 
patient progress and recovery.  In addition, it is important to better understand the education 
provided to patients diagnosed with Guillain-Barre’ syndrome so that additional information can 
be shared and care enhanced.  An essential part of nursing care is the provision of information to 
the patient and family about their illness and to provide adequate psychosocial support (Murray, 
1993).         
Economics of Guillain-Barre’ Syndrome 
 The financial impact of Guillain-Barre’ syndrome is high.  Considering direct costs, the 
cost of medical care, and the indirect costs, such as loss of wages and early death, it was 
estimated that GBS cost approximately 1.7 billion dollars per year in the United States based on 
2004 data (Frenzen, 2008).  This economic spend was made up of 0.2 billion in direct costs and 
1.5 billion in indirect costs.  Direct care costs include costs associated with inpatient 
hospitalization, rehabilitation and long term care, as well as outpatient care.  Table 3 illustrates 
data regarding the health burden of Guillain-Barre’ syndrome as measured by amount of 
healthcare resources utilized (Frenzen, 2008).  This data supports that Guillain-Barre’ syndrome 
is a significant healthcare concern that warrants additional research.   
 Another study performed by Napgal et al. (1999) specifically looked at treatment costs of 
the two gold standard treatments (i.e., Plasmapheresis and Intravenous Immunoglobulin) to 
understand better the financial impacts of these modalities.  This study revealed that 
plasmapheresis was a more economical option ($6,204 per patient) versus intravenous 
immunoglobulin ($10,165 per patient).  Hospitalized GBS patients experience a loss of salary,  
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Table 3 
Annual Health Burden Due to GBS in the United States (based on 2004 data) 
Measure Inpatient Care    
Estimate 
 
95% Confidence Interval 
Hospitalizations in community 
hospitals 
 
6,008 5,510 – 6,506 
Community  hospital patients 5,473 4,951 – 5,995 
Discharges to inpatient rehab 
facilities (IRFs) 
 
1,009 837 – 1,181 
Discharges to long term care 
hospitals (LTCHs) 
 
161 105 – 217 
Discharges to nursing homes 720 606 – 834 
                                                       Outpatient Care 
Physician visits       19,728 0 – 103,506 
Physical therapy visits 147,182 0 – 309,820 
Occupational therapy visits 7,821 0 – 29,553 
                                                        Lost Productivity 
Permanently disabled workers 574 512 – 636 
Deaths 
GBS was underlying cause of 
death 
 
247 216 - 278 
Note.  Adapted from “Economic cost of guillain-barre’ syndrome in the United States,” by P. 
Frenzen, 2008, Neurology, 71, 21-27. 
 
are often underinsured or noninsured, and can have a loss of employment related to length of 
illness and recovery (Murray, 1993).  These factors, including the cost of needed healthcare 
services, lead to a tremendous source of financial stress for GBS patients (Murray, 1993).  It is 
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important for healthcare providers to understand the financial impact of GBS to the healthcare 
system overall but also at the patient level.  Understanding the patient’s concern regarding the 
financial significance of this illness is important considering the impact of stress on the patient’s 
recovery and progression through the phases of the syndrome.    
  Nurses play a pivotal role in the delivery of the two primary therapies for GBS, 
intravenous immunoglobulin and plasmapharesis.  Nurses spend a significant amount of time 
with the patient compared to other healthcare professionals.  Intravenous immunoglobulin takes 
approximately 8.5 nursing hours compared to 17.5 hours for the patients receiving 
plasmapheresis (Nagpal et al., 1999).  This is just one example of the amount of time that nurses 
spend consecutively with GBS patients.  Compared to other healthcare professionals, nurses 
spend the most time daily with Guillain-Barre’ syndrome patients providing nurses the 
opportunity to make significant impacts on both the psychosocial and physical health of GBS 
patients (DeCort, 2011).  This was an important consideration as this study was concerned with 
enhancements that could be made to nursing practice based on the patient’s recall of events 
during care.    
Purpose of Study and Research Questions 
 The purpose of this study was to gain a richer understanding of the patient’s recalled 
experience of an acute episode of moderate to severe Guillain-Barre’ syndrome.  Guillain-Barre’ 
syndrome is a disabling disorder that has multiple implications for patients.  These implications 
include physical limitations, psychological effects, financial hardship, and stressors on support 
systems and family.  Many of these implications, particularly from a patient’s recalled 
experience about an acute episode, have not been studied fully.  This research aimed to better 
understand what the patient recalls about encounters during an acute episode of moderate to 
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severe Guillain-Barre’ syndrome and what insights could be shared with clinicians to enhance 
this care.       
 The study answered the following research questions: 
1. What are patients recalled experiences of care and caregiver interactions during an 
episode of moderate to severe Guillain-Barre' syndrome? 
2. What do patients recall about the characteristics and environmental conditions of the 
clinical area(s) where they received care? 
3. How do patients describe their change in knowledge of GBS over time from pre-
diagnosis to current time? 
Theoretical Framework and Theory Assumptions 
 Orem’s self care deficit theory of nursing was utilized to inform this study.  Orem (1995) 
supported that nurses should have qualifications to develop and deliver nursing care to patients 
who require nursing assistance.  Patients who experience a diagnosis of moderate to severe 
Guillain-Barre’ syndrome will require multiple levels of nursing care because of the physical and 
psychosocial impacts of this illness that can be devastating (Anderson, 1992).   
 Orem’s self care deficit theory of nursing is comprised of three theories:  (a) theory of 
self care, (b) theory of self care deficit and (c) the theory of nursing systems (Nursing Theories, 
2012).  Figure 1.1 illustrates the relationships between the key components of Orem’s self care 
deficit theory of nursing.  Essentially, the theory of self care is a theory that indicates that the 
term self care represents the activities that are performed by an individual, or on behalf of an 
individual, to maintain health, and the theory of self care agency is the ability to perform self 
care activities (Nursing Theories, 2012).  Orem (1985) describes three types of self care 
requisites including universal self care requisites, developmental self care requisites, and health 
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deviation self care requisites.  Universal self care requisites include the need for:  (a) air, (b) 
water, (c) food, (d) elimination, (e) activity and rest, (f) social interaction, (g) prevention of 
hazards, and (h) promotion of normalcy (Anderson, 1992).   
 
Figure 1.1. Self Care Deficit Theory  
 
Figure 1.1.  Relationship of the major components of Orem’s Self Care Deficit Theory. 
Gonzalo, A. (2011).  Theoretical Foundations of Nursing: Dorothea Orem.  Retrieved from  
http://nursingtheories.weebly.com/dorothea-e-orem.html. 
 
Because of the significance of paralysis in moderate to severe Guillain-Barre’ syndrome 
patients, universal self care requisites are not able to be met by the patient.  If an individual is not 
able to perform self care, the individual will experience a self care deficit.  Self care deficits are 
identified by nurses by conducting a comprehensive assessment (Nursing Theories, 2012).  Once 
self care deficits are identified, the nurse elects what nursing system will be required to address 
the patient’s needs.  Nursing systems include:  wholly compensatory, partly compensatory, 
and/or supportive and educative system (Nursing Theories, 2012).  Patients who are diagnosed 
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with Guillain-Barre’ syndrome will experience self care deficits and will rely on nurses to 
provide care.  Based on where the patient is at on the GBS illness trajectory, this care will come 
in the form of wholly compensatory, partly compensatory, or supportive and educative.  Nurses 
can provide the care that the patient is not able to deliver to themselves, education regarding the 
illness, as well as psychosocial support (Hudson & Macdonald, 2010).  Nurses should be 
educated as to the best practices when caring for patients with Guillain-Barre’ syndrome.  Care 
provided to Guillain-Barre’ syndrome patients will be informed by gaining a better 
understanding of the patients experience with moderate to severe Guillain-Barre’ syndrome so 
that care enhancements can be made.  The intent of Orem’s work was that it would be utilized in 
the improvement in nursing care (Cavanagh, 1991).    
Patients have reported that nurses misunderstand the needs of Guillain-Barre’ syndrome 
patients and lack the necessary knowledge to provide adequate care and relief of symptoms 
(DeCort, 2011; Uprichard, Martin & Evans, 1987).  Research is needed to better understand from 
the patient’s perspective how self-care requisites can be adequately provided by the healthcare 
team, particularly nurses. 
Definition of Terms 
 The following terms will be utilized throughout this paper and during the research study.  
The intent of this section is to provide clarity and consistency regarding definitions for each one 
of these terms. 
1.  Guillain-Barre’ syndrome – an acute autoimmune polyradiculoneuropathy with a clinical 
presentation of flaccid paralysis, areflexia, variable sensory disturbance, and elevated 
cerebrospinal fluid protein without pleocytosis.  Guillain-Barre’ syndrome is a rare, rapidly 
progressive disorder that consists of inflammation of the nerves causing muscle weakness (up to 
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and including paralysis), and is used as an umbrella term for a monophasic, post-infectious, 
immune-mediated disorder of the peripheral nervous system.  Guillain-Barre’ syndrome is 
comprised of several clinical variants including Acute Inflammatory Demyelinating 
Polyneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), Acute Motor and Sensory 
Axonal Neuropathy (AMSAN), and Miller Fisher Syndrome (MFS) which are also defined in 
Chapter Two.  Guillain-Barre’ syndrome presents at various levels of severity including mild, 
moderate, and severe cases (Asbury, 2000; Rinaldi, 2013).  For this study, participants self-
reported a diagnosis of Guillain-Barre’ syndrome (including any of the aforementioned clinical 
variants) as well as moderate to severe level of the illness severity.    
2.  Mild Guillain-Barre’ syndrome - is the point at which an illness with Guillain-Barre’ 
syndrome results in the patient being unable to ambulate without assistance (Burns, 2008) 
3.  Moderate Guillain-Barre’ syndrome – is the point at which an illness with Guillain-Barre’ 
syndrome includes paralysis of at least the lower extremities which results in the patients 
inability to ambulate (Burns, 2008) 
4.  Severe Guillain-Barre’ syndrome – is the point at which an illness with Guillain-Barre’ 
syndrome results in significant paralysis impacting respiratory musculature yielding the need for 
mechanical ventilatory support (Burns, 2008)  
5.  Patient experiences – the sum of all interactions, shaped by an organization’s (hospital’s) 
culture, that influence patient perceptions across the continuum of care (The Beryl Institute, 
2014) 
6.  Care – the services rendered by members of the health professions for the benefit of the 
patient (Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, 
2003) 
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7.  Caregiver interactions – the orchestrated touch-points of people, processes, policies, 
communication, actions, and environment (The Beryl Institute, 2014) 
8.  Knowledge level – the level of information, understanding or skill that one gets from 
experience or education; the state of being aware; the fact or condition of having information or 
being learned; the sum of what is known (Merriam-Webster Dictionary, n.d.) 
Assumptions of the Study 
 This section outlines the assumptions for this study as reflected on and identified by the 
researcher.  Participants were interviewed utilizing different interview techniques (in-person 
face-to-face interviews or technology assisted which includes electronic face-to-face interviews) 
based on the geographic distance between the researcher and participant.  The assumption is that 
both interview methods generated equitable data.  
This study utilized information obtained during interviews with participants who have a 
history of moderate to severe Guillain-Barre’ syndrome without regard for the time between the 
acute episode and the interview.  Another assumption of this study was that participants were 
able to recall their experiences during the period of time when they were receiving care for their 
illness with Guillain-Barre’ syndrome.  Studies have been performed to determine patient’s 
recall of care events while hospitalized in the intensive care unit (van de Leur et al., 2004; 
Rotondi et al., 2002).   
The assumptions for the current study were based on findings from previous research.  
Previous research shows that patients do have recall of events that cause discomfort or are 
considered stressful or bothersome.  Van de Leur et al.’s (2004) analyses suggested that there 
was a positive relationship between discomfort (related to noise, tubes and lines, test and 
treatments) and recollection of facts [(p<0.001)].  Rotondi et al.’s (2002) study concurred and 
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found that individuals who classified a care event or experience as at least moderately annoying 
had an increased likelihood of recalling that event or experience.  Rotondi et al. (2002) further 
concluded that moderate to extremely bothersome experiences were commonplace and resulted 
in stress to the patient which made recollection of these events easier.  If the patients’ experience 
could be better understood, and symptoms and stressful experiences better managed, the 
intensive care unit patient could benefit (Rotondi et al., 2002).   
For this study, participants self-reported the severity level of their illness with Guillain-
Barre’ syndrome.  The researcher provided information regarding inclusion criteria for the study 
during consent procedures, indicating that the study was for those participants who had a 
previous diagnosis of either moderate or severe Guillain-Barre’ syndrome.  The assumption was 
that by agreeing to participate in the study, participants were acknowledging that they had 
previously had a moderate to severe case of Guillain-Barre’ syndrome.     
The final assumption for this study relates to the recruitment of participants.  The 
researcher assumed that recruiting a number of participants that would allow for informational 
redundancy was achievable.  This assumption was determined based on conversations with 
leadership team members of the Guillain-Barre’ Syndrome/Chronic Inflammatory Demyelinating 
Polyneuropathy Foundation International (L. Butler, personal communication, August 26, 2014).    
Summary 
 Guillain-Barre’ syndrome is considered a rare disease impacting one to two persons per 
100,000.  This rare disease is complex due to the number of clinical variants that may present.  
This acute illness can have devastating consequences up to and including the need for 
mechanical ventilation in order for the patient to survive.  Patients who have moderate to severe 
Guillain-Barre’ syndrome are hospitalized in intensive care units in order to be monitored for 
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respiratory compromise and the need for mechanical ventilation.  In severe cases, patients 
experience total paralysis leaving them without the ability to communicate verbally or 
nonverbally.  This lack of communication impacts the nurse-patient relationship leaving the 
patient without the ability to express needs or concerns with care.  There is no available research 
in this area that evaluates the patient’s experience during this time.  In order to enhance care 
delivered to patients experiencing this illness during an acute episode of moderate to severe 
Guillain-Barre’ syndrome, research to understand better what the patient recalls about 
encounters, including caregiver interactions and the context within which the encounter 
occurred, is warranted.  The learnings gained from this study will be shared in order to educate 
patients and clinicians and otherwise enhance the care provided to patients affected by this 
illness.  By increasing nurses’ awareness of Guillain-Barre’ syndrome, and the related patient 
care management strategies for all phases of the illness, nurses will be able to provide a more 
informed and higher level of care for patients and their families impacted by this unique and 
challenging illness (Sulton, 2002).     
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Chapter Two:  Review of Literature 
The purpose of this Chapter is to provide a review of available literature on Guillain-
Barre’ syndrome.  A search of the Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) was performed utilizing “Guillain-Barre’ syndrome” and date limits between 2000 
and February 2012.  This search resulted in 497 articles.  Additional search terms were paired 
with Guillain-Barre’ syndrome to narrow the search and included patient experience (no 
articles); patient satisfaction (two articles); experience (11 articles); significance (eight articles); 
fear (one article); death (nine articles); communication (seven articles); anxiety (two articles); 
and nursing care (16 articles).  The abstracts for each of these articles were reviewed.  The search 
term pairings also included the following limits:  English language and peer reviewed articles.  
Studies specific to pediatric patients, and those focused on women who were pregnant at the time 
of their Guillain-Barre’ syndrome diagnosis, were not considered.  The results of this review of 
literature showed that research regarding diagnostic criteria and medical management of 
Guillain-Barre’ syndrome (GBS) were prevalent.  Little research exists however that investigates 
the patient’s experience during an acute episode of GBS or the nursing and supportive care 
necessary to ensure that the patient’s experience is as positive as possible.  Additional research 
was needed to better understand the Guillain-Barre’ syndrome patient’s recalled experience 
about their acute episode and the nursing and supportive care required to enhance the care 
experience.   
Guillain-Barre’ syndrome is a complex illness resulting in significant physical, 
emotional, social, and financial consequences for patients who experience this illness as well as 
their families and support systems.  The complexity of this illness, the associated sequelae 
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including tetraparesis and respiratory compromise, as well as Guillain-Barre’s classification as a 
rare disease produces extreme anxiety and fear in patients that are impacted by this disorder.   
Previous patients have revealed that the illness, and the associated paralysis, coupled with 
remaining cognitively intact, causes a feeling of terror on many levels (Anderson, 1992).  
Considering this, it is essential for clinical caregivers, and particularly nurses, to have an 
understanding of this disorder, progression of the illness, available treatments, required 
supportive care, and expected recovery in order to educate patients and their support systems 
with the goal of alleviating fear and anxiety and to enhance the patient’s care experience.   
A review of available studies revealed that little research has been done in the nursing 
literature to explore the patients recalled experience during an acute episode of Guillain-Barre’ 
syndrome.  Additional research was needed to better understand the patient’s recalled experience 
so that practicing clinical nurses and educators could become informed about this illness in order 
to enhance care provided to Guillain-Barre’ syndrome patients.  This study describes Guillain-
Barre’ syndrome patient’s recalled experiences so that nurses will better understand the 
challenges that are part of this disease from the patient’s perspective.  The information gained 
from this study will be utilized to inform nursing and supportive care.  It is anticipated that health 
professions staff and their patients will benefit from this knowledge.   
Guillain-Barre Syndrome 
Since the eradication of polio, Guillain-Barre’ syndrome is now the leading cause of 
neuromuscular paralysis in the United States (Pritchard, 2008).   Guillain-Barre syndrome is a 
disorder of the peripheral nervous system that can result in total paralysis.  The effects of 
moderate to severe Guillain-Barre’ syndrome can render a patient essentially lifeless without the 
ability to move and or communicate.  These patients require care in an Intensive Care Unit so 
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that they can be adequately monitored for disease progression and respiratory compromise.  
Patients experiencing severe Guillain-Barre’ syndrome require mechanical ventilatory support 
for survival.   
Incidence of Guillain-Barre’ Syndrome 
 The incidence of Guillain-Barre’ syndrome has been examined by researchers.  Three 
specific research articles on incidence were considered for this paper (Alshekhlee, Hussain, 
Sultan & Katirji, 2008; Chio et al., 2003; Moore & James, 1981).  The studies evaluated 
incidence of Guillain-Barre’ syndrome in the United States, Italy, and Australia.  When 
considering worldwide incidence data, rates have been reported between 0.6 and 4.0 cases per 
100,000 population (Chio et al., 2003).  In Alshekhlee’s et al. (2008) article, the United States 
National Inpatient Sample Database (NISD) data were utilized.  The results concluded, based on 
data from 2000 to 2004, that the disease incidence was stable over the study period at 1.65 to 
1.79 cases per 100,000 population (Alshekhlee et al., 2008).  McGrogan et al. (2009) performed 
a systematic literature review whereby 63 articles were reviewed to establish Guillain-Barre’ 
syndrome’s incidence that was reported to be between 1.1 to 1.8 cases per 100,000 population.  
In McGrogan’s et al. (2009) work, there appeared to be an increased number of Guillain-Barre’ 
syndrome cases in patients over the age of 50 where the incidence was reported to be between 
1.7 to 3.3 cases per 100,000 population.  Commonly the incidence of Guillain-Barre’ syndrome 
in the United States is simply stated to be between 1.0 and 2.0 cases per 100,000.  Considering 
this incidence rate, approximately 5000 individuals will be affected by Guillain-Barre’ syndrome 
in the United States annually (Kogos et al., 2005).  In a person’s lifetime, the likelihood of 
becoming ill with Guillain-Barre’ syndrome is approximately one in a 1000 (Burns, 2008; 
Meena, Khadlikar, & Murthy, 2011).   
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Phases of Guillain-Barre’ Syndrome 
 There are three distinct phases of illness in a patient who has been affected by Guillain-
Barre’ syndrome.  These phases include the:  (a) acute phase, (b) plateau phase, and (c) recovery 
phase.  The acute phase begins at the onset of the illness beginning with the first symptoms and 
continues as the symptoms worsen until clinical deterioration ceases (Anderson, 1992; Atkinson, 
Carr, Maybee, & Haynes, 2006).  Atkinson et al. (2006) reveals that the acute phase can last for 
up to four weeks and symptoms include pain, muscle weakness, and progressive paralysis that 
may involve the respiratory system.  The plateau phase begins when the symptoms have 
stabilized and the patient does not exhibit any additional new symptoms (Anderson, 1992; 
Atkinson et al., 2006).  The plateau phase can last for days but often lasts up to several weeks 
(Atkinson et al., 2006).  The final phase is the recovery phase.  This phase begins when the 
patient begins to show improvement in clinical symptoms and lasts until what is deemed 
recovery for the patient (Atkinson et al., 2006).  The rate of recovery in patients is gradual and 
quite variable (Anderson, 1992; Atkinson et al., 2006).  The recovery phase can last from weeks 
to years (Anderson, 1992; Atkinson et al., 2006).  In this phase, the patient will have axonal 
repair and remyelination of the nerves (Anderson, 1992).  Atkinson et al. (2006) indicates that 
the recovery phase is the phase where the patient begins to show functional improvement, can be 
weaned from mechanical ventilatory support (MVS), if MVS was required, and is able to utilize 
extremities that had been impacted by the illness (Atkinson et al., 2006).     
Despite patients’ clinical improvement during the recovery phase, residual deficits from 
the impact of Guillain-Barre’ syndrome can last for years after the patient regains functional 
abilities (Atkinson et al., 2006).  Researchers have investigated demographic predictors of poor 
overall recovery.  Atkinson et al. (2006) reports that these predictors include patients who are 60 
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years and older, who experience a rapid progression of the illness, patients that had axonal 
involvement versus demyelination alone, and those patients who required prolonged mechanical 
ventilatory support.  Many patients will continue to have functional deficits and not return to 
their pre-illness functional baseline (Frenzen, 2008).   
It is essential for nursing team members to have an understanding of the phases of 
Guillain-Barre’ syndrome.  Each of the phases of this illness can require different levels of 
nursing support in order to meet self-care deficit needs of the patient.  Based on the phase and 
the severity of illness, the support provided by nurses could include:  wholly compensatory care, 
partly compensatory care, and/or supportive-educative care (Anderson, 1992; Orem, 1995).  The 
knowledge that nurses gain from this research will inform their practice when caring for patients 
with this illness and lead to better education of patients impacted by this syndrome as well as 
enhanced care.              
Variants of Guillain-Barre’ Syndrome 
 Researchers now understand that the diagnosis of Guillain-Barre’ syndrome actually 
represents a set of heterogeneous illnesses that have variant immunological pathways (Pritchard, 
2008).  It is important to understand the variant, or subtype, of Guillain-Barre’ syndrome as this 
informs the clinical team about the symptoms that may be displayed by the patient.  In addition, 
an understanding of the Guillain-Barre’ syndrome variant will guide the medical management of 
the patient as well as yield information regarding the patient’s prognosis (Pritchard, 2008).  The 
subtype of Guillain-Barre’ syndrome is determined by utilizing findings from the physical exam 
as well as a determination of how the nervous system is working (Pritchard, 2008).  Subtypes are 
determined based on whether there is axonal impairment or demyelination of the nerve as well as 
the type of nerve involved, either motor, sensory, or both (Pritchard, 2008).  Researchers have 
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described several variants of Guillain-Barre’ syndrome.  The four main variants, or subtypes, 
include: (a) Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP), (b) Acute 
Motor Axonal Neuropathy (AMAN), (c) Acute Motor and Sensory Axonal Neuropathy 
(AMSAN), and (d) Miller Fisher syndrome (MFS) (McGrogan et al., 2009). 
Acute Inflammatory Demyelinating Polyradiculoneuropathy 
 Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) is what is classically 
known as Guillain-Barre’ syndrome (Asbury, 2000).  The terms Guillain-Barre’ syndrome and 
AIDP are often used synonymously.  Asbury (2000) provides information regarding Acute 
Inflammatory Demyelinating Polyradiculoneuropathy.  Acute Inflammatory Demyelinating 
Polyradiculoneuropathy can affect patients throughout the year without regard to seasonality.  
Acute Inflammatory Demyelinating Polyradiculoneuropathy impacts people in all age groups.  
Acute Inflammatory Demyelinating Polyradiculoneuropathy is responsible for greater than 90% 
of the cases of Guillain-Barre’ syndrome in North America, Europe, and Australia.  Generally 
the most common clinical presentation with AIDP involves an ascending paralysis with noted 
sensory nerve involvement.  Asbury (2000) reveals that in AIDP symptoms can appear quickly 
and result in the need for mechanical ventilatory support in as little as 48 hours.  Providers 
treating patients who are experiencing a fever at the onset of the illness should consider other 
differential diagnoses as patients with GBS are typically not febrile.  Changes in cerebrospinal 
fluid protein levels and electro-diagnostic features that indicate demyelination generally occur 
after clinical symptoms become apparent. 
Acute Motor Axonal Neuropathy and Acute Motor and Sensory Axonal Neuropathy 
  Axonal forms of Guillain-Barre’ syndrome, as opposed to the primarily demyelinating 
form (AIDP), include (a) Acute Motor Axonal Neuropathy and (b) Acute Motor and Sensory 
26 
 
Axonal Neuropathy.  Axonal forms of the syndrome were first highlighted in the literature in 
1986 (Feasby et al., 1986).  In axonal forms of Guillain-Barre’ syndrome, the immune assault 
targets the axolemma versus the Schwann cells and myelin (Meena et al., 2011).  This results in 
damage to the axon which is what causes the symptoms that the patient experiences.  Acute 
Motor Axonal Neuropathy is typically seen following an infection with Campylobacter jejuni 
and is most common in China (Asbury, 2000).  Acute Motor Axonal Neuropathy is more 
frequently seen in children and young adults and generally occurs as an epidemic during the 
summer months in rural sections of northern China (Meena et al., 2011).  Patients typically 
present with an abrupt onset of motor weakness with neck and back stiffness that resolves 
quickly (Meena et al., 2011).  Acute Motor and Sensory Axonal Neuropathy more frequently is 
seen in adults (versus children in AMAN) and is not limited to rural areas in northern China 
(Meena et al., 2011).  Cases of AMSAN have been reported in northern China as well as in 
Western countries, Japan, and Latin America (Asbury, 2000).  Acute Motor and Sensory Axonal 
Neuropathy differs from AMAN in that sensory nerves are impacted in addition to motor nerves.  
Acute Motor and Sensory Axonal Neuropathy does not have a seasonal component and is seen 
throughout the year (Meena et al., 2011). The onset of AMSAN is abrupt and the illness 
progresses quickly rendering most patients dependent on mechanical ventilatory support within 
days of the initial symptoms (Meena et al., 2011).  Acute Motor and Sensory Axonal Neuropathy 
is usually a very lengthy illness and has an associated poor prognosis (Meena et al., 2011).  
Meena et al. (2011) report that only 20 percent of patients diagnosed with AMSAN are able to 
ambulate one year after diagnosis.  Table 4 compares key features of AMAN and AMSAN 
(Meena et al., 2011). 
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Table 4 
A Comparison of Key Characteristics of Acute Motor Axonal Neuropathy (AMAN) Versus 
Acute Motor and Sensory Axonal Neuropathy (AMSAN) 
 
 AMAN AMSAN 
Seasonality More common in summer 
months 
Occurs throughout the year 
without regard to season 
 
Geography More common in rural areas 
in Northern China 
Can be found in Northern 
China but not restricted to 
rural areas; Western world 
(USA, Canada, Europe, 
Australia); Japan; Latin 
America 
 
Typical age of patient More common in children 
and young adults 
 
More common in adults 
Onset Abrupt motor weakness Abrupt onset with rapid 
progression 
 
Sensory Nerve Conduction 
Studies 
 
Normal Abnormal 
Needle Electromyography Denervating potentials seen Widespread denervation 
Note.  Adapted from “Treatment guidelines for guillain-barre’ syndrome,” by A. Meena, S. 
Khadikar, & J. Murthy, 2011, Annals of Indian Academy of Neurology, 14(S1), S73-S81.    
 
Miller Fisher Syndrome       
 Another subtype of Guillain-Barre’ syndrome is known as Miller Fisher syndrome 
(MFS).  This subtype was first described in 1956 by Dr. Charles Miller Fisher (Asbury, 2000; 
Pritchard, 2008).  As in other subtypes of Guillain-Barre’ syndrome, MFS is often preceded by 
some type of infection (Meena et al., 2011).  Patients diagnosed with MFS generally present with 
a classic clinical triad of symptoms including:  (a) ataxia, (b) areflexia, and (c) external 
ophthalmoplegia (Pritchard, 2008).  While the triad of symptoms is the most common 
28 
 
presentation, patients also can have bulbar dysfunction, ptosis, papillary abnormalities, facial 
weakness, oropharyngeal weakness, internal ophthalmoplegia, and central nervous system 
involvement (Meena et al., 2011; Pritchard, 2008).  Meena et al. (2011) report that unlike the 
other subtypes of Guillain-Barre’ syndrome, MFS typically has a shorter course and is a self-
limiting condition with good clinical outcome for the patient with ophthalmoplegia typically 
resolving in 30 to 60 days, ataxia resolving in 90 to 120 days, and achievement of pre-diagnosis 
normal activities within 180 days. 
 Because of the variations that are associated with the Guillain-Barre’ syndrome subtypes, 
it is essential for the clinical team to have an awareness of these subtypes and be educated as to 
the course of care required for patients and the potential outcomes that may be experienced.  This 
knowledge can then be shared with patients, clinical partners, and the patient’s support system in 
order to keep them informed about how the illness may progress.        
History of the Illness 
 What is now known as Guillain-Barre Syndrome was first described in 1859 by Jean 
Baptiste Octave Landry de Theizillat (Afifi, 1994; Burns, 2008; Pearce, 1997).  Landry first 
described this illness in ten patients who experienced sensory changes in the extremities and an 
ascending type of paralysis (Pearce, 1997).  In fact, Landry simply called the illness ascending 
paralysis (Pearce, 1997).  Five years after Landry wrote about ascending paralysis, Dumenil 
related what was being seen in terms of clinical presentation to pathology of the peripheral 
nerves (Pearce, 1997).  No other research was identified in the literature between Landry’s work 
and that of Guillain, Barre’, and Strohl.  Guillain, Barre’ and Strohl’s landmark work on the 
illness was conducted in 1916 when these researchers described the illness in two soldiers 
(Burns, 2008; Pearce, 1997).  The French soldiers presented with areflexia and paralysis 
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(Galloway, 2006).  Haymaker and Kernohan coined the illness Landry-Guillain-Barre’s 
syndrome (Pearce, 1997).  Their work presented information on the symptomatology and 
laboratory findings of the illness in 50 cases that resulted in the patient’s death (Burns, 2008).     
While the patients described by Landry, and those described by Guillain, Barre’, and Strohl 
presented similarly, Guillain did not believe that Landry should be included in the naming of the 
syndrome because of what he considered to be two distinct differences:  (a) poor prognosis in 
Landry’s patients as compared to better prognosis in his patients, and (b) Guillain’s collection of 
cerebrospinal fluid samples (considering confirmation of the diagnosis in Guillain, Barre, and 
Strohl’s work was related to increase levels of protein in the cerebrospinal fluid) (Afifi, 1994; 
Burns, 2008; Pearce, 1997).  Obtaining cerebrospinal fluid samples by spinal tap began in 1891, 
which was after Landry’s description of ascending paralysis and therefore justification to 
Guillain that Landry’s name should not be included in the naming of the illness (Pearce, 1997).  
Landry’s name was not included at all in Guillain, Barre, and Strohl’s 1916 article on the 
syndrome despite the similar presentation of their patients to those described by Landry (Afifi, 
1994).  Guillain, Barre and Strohl wrote another article in 1919 regarding this syndrome.  
Subsequent to this article, Strohl’s name also was eliminated from the syndrome’s name (Afifi, 
1994).  It is unclear as to the exact rationale for Strohl’s name being removed from the 
syndrome’s name; however, there are three schools of thought and include:  (a) Strohl’s youth 
only having recently graduated from his medical program, (b) Strohl’s birthplace, and (c) 
Strohl’s training as a radiologist instead of a neurologist coupled with his varied research interest 
(Afifi, 1994).  The previous changes, as described regarding the naming of this illness, have lead 
to what we now know as Guillain-Barre’ syndrome.  Guillain-Barre’ syndrome became better 
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known as an illness in the general population after an increase in the number of cases in 1976 
following influenza vaccination (Afifi, 1994). 
Preceding Illness and Risk Factors 
 Guillain-Barre’ syndrome is typically preceded by some type of infection.  In fact, studies 
show that approximately two out of three cases of GBS can be linked to a preceding infection 
(Dimachkie & Barohn, 2013; McGrogan et al., 2009; Pritchard, 2008).  Generally, the antecedent 
infection will have been recognized between two and four weeks prior to the onset of Guillain-
Barre’ syndrome (Dimachkie & Barohn, 2013).  These antecedent infections can be caused by a 
virus or bacteria.  Infections that precede Guillain-Barre’ syndrome can include:  (a) 
Campylobacter jejuni, (b) Epstein-Barr virus (EBV), (c) Cytomegalovirus (CMV), and (d) 
Human Immunodeficiency Virus (HIV), just to name a few (Dimachkie & Barohn, 2013).  
Commonly, upper respiratory infections precede Guillain-Barre’ syndrome (Dimachkie & 
Barohn, 2013).  While the strong association of antecedent infections to the onset of Guillain-
Barre’ syndrome exist, it is not necessary to screen for these illnesses prior to or once a patient 
has been diagnosed with Guillain-Barre’ syndrome (Pritchard, 2008). 
Anatomy and Physiology 
 Guillain-Barre’ syndrome impacts the peripheral nervous system.  Considering this, it is 
important to understand the normal anatomy and physiology of the peripheral nervous system.  
Knowledge of the components of the peripheral nervous system, as well as the normal anatomy 
and physiology of the peripheral nervous system, will aid in the understanding of 
pathophysiologic findings in this syndrome. 
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Normal Peripheral Nervous System Anatomy 
 Chawla (2013) provides a review of the nervous system anatomy.  There are two 
divisions of the nervous system:  central and peripheral.  The peripheral nervous system is the 
component outside of the brain and spinal cord and includes:  (a) cranial nerves, (b) spinal 
nerves, (c) peripheral nerves, and (d) neuromuscular junctions.  There are twelve cranial nerves 
and thirty-one pairs of spinal nerves.  The peripheral nervous system’s responsibility is to carry 
information to and from the central nervous system.  Nerve cells, also known as neurons, are 
made up of three major components:  the cell body, dendrites, and the axon.  Figure 2.1 presents 
the normal structure of a typical nerve cell.  Dendrites carry electrical information to the cell 
body whereas the axon carries information away from the cell body.  Dendrites of one nerve cell 
do not touch the axon of another nerve cell.  The space between nerve cells is known as the 
synapse.  The transmission of information by way of the nervous system is a complex process.  
A sensory nerve impulse, known as an action potential, is generated secondary to some sort of 
stimulus.  Dendrites are activated by an electrical stimuli which in turn sends information to the 
cell body and then to the axon.  Chawla (2013) reveals that when the action potential reaches the 
end of the axon a chemical transmitter, such as acetylcholine (ACh), moves the information 
across the synapse to the receiving dendrite of the next neuron.  Schwann cells located around 
the axon produce myelin, a lipoprotein, which creates a myelin sheath that insulates the axon 
(Atkinson et al., 2006; Chawla, 2013).  The function of the myelin sheath is to insulate the axon 
and make the process of nerve conduction more efficient by enhancing speed of transmission as 
well as allowing for information to long travel distances (Atkinson et al., 2006; Chawla, 2013).  
The myelin sheath is not continuous (Franssen & Straver, 2013).  The spaces between the 
segments of myelin sheath are known as the nodes of Ranvier (Franssen & Straver, 2013).  
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Information or signals moving from the dendrites to the axon terminals do not travel the entire 
length of the axon but rather “skip” to each of the nodes of Ranvier (Franssen & Straver, 2013).  
Insult to the myelin sheath (or the axon) disrupts the movement of the information or signal 
being transmitted through the nerve and leads to neuromuscular clinical findings such as those 
symptoms observed in Guillain-Barre’ syndrome patients (Chawla, 2013).  The area of insult, 
either the myelin sheath, the axon itself, or both, depends on the variant of Guillain-Barre’ 
syndrome that the patient experiences (Dimachkie & Barohn, 2013).   
Figure 2.1.  Neuron Key Structures      
 
Figure 2.1.  Graphic identifying key structures of a typical nerve cell (neuron).  Retrieved from  
http://training.seer.cancer.gov/brain/tumors/anatomy/neurons.html. 
Pathophysiologic Findings in Guillain-Barre’ Syndrome 
 Understanding the pathophysiology of Guillain-Barre’ syndrome is complicated (Rinaldi, 
2013).  As we see different variants within the overarching illness of Guillain-Barre’ syndrome, 
we also observe different pathophysiologic presentations.  The literature reveals 
pathophysiologic pathways that occur in Guillain-Barre’ syndrome.  These pathophysiologic 
pathways are related to the variant of Guillain-Barre’ syndrome that the patient is experiencing 
and includes:  (a) the pathophysiologic findings in the acute inflammatory demyelinating 
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polyneuropathy and Miller Fisher variants, and (b) the pathophysiologic findings in the axonal 
variants (Asbury, 2000; Atkinson et al., 2006; Burns, 2008; Galloway, 2006; Pritchard, 2008).  
Table 5 summarizes key information regarding the pathophysiology of Guillain-Barre’ syndrome 
variants (Asbury, 2000; Galloway, 2006; Leray, 2014 & Pritchard, 2008).  
Treatment and Management Options 
Currently there is not a known cure for Guillain-Barre’ syndrome.  In addition, there has 
not been a treatment identified that has definitely reduced the initial severity of the illness (Parry 
& Steinberg, 2007).  Considering this, clinical management of the syndrome is focused on 
decreasing the overall severity of the illness, providing supportive care and hastening recovery 
for patients (National Institute of Neurological Disorders and Stroke, 2011).  Atkinson et al. 
(2006) review four therapies that have been utilized in the medical management of Guillain-
Barre’ syndrome which include:  (a) corticosteroid therapy, (b) cerebrospinal fluid filtration, (c) 
plasma exchange (or plasmapheresis, PE), and (d) the administration of intravenous 
immunoglobulin (IVIg).  Information regarding treatment options is further summarized in 
Appendix A.  Additional information is needed from the patient’s perspective in order to inform 
nursing and supportive care.    
Treatment Guidelines 
Based on the studies outlined, and guidance from the American Academy of Neurology Practice 
Parameters, there are standard recommendations for the treatment of Guillain-Barre’ syndrome.  
Rapid recognition of Guillain-Barre’ syndrome is essential when considering treatment options.  
Patients typically see enhanced benefit of early therapy.  Essentially, providers should utilize 
plasmapheresis or intravenous immunoglobulin as first-line therapy (Atkinson et al., 2006; 
Dimachkie & Barohn, 2013; Pritchard, 2008).  Table 6 illustrates appropriate treatment 
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Table 5 
Subtypes of Guillain-Barre’ Syndrome and Pathophysiologic Presentations  
Subtype Electrodiagnosis Pathology Mechanisms 
Involved  
AIDP Demyelinating Initial attack on 
Schwann cell; 
widespread myelin 
damage; macrophage 
activation; lymphocytic 
infiltration 
 
T cells directed 
against myelin 
proteins 
AMAN Axonal Attack is at nodes of 
Ranvier in motor 
nerves; macrophage 
activation; few 
lymphocytes; axonal 
damage variable  
 
Antibodies directed 
against GM1, GM1b, 
GD1a, GalNAc-GD1 
AMSAN Axonal Similar to AMAN;  
includes motor and 
sensory nerves; axonal 
damage severe; myelin 
damage occurs but is 
secondary  
 
Antibodies directed 
against GM1, GM1b, 
GD1a 
MFS Demyelinating Resembles 
pathophysiology as 
found in AIDP but 
mainly affects nerves 
the oculomotor, 
trochlear, and abducens 
nerves  
Antibodies directed 
against GQ1b, GT1a 
GD3 
Note.  Svennerholm developed a nomenclature for the identification of gangliosides.  The 
nomenclature includes:  G=ganglioside; M=monosialo; D=Disialo; T=Trisialo; GaINAc=N-
acetyl galactosamine; The number (1, 2, 3) characterizes the carbohydrate sequence. 
Adapted from “The gangliosides,”  by L. Svennerholm, 1964, Journal of Lipid Research, 5, 
145 -155. 
 
guidelines utilizing immunotherapy modalities in patients with Guillain-Barre’ syndrome based 
on the patient’s ability to ambulate (Dimachkie & Barohn, 2013). 
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It is important for nurses and patients to understand that the earlier that treatment is 
initiated, the higher the likelihood of the efficacy of the treatment.  Nurses play a key role in 
educating patients and clarifying information on possible treatments.  This education has the 
potential to engage the patient in decision making as well as reducing the patient’s anxiety 
associated with the disease and the available treatment.  When a patient is not aware, or is not 
prepared, for clinical care that will be initiated, an increase stress level for the patient occurs   
(Anderson, 1992).  Murray (1993) reveals that critical elements of the provision of nursing care  
in the acute period during hospitalization is around the psychosocial element as well as a focus 
on increasing the patients’ and families knowledge level of illness.       
Table 6 
Guillain-Barre’ Syndrome Recommended Timing of Treatment Options 
Patients ability to ambulate Plasma Exchange 
(Plasmapheresis, PE) 
Administration of IVIg 
(Intravenous 
Immunoglobulin) 
 
Ambulant  PE is recommended in 
patients within two weeks of 
symptom onset (*Level B) 
 
IVIg is not recommended in 
ambulant patients  
Nonambulant PE is recommended in 
patients within four weeks of 
symptom onset (*Level A) 
IVIg is recommended in 
patients within two weeks of 
symptom onset (*Level A) 
and up to four weeks (*Level 
B) 
 
Note.  Level A evidence has good scientific support for the recommendation.  Level B 
evidence has fair scientific support for the recommendation. 
Adapted from “Guillain-barre’ syndrome and variants,” by M. Dimachkie & R. Barohn, 2013, 
Neurologic Clinics, 31(2), 491-510.   
 
Supportive and Nursing Care 
 Because Guillain-Barre’ can lead to paralysis of the respiratory musculature, this 
syndrome is considered a medical emergency (Worsham, 2000).  Nurses should feel comfortable 
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assessing GBS patients frequently to observe for changes due to the progressive nature of this 
syndrome (George, 1988; Murray, 1993; Worsham, 2000).  In order to provide prompt care for 
patients impacted by the syndrome, nurses should know the progression of the syndrome, basis 
for diagnosing and treating the illness, and the issues that GBS patients may face while 
hospitalized (Worsham, 2000).  Nurses play an essential role in providing the complex care that 
is required by GBS patients (Atkinson et al., 2006; Knight, 2011; Sulton, 2002).   
Despite the fact that exceptional nursing services, coupled with intensivists level care, are 
the mainstays of treatment for severely impacted GBS patients, little has been done in the way of 
research to better understand what improvements could be made in nursing care to enhance the 
GBS patient’s experience (Chalela, 2001).  Hughes et al. (2005) provided recommendations for 
general supportive care for patients.  A team of nine individuals met to develop these 
recommendations.  There were no nurses or Guillain-Barre’ syndrome patients represented on 
this committee.  In addition, there were no randomized controlled trials to inform this group; and 
therefore, the recommendations were based on consensus derived from observational studies and 
expert opinion (Hughes et al., 2005).   Table 7 summarizes this and other recommendations 
related to the nursing and supportive care requirements of patients with Guillain-Barre’ 
syndrome (Atkinson et al., 2006; Chalela, 2001; Haldeman & Zulkosky, 2005; Henderson, 
Lawn, Fletcher, McClelland, Wijdicks, 2003; Hughes et al., 2005; Hund, Borel, Cornblath, 
Hanley, McKhann, 1993; Sammonds, 1980; Walsh, 2006; Worsham, 2000).   
Due to the scarcity of research in nursing related to GBS, nursing care for patients with 
this illness have been based primarily on patients who experience periods of immobility and not 
specifically GBS (Murray, 1993).   Additional research is needed to better understand from the  
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Table 7 
Recommendation for Supportive and Nursing Care 
Issue Recommendations 
Deep Vein Thrombosis (DVT) 
Prophylaxis  
(in the nonambulant GBS patient) 
Administer Heparin 5000 units subcutaneously every 
12 hours  or Enoxaparin 40 mg subcutaneously daily 
 
Apply sequential compression devices or anti-
embolism stockings 
 
Continue therapies until patient is able to ambulate 
independently 
 
Cardiac and Hemodynamic 
Monitoring  
(in severely affected patients to assess 
for autonomic dysfunction which can 
occur in up to 65% of patients) 
 
Monitor blood pressure 
Monitor pulse 
Respiratory Monitoring and Airway 
Protection/Timing and Method of 
Tracheostomy 
(up to 33% of GBS patients will 
experience neuromuscular respiratory 
compromise requiring mechanical 
ventilatory support; early 
tracheostomy increases comfort for 
the patient, enhances airway safety, 
and may help in weaning)  
Monitor respiratory function (assess for the six 
predictors that suggest the need for mechanical 
ventilation including:  (1) onset of symptoms to 
admission  < 7 days; (2) inability to cough; (3) 
inability to stand; (4) inability to flex arms or head; 
(5) increase liver enzymes; (6) vital capacity 
measurement changes 
 
Provide appropriate tracheostomy care  
Utilize ventilator care bundle 
Utilize pulmonary function test ratio to estimate 
ventilator weaning, consider percutaneous 
tracheostomy placement at 2 weeks post intubation  
Attempt ventilator weaning once improvement in 
pulmonary function test 
 
Identify alternate methods of communication 
secondary to endotracheal tube and/or paralysis (i.e. 
lip reading, letter and picture boards, blinking, tongue 
click, minimal pressure activated call light, etc)  
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Table 7 
Recommendation for Supportive and Nursing Care 
Issue Recommendations 
Pain Management 
(Pain has been reported by as many as 
89% of patients with GBS of which 
50% described the pain as severe) 
Administer first line therapy:  Acetaminophen and 
nonsteroidal anti-inflammatory drugs 
 
Administer oral/parenteral opioids (required by 75% 
of patients; caution related to side effects) 
 
Administer intravenous morphine 1 to 7 mg/hour 
(required by 30% of patients; use with caution)  
 
Consider tricyclic antidepressants or anticonvulsants 
Management of Bowel and Bladder 
dysfunction 
(Assess for adynamic ileus; 
constipation; bladder areflexia) 
Daily abdominal auscultation to assess bowel function 
Do not administer promotility agents in patients with 
dysautonomia 
 
Administer stool softener as ordered 
Bladder catheterization as ordered (avoid use of 
catheter for urine samples) 
 
Nutrition 
(GBS is a hypercatabolic state 
comparable to severe trauma or 
sepsis) 
Administer continuous enteral tube feedings per 
provider order (Provider should consider high-protein, 
high-calorie enteral formulas 
 
Can utilize parenteral feeding with TPN if gut not 
functioning 
 
Follow appropriate safety precautions (head of bed 
elevated, suspend feeding when patient lying supine 
for care, etc.) 
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Table 7 
Recommendation for Supportive and Nursing Care 
Issue Recommendations 
Weigh patient as ordered 
Assess for feeding residuals  
Review nutritional related lab results (i.e. serum 
albumin, total protein, etc) 
 
Rehabilitation 
(caution not to over fatigue as this can 
actually slow recovery; prolonged 
immobilization leads to reduced 
blood volume, increase incidence of 
postural hypotension, peripheral 
nerve compression, development of 
pressure sores) 
Assess for muscle shortening and development of 
contractures 
 
Therapy team should develop an individualized 
treatment plan 
 
Follow current guidelines on proper position and 
turning 
 
Consider use of tilt table 
Consider use of alternating pressure mattress overlay 
or specialty bed 
 
Management of Fatigue 
(severe fatigue persists in as many as 
80% of patients) 
 
Develop exercise program 
Future Immunizations 
 
Do not administer immunizations during the acute 
phase of the illness (an up to as long as 1 year post 
illness) 
 
If an immunization was given during the 6 weeks 
prior to GBS illness, consider risk and benefits and 
need to withhold immunization (discuss with an 
individual’s provider) 
 
Immunizations, other than as stated above, should not 
be withheld 
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patient’s perspective the care that was received during their illness with GBS and how this 
information can be utilized to inform nursing and supportive care.  
In addition to the nursing and supportive care recommendations identified in Table 7, 
intensive care unit nurses must focus on routine intensive care unit patient responsibilities but 
must also prioritize the psychosocial needs in Guillain-Barre’ syndrome patients and their 
support system (Walsh, 2006).  “Providing patients and their families with education, support, 
and the best nursing care possible will help them cope with the stress and chaos this disorder 
brings to their lives” (Worsham , 2000, p. 49).   
Patient and Family Experience 
 Patients, and their family members, who encounter GBS experience significant 
psychosocial issues (Murray, 1993).  Table 8 reveals the number and types of publications and 
studies that were found in the literature regarding the psychosocial and physical needs of 
Guillain-Barre’ syndrome patients.   
 These studies have identified that patients impacted by Guillain-Barre’ syndrome have 
expressed experiencing fear, anxiety, apprehension, vulnerability, helplessness, guilt, anger, 
annoyance, frustration, dependence, disappointment, insecurity and isolation (Bowes, 1984; 
Eisendrath et al., 1983; Forsberg et al., 2008).  Patients also revealed feeling depressed and 
reported having visual hallucinations (Eisendrath et al., 1983).  It is important for nurses/nursing 
researchers to understand these feelings and the factors contributing to them so that nursing care 
can work to ameliorate these symptoms.  
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Table 8 
Available Literature from the Patient’s Perspective 
Author(s) Date of Publication Type of 
Publication/Research 
Number of 
Participants 
 
Baier, S. & 
Schomaker, M. 
 
1986 Autobiography 1 
Bowes, D. 1984 Autobiography 1 
Eisendrath, S.,  
Zimmerman, J.,  
Matthay, M.,  
Layzer, R. & 
Dunkel, J. 
 
1983 Record Review 
Interview 
 
8 
Forsberg, A., 
Ahlstrom, G. & 
Holmqvist, L. 
2008 Interviews 
Qualitative Content 
Analysis 
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Forsberg, A.,   
de Pedro-Cuesta, 
J. & Holmqvist, 
L. 
2006 Record Review 
Interviews 
Questionnaires x 2 
Katz E-ADL Index 
Review of Computer 
Registry (utilizing a 
protocol) 
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Gregory, R. 2003 Autobiography 1 
Grove, T., Drain, 
S., Bruckner, E., 
Ryder, S., 
Weagant, L. & 
Thorndal, C. 
 
1987 Case Study 1 
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Table 8 
Available Literature from the Patient’s Perspective 
Author(s) Date of Publication Type of 
Publication/Research 
Number of 
Participants 
 
Heller, J. & 
Vogel, S. 
 
1986 Autobiography 1 
Henschel, E. 1977 & 1978 Autobiography 1 
King, E. & 
Jacobs, H.  
1971 Case Study (pediatric 
and adult patients) 
 
14 
Rice, D. 1977 Autobiography 1 
Shearn, M & 
Shearn, L. 
1986 Autobiography 2* 
(*Patient and family 
member) 
 
Uprichard, E., 
Martin, A., 
Evans, S. 
 
1987 Interviews 3 
Ventres, W. 2013 Autobiography 1 
Weiss. H., 
Rastan, V., 
Mullges, W., 
Wagner, R. & 
Toyka, K. 
2002 Interviews 49 
 
Available Resources for Patients/Families with Guillain-Barre’ Syndrome 
 Health professionals need to be aware of resources to support patients and their families 
during the acute GBS event as well as during the period of recovery.  Patients and their families 
have access to the Guillain-Barre’ Syndrome/Chronic Inflammatory Demyelinating 
Polyneuropathy Foundation International, an international organization that was founded in 1980 
by the Benson family.  The organization is an international group of 30,000 members 
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representing 182 chapters in 33 countries (www.gbs-cidp.org).  Estelle and Robert Benson 
founded the nonprofit organization in response to Robert’s illness with Guillain-Barre’ 
syndrome.  The organization was born in the Fall of 1980 with eight people who came together 
as the Guillain-Barre’ Support Group around the Benson’s dining room table.  The group grew to 
25 members in 1981 based on referrals from 32 Philadelphia hospitals.  The group registered 
with the National Health Information Clearing House and a GBS Hotline was established to field 
calls from all over the United States.  The organization grew to 100 members by 1983 and a 
medical advisory board, chaired by Dr. Asbury, was created.   
 The mission and vision of the organization is presented on the organization’s website 
(www.gbs-cidp.org).  The mission of the organization is to enhance the quality of life for those 
individuals around the world, and their support systems, who have been impacted by GBS or and 
an associated illness.  The foundation plans on achieving its mission by:  (a) “providing a 
network for all patients, their caregivers and families so that GBS (or CIDP) patients can depend 
on the Foundation for support, and reliable up-to-date information”, (b)  “providing public and 
professional educational programs [on a worldwide basis] designed to heighten awareness and 
improve the understanding and treatment of GBS, CIDP and variants”, and (c) by “expanding the 
Foundation’s role in sponsoring research and engaging in patient advocacy”.  The vision of the 
organization is that individuals who have been diagnosed with Guillain-Barre’ syndrome will 
have “convenient access to early and accurate diagnosis, appropriate and affordable treatments, 
and dependable support services”.  It is essential for healthcare providers to know about this 
important resource for patients and their support system so that this information can be shared. 
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Summary 
 Guillain-Barre’ syndrome is often a catastrophic illness in moderate and severe cases.  
Patients are often confused, anxious and fearful about the diagnosis and the path that they will 
encounter.  Because the syndrome is classified as rare, many practitioners have not had the 
opportunity to care for patients with this diagnosis.  Future research is needed in the area of 
nursing and supportive care (Henderson et al., 2003; Hughes et al., 2005) to better understand the 
GBS patient’s experience in order to educate practitioners to enhance and ensure the delivery of 
high quality patient focused care.    
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Chapter Three:  Methodology 
Introduction 
 Guillain-Barre’ syndrome is a disabling disorder that has multiple implications for 
patients.  These implications include physical limitations, psychological effects, financial 
hardship, and stressors on support systems and family.  Many of these implications, particularly 
from a patient’s recalled experience about an acute episode, have not been fully studied.  The 
purpose of this study was to gain a richer understanding of the patient’s recalled experience of an 
acute episode of moderate to severe Guillain-Barre’ syndrome.  This chapter outlines the 
methodology that was utilized in the study.  Key areas presented in this chapter include an 
overview of the research design, a description of the sample and setting, the process for data 
collection, how trustworthiness and credibility was achieved, the data analysis plan, and ethical 
considerations including the process by which participants were protected. 
Research Design 
 To achieve the stated purpose, this study utilized a qualitative descriptive research design 
with inductive content analysis.  The rationale for selecting the qualitative descriptive approach 
is that qualitative research designs, in general, equip researchers with techniques that can explore 
a participant’s view of a human problem (Creswell, 2009).  The qualitative descriptive research 
design specifically aims to provide a rich discussion of an individual’s experience keeping the 
researcher close to the data which is the participant’s own words (Neergaard et al., 2009).  The 
qualitative descriptive design was chosen for this study in order to describe the patient’s recalled 
experiences during a moderate to severe case of Guillain-Barre’ syndrome.  The major focus of 
this study was to provide a comprehensive account, in the words of the patient, of the recalled 
experience of care, caregiver interactions, patient knowledge of the illness and the environmental 
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conditions present during an acute episode of Guillain-Barre’ syndrome.  This qualitative 
descriptive research approach allowed for the description of a human problem (care during an 
acute episode of GBS) and kept the researcher close to the data.   
Qualitative descriptive design is the preferred method when a straight account of an 
experience or occurrence is the goal and this design is commonly used in practice disciplines 
including nursing (Sandelowski, 2000).  This study explored what the patient recalled about 
experiences during an acute episode of moderate to severe Guillain-Barre’ syndrome so that  
information could be gleaned and shared with educators and clinicians to enhance the care 
provided to patients affected by this syndrome.  A review of the literature as presented in 
Chapter Two reveals that few empirical studies  have addressed the patient’s recalled experience 
during an acute episode of Guillain-Barre’.  The qualitative descriptive design was chosen 
because of the significant gaps that exist in the literature related to this phenomenon.  The 
qualitative research design is ideal for studies that seek to explore the patient experience related 
to a disease or illness state where little information has been published.  Qualitative research, in 
general, encompasses designs that researchers can use to explore and describe the human 
experience with health and illness as well as care delivery and care environments (Magilvy & 
Thomas, 2009).  The research questions for this study ask “how” and “what” questions which 
allows for an emerging design (Creswell, 2009; Onwuegbuzie and Leech’s (2006).  This allowed 
the participants experiences to guide further exploration and further questions to emerge.   The 
research questions for this study provided the direction for the research design (Onwuegbuzie & 
Leech, 2006). 
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Sample and Setting 
 Determining sample size in qualitative study requires significant reflection.  Researchers 
utilizing a qualitative study design use their judgment when selecting a sample size (Munhall, 
2007; Sandelowski, 1995).  The goal in qualitative research is to reach informational redundancy 
where the researcher is not identifying any new ideas from newly interviewed participants 
(Sandelowski, 1995).   Magilvy and Thomas (2009) reveal that sample size in qualitative 
descriptive studies can range from three to twenty participants.  In light of this range, multiple 
other qualitative descriptive research studies related to patients’ encounters with an illness were 
reviewed to assess sample size (Anderson & Fagerlund, 2012; Granger, Sandelowski, Tahshjain, 
Swedberg & Eckman, 2009; Mousing & Lomborg, 2012).  Sample sizes in these studies were 13, 
12, and 11, respectively.  Considering the goal of reaching informational redundancy and a 
review of other research studies, it was anticipated that ten to twelve individuals would 
participate in this study.  The researcher was mindful throughout the research study of what data 
were collected and what the data were revealing allowing the researcher to know when enough 
participants had been interviewed to reach informational redundancy.   
Criteria for inclusion in the study were: (a) adult patients 18 years of age and older, (b) 
individuals with a prior self-identified diagnosis of moderate to severe Guillain-Barre syndrome, 
(c) individuals who were alert and oriented, (d) individuals able to respond to interview 
questions, (e) individuals with English as a primary or secondary language, and (f) those who 
were able to give informed consent.   
Exclusion criteria were individuals: (a) less than 18 years of age, (b) that were nonverbal, 
(c) without the ability to read or speak English, (d) who were currently hospitalized, and (e) with 
a diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy.          
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Study subjects were recruited after approval by a Midwestern academic medical center 
Institutional Review Board (IRB) and were purposively selected using four primary strategies.  
These strategies included:  (a) notification of the Guillain-Barre’ Syndrome/ Chronic 
Inflammatory Demyelinating Polyneuropathy Foundation International’s (GBS Foundation) 
network of members through email to advise them of the study and to ascertain their interest in 
participating, (b) announcement of the study on the GBS Foundation’s website, (c) 
announcement of the study on the GBS Foundation’s Facebook© page, and (d) snowballing (or 
networking) technique.  The combination of these four recruitment strategies allowed for 
maximum variation in participants. 
The Guillain-Barre’ Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy 
Foundation International has an extensive network of members.  Typically, these members are 
persons who have been impacted by Guillain-Barre’ syndrome (or Chronic Inflammatory 
Demyelinating Polyneuropathy but these individuals will not be utilized in this study).  Other 
members of the organization include family members of individuals who have had GBS, 
professional clinicians and lay caregivers who have provided support to an individual who has 
experienced GBS, as well as industry vendors who have developed or provided 
treatment/treatment options to patients who have experienced GBS.  Only individuals who had 
moderate to severe GBS qualified for this study.  The GBS Foundation was in support of this 
research and agreed to assist in marketing the study.  Their letter of support is included in 
Appendix B.   
The GBS membership were notified of the study through electronic email (Appendix C).  
The email letter described the study’s purpose and inclusion parameters, was written by the 
researcher, and was approved by the dissertation committee and the Foundation’s Executive 
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Director (or designee).  After all approvals had been obtained, including Institutional Review 
Board review, the email notification was sent to the GBS Foundation membership from the 
Executive Director. 
The Guillain-Barre’ Syndrome Chronic Inflammatory Demyelinating Polyneuropathy 
Foundation International was instrumental in the recruitment of participants for this study.  The 
Foundation notified potential participants of this research study by email as indicated.  
Specifically, the GBS Foundation had email addresses of interested parties located within their 
database.  The database was initiated by the Foundation in order to manage email addresses and 
other pertinent information about its members.  Maintaining the database allowed the Foundation 
to send communication to individuals that may be interested in participating.  Their members had 
already identified that they would be interested in receiving information from the Guillain-Barre’ 
syndrome/Chronic Inflammatory Demyelinating Polyneuropathy organization.  The Guillain-
Barre’ syndrome Foundation holds the membership information in a confidential manner and did 
not release any membership information from the database to the researcher.  The researcher did 
not have access to the GBS Foundation membership email list.  The GBS Foundation identified 
possible participants based on their physical address in their database.  If an interested party lived 
within a 50 mile radius of the major metropolitan area where the researcher lived, they received 
an email with the study information.   It was the potential participant’s responsibility to review 
the information and reach out via email or phone to the primary researcher.  In addition, the 
Foundation also posted the research announcement on the organization’s website as well as on 
the organization’s official Facebook page.  This opened up the study to participants regardless of 
geographic locale.   
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The researcher had also planned to use snowball sampling (chain or network) technique 
to accrue the study sample.  The snowball technique is achieved by the researcher asking 
participants to identify other potential participants (Polit & Beck, 2004).  This strategy was only 
utilized at the beginning of the study with the first two participants.  The snowballing technique 
was stopped by the researcher when it became evident based on the number of responses to the 
study’s announcement that this strategy was not going to be needed.        
In the case of this study, the researcher asked the first two participants to consider sharing 
information regarding the study with other known Guillain-Barre’ syndrome patients.  This 
request occurred at the end of the interview.  Specifically, the researcher provided the participant 
with a written notification (Appendix D) that requested the individual to share study information 
with others who they think may be interested in participating in this research.  The notification 
included directions about how potential future participants should contact the researcher.  The 
researcher reviewed the information and was clear that referral of another individual and the 
subsequent participation of the referred individual was completely voluntary.  The researcher 
used caution to ensure that the participant did not feel pressured to make a referral.  This 
technique has advantages because it connects the researcher with potential participants that the 
researcher may have not known about or had access to.  In addition, this technique can often lead 
to trust building with a potential participant more quickly since participants are referred by 
individuals that they know and have a relationship with (Polit & Beck, 2004).  Because of the 
number of interested potential participants, the snowballing strategy was discontinued early in 
the study.          
If additional participants were needed to reach informational redundancy, the researcher 
had planned on employing other recruitment strategies.  Those strategies included:  (a) 
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announcement of the study through the nationwide network of Guillain-Barre’ syndrome support 
groups with focus on the four support group chapters in Georgia and the four support group 
chapters in North Carolina (a focus on these areas secondary to distance from researcher) and (b) 
announcement of the study at medical centers in the United States that have a Guillain-Barre’ 
syndrome Center of Excellence (Appendix E).  These strategies were not utilized as the number 
of responses to the initial study announcement generated sufficient participant interest.   
Data Collection 
 Data were collected through the use of a demographic questionnaire (see Appendix F) 
and interviews.  Qualitative data were collected from participants who self-identified during the 
consent procedure that they had moderate or severe Guillain-Barre’ syndrome.  Interviews were 
collected through in-person face-to-face and electronic face-to-face interviews with the goal of 
describing the patient’s recalled experience with a moderate to severe case of Guillain-Barre’ 
syndrome.  All individual interviews were guided by a semi-structured interview guide (see 
Appendix G) that included open ended questions as well as probing questions.  Observations of 
environmental conditions and participant reactions, including nonverbal communication, during 
interviews were recorded in writing by the researcher.  Public spaces, including libraries and 
office conference rooms, were arranged for the in-person face-to-face interviews, meeting the 
participants’ need for convenience.  Persons who were prohibited by distance from meeting face- 
to-face were interviewed with online technology.        
Demographic Questionnaire 
The demographic questionnaire was created by the researcher after a review of the 
literature and consists of thirty total items.  The researcher administered the demographic 
questionnaire for the participant to complete.  For in-person face-to-face interviews, the 
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questionnaire was a typed form that required the participant to read the item or question and 
write or select the response.  For electronic face-to-face interviews, the demographic 
questionnaire was emailed to participants.  The participant recorded their responses on the 
questionnaire and returned the form electronically to the researcher.  Participants were 
encouraged to complete all demographic questionnaire items; however, the participant could 
elect to leave some item(s) blank if they did not desire to answer. 
When clarification regarding a response on the Demographic Questionnaire was needed, 
the researcher discussed this with the participant at the end of the interview.  If a response was 
unclear or an item(s) was left blank and this was discovered after the participant had left the 
interview, the researcher clarified these items later by email and/or phone contact with the 
participant.   
Semi-Structured Interview Guide 
The semi-structured interview guide used to interview study subjects was developed by 
the primary researcher after performing a review of the literature and considering professional 
encounters with patients who have experienced Guillain-Barre’ syndrome.  The guide was 
comprised of eleven questions and several probing questions dispersed throughout the tool (See 
Appendix G).  The purpose of the interview guide was to generally guide the interview similarly 
for all participants (Patton, 2002).  The interview guide was semi-structured so that the 
researcher could have flexibility with where the participant might want to take the interview.  In 
the event that the participant did not offer full and comprehensive answers to the open ended 
questions, the suggested probing questions were present for the researcher to use.  The researcher 
developed rapport with the participants explaining the process for the interview.  The goal was to 
make participants feel comfortable enough to share recollections of their experience with GBS   
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as recommended by Polit and Beck (2004).  Based on the flow of the responses from the 
participant, the researcher added additional probing and impromptu questions to delve deeper 
into a component of the participants’ experience.  When this occurred, the researcher 
documented these probes to be considered for future interviews.  Participants could have elected 
to not respond to any interview question and could have requested that the interview be paused 
or ended at any time.  This was covered with participants during the informed consent process.   
 The interviews were preferably held in-person; however, electronic face-to-face (Skype, 
Go-to-meeting, etc.) were made available based on the distance and associated travel limitations 
between the researcher and the participant.  Polit and Beck (2004) indicate that face-to-face 
interviews are the most effective method of collecting interview data and are preferred over 
telephonic interviews because of the quality of the data that can be garnered through these 
interviews.  Efforts to conduct in-person face-to-face interviews included car and plane travel to 
geographically near locations.  It was anticipated that the interviews would last 60 to 90 minutes 
with a potential follow-up communication that would last no longer than 30 minutes. The length 
of actual interviews ranged from 35 to 110 minutes.  The purpose of the follow-up 
communication was to clarify any of the participant’s responses and perform member checking.     
Data Management 
 All interviews, whether in-person or technology assisted, were digitally recorded.  Digital 
recordings were transcribed verbatim.  The transcription was verified to be completely accurate 
by comparing the typed document to the digital recording.  When transferring data via electronic 
means, such as email, a secure email system was utilized.  The researcher’s personal computer 
where any data will reside was password protected.  
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Data Analysis 
The researcher analyzed the data in this study manually.  Qualitative content analysis was 
used as the method for analyzing data obtained during this study.  Graneheim and Lundman 
(2004) report that qualitative content analysis is used in nursing research and has been applied to 
different types of data at varying levels of interpretation.  In qualitative content analysis, the 
researcher must determine the unit of analysis (Graneheim and Lundman, 2004).  For this study, 
the unit of analysis was the data obtained during one entire interview.  Each of the individual 
interviews was digitally recorded and transcribed verbatim.  Transcription of interviews took 
place after each of the interviews.  Once transcription was completed for each interview, the 
researcher listened and then re-listened to the digital recording of the interview in its entirety and 
reviewed the transcription concurrently to verify that the transcription was produced verbatim.  
After ensuring accuracy of the transcription, the researcher read and reread several times the 
entire interview to begin the data analysis process.   
The researcher began data analysis with the collection of data during the first interview.  
Transcribed interviews were read by the researcher numerous times in order to gain 
understanding of the meaning of the data.  Organizing the data and becoming immersed in it is 
an essential component of qualitative analysis (Marshall & Rossman, 2006).  The researcher 
reviewed the transcribed interviews to look for statements that revealed a central meaning.  
Graneheim and Lundman (2004) define a meaning unit as “words, sentences, of paragraphs 
containing aspects related to each other through their content and context” (p. 106).  Once these 
meaning units were identified, the researcher established a code for that segment of the data. 
Creswell (2009) describes coding as the mechanism of organizing data into categories and then 
“labeling those categories with a term [which is] often…based in the actual language of the 
55 
 
participant” (p. 186).  Codes were reviewed with the intent of creating categories.  Categories are 
segments of words and/or sentences that shared a common message (Graneheim & Lundman, 
2004).  Once these categories were established, the researcher evaluated the relationship between 
the codes and categories to determine themes that were evident in the data.  Themes are defined 
as elements of meaning that are recurrent throughout multiple interviews (Graneheim & 
Lundeman, 2004).  Throughout the process of data organization, immersion, coding, and the 
development of themes, the researcher discussed the data analysis process and findings with the 
peer debriefer, a doctorally prepared qualitative researcher who was a member of the dissertation 
committee.   
Data also were generated from the Demographic Questionnaire.  The goal of the 
responses to the demographic questionnaire items was to generally describe the participants.  
Data were compared to that found in prior studies.         
Trustworthiness of Qualitative Data 
Lincoln and Guba (1985) reveal multiple strategies that can be employed in order to 
achieve trustworthiness in qualitative research designs.  Trustworthiness is a concept that 
essentially means whether the reader of the research will find that the research produced findings 
that were noteworthy and were worthy of review (Lincoln & Guba, 1985).  The four key 
elements leading to trustworthiness include:  credibility, transferability, dependability, and 
confirmability (Lincoln & Guba, 1985).  Table 9 indicates the tactics that were utilized in this 
study to contribute to each of the key elements (Krefting, L. 1991).  
Prolonged engagement, persistent observation, member checking, peer examination, and 
triangulation were utilized to achieve credibility in this study.  The researcher for this study has 
had an interest in Guillain-Barre’ syndrome since 2005.  The researcher was serving in an 
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Table 9   
Tactics to achieve trustworthiness 
Criterion Qualitative Approach Tactics for use in this study 
Truth Value Credibility Prolonged engagement 
Persistent observation 
Member checking 
Peer examination 
Triangulation 
Applicability Transferability Thick description 
Consistency Dependability Audit trail 
Triangulation 
Neutrality Confirmability Reflexive journaling 
Triangulation 
Note.  Adapted from “Rigor in qualitative research:  The assessment of trustworthiness,” by L. 
Krefting, 1991, American Journal of Occupational Therapy, 45, 214-222. 
 
administrative leadership position in a specialty hospital where he encountered the family 
member of a patient diagnosed with Guillain-Barre’ syndrome.  Since that the time, the 
researcher has spent time reading and learning about Guillain-Barre’ syndrome and its affect and 
impact on patients and their families.  In addition, the researcher has been exposed to two clinical 
areas where Guillain-Barre’ syndrome patients have received care.  The researcher also has 
attended two International meetings focused on the education and support of patients and 
caregivers who have been impacted by Guillain-Barre’ syndrome.  The researcher has also 
traveled to multiple states to meet with participants for the in-person face-to-face interview.  The 
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researcher has also been involved in interviewing participants and the review of data for 
approximately 6 months.  This prolonged engagement and persistent observation has contributed 
to credibility in this study. 
 Member checking was utilized to ensure that the researcher understood the intended 
message from the participant.  Lincoln and Guba (1985) indicate that member checking can be 
done throughout contact with the participant as well as immediately after the interview to correct 
any misinformation or inaccurate interpretations.  This researcher reviewed key information 
obtained during the interview and clarified any questions about the data obtained immediately 
following the interview.  The researcher also reached out to participants after the interview 
session, and during the data analysis phase of the study, so that the researcher could clarify any 
questions or uncertainties about the data that were collected.      
Another strategy that was utilized to contribute to credibility was peer examination (also 
known as peer debriefing).  Lincoln and Guba (1985) define peer debriefing as “a process of 
exposing oneself to a disinterested peer in a manner paralleling an analytic session and for the 
purpose of exploring aspects of the inquiry that might otherwise remain only implicit within the 
inquirer’s mind” (p. 308).  This researcher identified a doctorally prepared nurse faculty with 
qualitative research experience to serve as a peer in the peer examination process.  The 
researcher met with the doctorally prepared nurse faculty peer, who is a member of the 
dissertation committee, on a regular and ongoing basis by phone during the data collection and 
data analysis phases of this study.  The purpose of these meetings was to establish understanding 
about what the data are saying and to ensure that themes that are emerging are being identified.   
Triangulation is useful and contributory to several areas of trustworthiness including 
credibility, dependability, and confirmability  The concept of triangulation was applied in this 
58 
 
study via multiple data sources (data retrieved from interviews, data gleaned from the literature, 
data obtained through the researcher’s written notes during interview observations, and data from 
information found at the Guillain-Barre’ Syndrome/Chronic Inflammatory Demyelinating 
Polyneuropathy Foundation International website).  Triangulation was also accomplished 
through the use of the peer debriefing technique where the primary researcher and a member of 
the dissertation committee member evaluated the data independently and then simultaneously. 
Transferability allows an individual the ability to read the results of research and 
determine if the transfer of the findings is possible in other contexts or within the same context 
during a different period of time (Lincoln & Guba, 1985).  In this study, transferability was 
achieved by providing a rich description of the study’s design and findings.  Rich description 
will allow the reader to make conclusions about the transfer of these findings.  The maximum 
variation in the participants within the sample also contributed to transferability. 
The researcher maintained an audit trail and reflexive journal to accomplish 
dependability and confirmability.  The reflexive journal was utilized throughout the research 
study.  The entries in the journal summarized the researchers thoughts initially about Guillain-
Barre’ to ensure that the researcher had an awareness of these thoughts.  Additional entries were 
made throughout, and after discussions with the peer de-briefer.  Entries included emotions that 
participants experienced during the interview, environmental conditions that the researcher 
thought were of interest, and various other points of interest to the researcher.  The researcher 
also created a log that was used throughout the study to document decisions made about data 
analysis.       
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Protection of Human Subjects/Ethical Considerations 
This research proposal was submitted to the University of Kansas Medical Center’s 
Human Subjects Committee for review and approval prior to the initiation of the study.  All 
interested potential participants received a full, written copy of the Research Consent Form 
(Appendix H) by email.  The researcher reviewed the study and informed consent with potential 
participants using the consent form as a script.  Informed consent was obtained in advance of 
participation and prior to the collection of any data.  All participants provided signed written 
consent either in person or electronically by email.  The Research Consent Form defined criteria 
for moderate and severe Guillain-Barre’ syndrome indicating that those who agree to participate 
satisfy inclusion criteria.  Participants received a copy of the Research Consent Form (Appendix 
H).  The researcher obtained a copy of the signed Research Consent Form in order to establish 
informed consent and the participant’s willingness to be part of the study.  Participants were 
identified by a pseudonym to protect their identity.  Research materials, including transcription, 
digital recordings, and any other confidential data were kept secure in a locked location by the 
researcher.  Digital recorders were securely stored by the researcher under lock and key at all 
times.  After transcription, the transcribed interviews were also stored by the researcher under 
lock and key or password protected at all times and will be maintained for a period of 15 years.  
Participants were advised that their participation in the study was completely voluntary and that 
they could discontinue their participation without fear of repercussion or consequence at any 
time.     
Summary 
 This qualitative descriptive study was utilized to answer three research questions related 
to patient’s recalled experiences of care and caregiver interactions, environmental conditions in 
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the care environment, and knowledge level about Guillain-Barre’ syndrome.  This research 
looked to better understand what the patient recalls about encounters during an acute episode of 
moderate to severe Guillain-Barre’ syndrome and what learnings could be shared with educators 
and clinicians to enhance the care provided to patients affected by this illness.    The participants 
were patients who had been previously diagnosed with moderate to severe case of Guillain-
Barre’ syndrome.  Inductive content analysis was utilized to analyze the data to establish themes.   
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Chapter Four:  Results 
 The purpose of this qualitative descriptive study was to gain a richer understanding of the 
patient’s recalled experience of an acute episode of moderate to severe Guillain-Barre’ 
syndrome.  This chapter presents the results from data collected in in-person face-to-face and 
electronic face-to-face interviews.  The five themes and 14 subthemes that emerged from the 
data are presented, including a rich description of the participants’ recollection of events and 
occurrences during their illness with Guillain-Barre’ syndrome, using their own words.   Chapter 
Four also presents a description of the 14-participant sample based on their responses to 
questions on the 30-item Demographic Questionnaire.   
Sample and Setting 
There were a total of 89 individuals who either called or emailed about participating in 
the study.  Of the 89, there were 65 females and 24 males. These numbers closely align with the 
final sample percentages for the study as noted in the following:  Interested individuals (female 
73.0%; male 27%); Sample (female 71.4%; male 28.6%).   
One person was deemed ineligible for this research study because of age.  Specifically, 
the individual was seven years old and resided in Australia.  The researcher was contacted via 
email by parents who inquired about the study.  Three other persons were deemed ineligible for 
this research study secondary to the individuals continued to require hospitalization and in one 
case was still intubated requiring mechanical ventilatory support.  Again, the researcher was 
contacted by email or phone on behalf of these individuals by members of their family.   
If individuals were deemed eligible, the researcher emailed study related information 
which included a short electronic note from the primary researcher, the formal research study 
announcement, and the Research Consent Form.  Interviews of participants began after the 
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participant signed the Research Consent Form and had a phone conversation with the researcher 
to review the Research Consent Form and field any study related questions.   
The final sample consisted of 14 participants who self-identified as having had a 
moderate to severe case of Guillain-Barre’ syndrome.  These fourteen participants were 
interviewed either in-person face-to-face or electronically face-to-face (via the Internet video 
software, Skype) between January 2015 and March 2015.  Participants were located in eight 
states including: (a) Alabama (2 participants), (b) Arizona (2 participants), (c) California 
(1participant), (d) Florida (1 participant), (e) Georgia (4 participants), (f) Mississippi (1 
participant), (g) North Carolina (2 participants), and (h) Texas (1 participant).  The researcher 
conducted nine in-person face-to-face interviews in five states including Alabama, Florida, 
Georgia, Mississippi and North Carolina.   The remaining five interviews were conducted 
electronically face-to-face utilizing Skype.     
There were 10 female and four male participants.  Participants’ ages ranged from 16 to 76 
at the onset of their illness with Guillain-Barre’ syndrome.  Twelve participants identified 
themselves as Caucasian/white, one identified as Scots/French American, and one as Hispanic 
Mexican American.  Ten of the participants were married at the onset of their illness with 
Guillain-Barre’ syndrome and four were single.  Table 10 depicts other key demographic 
information.    
Of the 14 participants, all had required hospitalization for care related to Guillain-Barre’ 
syndrome.  Participants reported being hospitalized between five and 405 days.  Table 11 
provides a summary of the number of days that participants reported being hospitalized.  Twelve 
of the 14 participants reported being admitted emergently.  Ten participants received hospital 
care in an intensive care unit.  Twelve reported that they were unable to ambulate at all while 
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two reported that they could ambulate but ambulation was significantly impacted.  Responses 
were consistent with those related to lower extremity paralysis (LEP) where 12 participants 
responded that they did have paralysis and two responded that they did not experience LEP.    
Table 10 
Participant Demographic Data 
Demographic Characteristic Response Options  
Gender Male Female 
 4 (28.6%) 10 (71.4%) 
Race Caucasian (White) Other 
 12 (85.7%) 2(14.3%) 
Marital Status at Onset of 
Illness 
Single Married 
 4 (28.6%) 10 (71.4%) 
Education High School 
Graduate 
College 
Graduate with 
Diploma 
 
College 
Graduate with 
Bachelors 
College 
Graduate with 
Masters 
 3 (21.4%) 1 (7.1%) 6 (42.9%) 4 (28.6%) 
 
Table 11 
 
Number of days spent in hospital 
 
Range of days 
 
Number of participants 
< 10 days 3 
10 – 30 days 3 
31 – 60 days 6 
61 – 90 days 0 
91 – 120 days 1 
121 – 150 days 0 
> 365 days 1 
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Table 12 presents the age of the participants at the time of their illness with GBS as well 
as their current age at the time they were completing the Demographic Questionnaire.   Their 
illness with Guillain-Barre’ syndrome occurred between the years of 1979 to 2014.   
   Table 12 
Summary of current age ranges 
Age Ranges Number Currently in Age 
Range 
 
Number in Age Range at 
Onset of GBS 
10 - 19 1 1 
20 - 29 1 2 
30 - 39 0 1 
40 -49 0 2 
50 - 59 2 3 
60 - 69 5 4 
70 -79 5 1 
Note.  GBS=Guillain-Barre’ syndrome 
Participants were queried regarding any preceding illnesses or immunizations that occurred 
before the onset of their illness with GBS.  Table 13 presents the data related to immunizations 
and illnesses.  All participants denied having any family members that had been diagnosed with 
Guillain-Barre’ syndrome.     
Themes and Subthemes 
Data from the 14 participant interviews were analyzed.  The analysis process included the 
researcher becoming immersed in the data.  This was achieved by reviewing transcripts for  
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Table 13 
Summary of data related to illnesses and immunizations that preceded participant’s diagnosis of 
Guillain-Barre’ syndrome 
 
 Yes No Unknown 
C. jejuni 0 12 2 
Other Illnesses 6 8 0 
Immunizations 7 6 1 
Note.  Participants were asked “Were you told that Campylobacter jejuni preceded your illness?; 
Were you told about any other illnesses that may have preceded your GBS, Did you have any 
immunizations within the 6 months prior to your GBS? 
C. jejuni=Campylobacter jejuni 
accuracy while listening to the digital recordings of the interviews.  The researcher listened to 
each of the recordings a minimum of two times.  The researcher verified that all interviews were 
transcribed verbatim.  The researcher then read and reread each of the transcripts several times.  
The transcripts were put into table form allowing for the identification of meaning units, codes, 
and formulated meanings.  While this process was occurring the researcher had weekly dialogue 
with a member of the dissertation committee.  The purpose of the weekly meetings was for the 
member of the dissertation committee to serve in the peer debriefing role.  Peer debriefing is 
important step to establish trustworthiness.  This process was to ensure that there was 
understanding regarding what the data were saying and to ensure that themes that were emerging 
were being identified.  From this process, five themes and 14 subthemes emerged.  Table 14 lists 
the themes and associated subthemes. 
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Table 14 
Themes and Subthemes 
Themes Subthemes 
Theme 1:  Physical manifestations of GBS ST1: “ A Strange Sensation” 
 ST2:  A Rationalizing of Symptoms 
 ST3:  “The Downward Spiral” 
 ST4:  Pain and Fatigue 
Theme 2:  Attitudes and Emotions ST5:  The “Emotional Rollercoaster” 
 ST6:  “Attitude is Everything” 
 ST7:  Seeking Independence 
 ST8:  Concerns for Others 
Theme 3:  Knowledge and Awareness ST9:  “No Earthly Idea what GBS was” 
 ST10:  A Desire for More Knowledge 
Theme 4:  The Value of Peer Contact  
Theme 5:  Care Concepts ST11:  Staff Knowledge and Available 
Information was “Remarkably Absent” 
 
 ST12:  Personalized Patient Centered Care 
 ST13:  Communication with Caregivers 
 ST14:  Impact of Achievements 
 Note.  ST=Subtheme  
 Theme 1:  Physical Manifestations of Guillain-Barre’ Syndrome 
The first theme that emerged from the data was the physical manifestations that 
participants experienced during their acute episode of a moderate to severe case of Guillain-
Barre’ syndrome.  Participants described the manifestations of physical symptoms at the 
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beginning of their illness, what they thought of these symptoms, and the subsequent progression 
of symptoms.  There were four subthemes related to physical manifestations of Guillain-Barre’ 
syndrome including: (a) “a strange sensation”, (b) a rationalizing of the symptoms, (c) “the 
downward spiral”, and (d) pain and fatigue.      
“A Strange Sensation”. 
The interviews began with a question to participants asking them to share what initially 
occurred at the beginning of their illness with a special focus on symptoms and how they felt 
during the time when they recognized physical symptoms.  Most participants described the initial 
symptoms that were manifested as strange or odd sensations or peculiar feelings. 
One participant revealed “I started feeling tingling in my feet” and “I couldn’t sleep 
because my – I just couldn’t get comfortable.  My legs are feeling weird, and they would start 
cramping up too” and “My hands are just feeling a little weird”.  As the symptoms progressed, 
this participant further stated, “So it was strange because I couldn’t feel things.  But when I could 
feel something it was – it was like extreme – multiplied”.  Another participant stated, “I had 
difficulty balancing.  And I kept getting weaker and weaker during the day.  And had, kind of, 
just unusual weird sensations”.  Another participant discussed symptoms that he experienced 
while on vacation.  He revealed that he “had been on vacation up in New England during July of 
2006.  And [that he had] noticed …when [he was] in Boston, [that he] had a little weakness in 
[his] legs when walking around, which was really odd…because [he] was in pretty darn good 
shape”.  Several participants noticed these symptoms during normally planned routine activities.  
For instance, another participant had plans to care for her grandchild while her daughter was at 
an appointment.  When awakening that morning she reported that “I couldn’t move my legs 
normally….it was like I couldn’t -- I had to sort of slide my feet.  It was like I couldn’t –couldn’t 
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pick them up…I said:  There’s just something strange going on…I can’t walk correctly”.  
Another participant said “I felt – I felt like my legs weren’t there almost”.  Yet another 
participant stated “I didn’t feel great, but in the morning I only drank coffee.  And that morning I 
thought:  Well, I’m going to drink a little bit of orange juice.  So I went to the refrigerator to get 
orange juice, and I had difficulty opening the lid.  And I thought:  That’s strange.  You know, 
just in my mind, I thought that was strange [then later]…my arm feels funny…my arm felt 
strange; and it was my left arm”.  One of the participants also described the sensations that she 
was having as an odd and strange feeling.  “I had an inkling that something was wrong because 
we were shopping for another piece of luggage.  We were getting ready to go on this trip, and I 
had a shoulder bag that I couldn’t keep the shoulder bag on my shoulder for more than 10 
seconds, and then I wanted to switch it to the other shoulder.  I thought:  That’s odd…[and then 
at work] you always have to sign your initials anytime you do anything, sign your initials, and it 
was getting difficult to sign my initials.  I thought:  Well, this is strange” and when the 
participant arrived at the hospital to be evaluated she reported that “it was like I was walking six 
inches above the floor.  It felt like I could fall at any minute.  It was a strange sensation”.  
Likewise another participant described her symptoms as strange and peculiar.  This participant 
was talking with her husband and “said to him:  It’s funny.  I have a little oval area on my left 
thigh that feels like somebody had given me a shot of Novocain.  It’s just, kind of, 
numb…peculiar”.  Later that night after going to bed, this participant awoke “about midnight, 
and…had to go to the bathroom.  So [she] got up and when [her] feet touch the tile floors, [she] 
thought:  This feels strange…[she] felt like [she] had a sock on [her] foot, which [she] 
didn’t…But I couldn’t understand why that felt so strange.”  Another participant used an analogy 
to describe her symptoms where she related the sensation in her legs to that of bugs crawling on 
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her.  She stated “a couple of days before, I was driving, and I felt like I had ants on my legs; and 
I kept reaching down trying to get them off; and there was nothing there; it was just the sensation 
of ants on my legs…I had the feeling of bugs crawling all over me”.      
A Rationalizing of Symptoms. 
When participants initially started to experience symptoms (that would later be 
recognized as the onset of Guillain-Barre’ syndrome), they tried to explain away the symptoms.  
The participants attempted to relate these symptoms to normal everyday activities and/or 
occurrences.  Participants thought that perhaps these activities and/or occurrences could have 
precipitated the symptoms that they were experiencing.  They believed that these normal 
everyday activities and experiences contributed to the manifestation of symptoms.  One 
participant discussed having a possible sinus infection prior to GBS related symptoms.  She 
sought medical evaluation and was prescribed an antibiotic.  When she experienced a tingling 
sensation in her lower extremities, she “started thinking maybe this was like a side effect of the 
medication.  So I saw the doctor on Friday, and she took some blood work.  And she told me she 
didn’t think it was the medicine, but I was pretty sure it was the medicine; so I stopped taking it”.  
“I didn’t take it very seriously.  And looking back, I don’t know what I was thinking.  That it 
would just go away.  Or if I just stopped taking the medicine, maybe it would be okay…and I 
guess since it wasn’t that bad, I just thought it would go away”.  Another participant reported 
that she had had an ear infection and had taken antibiotics as prescribed by her physician.  This 
led her to believe that her symptoms were related to the ear infection.  She “figured it was like an 
inner ear infection that had come from the earache.  I didn’t think much about it”.  Similarly 
another participant revealed that she related her symptoms to either the effects of durable 
medical equipment that she used at home or an injection that she received for back pain.  “When 
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I got up in the morning—I have a machine that sort of vibrates and helps my legs, just the blood 
start flowing—and I got off of that machine, and I could not move.  And I thought maybe the 
machine had done something, you know because it does shake the legs a lot.  So I got off of that 
machine, and I couldn’t move my legs normally.”  After talking with her son, who is a nurse, she 
also thought that it may have been related to an injection related to lumbar arthritis.  Her son 
“wanted [her] to go on to the hospital then.   And [she] said:  No.  [She] said:  I think, maybe it’s 
this shot I’ve been having in my back…So, I thought it was that, and I said:  No, I’m going to 
wait and go to the doctor on Monday”.  Another participant commented that he had been healthy 
all of his life and had never really been sick.  He revealed “I was just a beefy guy, and I had been 
since college.  But I noticed a weakness in my legs, and that’s the first time I’d ever noticed that.  
It was no big deal.  I thought: Now I’ll have to see my doctor when I get back [from vacation]”.  
Another participant related her symptoms to a busy schedule.  “I had gone to watch a movie.  I 
sat down and a few hours later, I stood up.  I was really unsteady.  I noticed some pain in my legs 
that day, but I’d been pretty busy; so I just thought it wasn’t anything to be worried about”.  
Another participant had gone to visit family in New York when she began to have symptoms.  
She indicated that “I went to New York…I’d been there approximately 10 days, and I did have 
what I would call an upper respiratory problem…I’ll preface that by saying when I go to New 
York, I always would get sick, so I did not think that was unusual for me to be that way”.  One 
participant physically was very active and she related the symptoms that she was having to all of 
the physical activity that day.  She “went to [her] usual 6 a.m. power yoga class…and then when 
[she] got home it was a beautiful spring day, and [she and her] husband…had cleaned off [their] 
screened porch:  moving furniture, mopping floors, and doing all that physical activity…and then 
[she] had some running around to do in the afternoon…that evening…attended a lecture with an 
71 
 
older friend of mine.  It was at a church.  We sat on wood pews.  And it was over at about 8 
o’clock.  And when [she] stood up, [she] went eewwhh.  [Her] back was hurting because sitting 
on [those] wooden pews…and, [she] thought:  I have hurt my back somehow doing all this stuff 
I’ve done today.  And mentally said to [herself]:  Aha…60 is catching up with me”.  Another 
participant had children and discussed her level of fatigue.  She said “I just had no energy 
whatsoever to…to do anything…Life goes on when you’re a mom”.   
“The Downward Spiral”. 
Most participants described the pace and progression of symptoms.  Generally, symptoms 
worsened during the initial period of the illness and often included pain and fatigue as well as 
other physical symptoms.  A participant said “before I was intubated, there was that slow 
progression of down – the downward spiral”.  Another participant reported that “I had to travel 
to L.A. for work, and I started getting these massive headaches the week before…I took a few 
days before to actually do some traveling [in L.A.], and I couldn’t make it very long in the day.  I 
would get to the hotel and just fall asleep. And I’d be extremely tired, and I’d get these 
headaches again”.   “Over the weekend—it got worse…I was starting to feel numbness in my 
mouth...I woke up and couldn’t feel my toes.  Like I would wiggle them whenever I woke up, 
and I couldn’t feel them; so I panicked, and we went to the hospital”.  “I feel like very quickly 
after that, I mean, maybe like two, three days in the hospital, I couldn’t walk anymore”.  “It felt 
like everything went downhill”.  Another participant described how his symptoms quickly 
progressed.  “Well, a couple of days later [after my “wicked” eye infection] get up to go to work, 
put on a pot of coffee—and I’d go to work early in the morning….and the night before I’d felt a 
tingling  in my toes, and we called the emergency room.  The doctor on duty said:  Ah, don’t 
worry about it.  Just come on in tomorrow if it’s any worse, so I woke [my wife] up and said:  
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Look, I’m going to put on some coffee, take a shower, get dressed, and I – then you can drive me 
to the hospital…and realized all of the sudden that, whoa, I’m unsteady on my legs.  And I’m 
about ready to lose my balance and I feel weak…went into kitchen, poured a cup of coffee and 
realized if I didn’t lay down on the floor, I was going to fall down…and [my wife]…called the 
ambulance”.  Yet another participant also experienced a progression in her symptoms. She 
revealed that my legs “went from a little bit of weakness overnight to, pretty much, complete 
non-being able to use them”.  Another participant discussed her progression of symptoms that 
have now led to her permanent disability.  This participant went to the physician’s office for 
care.  The physician’s office called for emergency support and transport because they felt this 
participant was having a stroke.  The participant reported that “they called the paramedics to 
come and get me and take me to the hospital.  And I’m lying on the table; three guys came in 
with their thing (backboard for transporting individuals up or down flights of stairs).  Of course, 
they have to put you on a funny kind of stretcher to get you up the steps [from the doctor’s office 
that was in the basement of this building in New York].  And it was lying there on the floor.  
And I just started to step off of the examining table – the way you would normally do – and 
when I stepped off, I just fell flat on my face in the floor.  That was on the 19th of November at 
about 3 o’clock in the afternoon.  Never stood up another day in my life.  I just – that’s how fast 
it hit me”.  One participant had a similar experience with the rapid progression of symptoms.  
She stated “that strange feeling was sort of spreading…I was losing function per hour – I mean, 
probably per minute…I was unable to do more and more as the time progressed…So, within 24 
hours, I couldn’t do anything”. 
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Pain and Fatigue. 
Most participants experienced moderate to severe pain during their illness.  Many 
described that minimal touch aggravated the pain where a few participants indicated that rubbing 
of the upper extremities actually helped with the pain.  Other treatments such as hot baths or ice 
packs were also mentioned as being effective for pain control in some patients.  Pain was a 
significant complication for most participants.  In addition to pain, participants also often 
described ongoing fatigue as part of their acute illness and also in recovery.  [My legs] “were just 
like these blocks of pain.  And I do remember my feet feeling like they were on fire…so the only 
symptoms I had were weakness and pain at first”.  A participant indicated that “anytime I would 
try to cross my arms, cross my legs, I would just be in horrible pain.  So I stayed awake all 
night…in the morning hours, I just got my husband up around 4:00, and I said:  I’ve got to go 
back to the hospital.  I said:  I am in so much pain—plus four days of not having any sleep”.   
Another participant revealed that he also experienced severe pain that required multiple 
analgesics.  “I had – when I was regaining my muscle – muscle functions, I had a lot of pain…I 
had really extreme pain in my muscles…and I had a lot of pain in my arms.   It just felt like 
somebody was pulling the muscles off.  It was excruciating pain in the arms, in particular, and in 
my face”.  Another participant described his intense pain as the feeling of muscle tearing as well.  
He stated “one morning, you know how you stretch after you wake up?  I was doing that.  And I 
can’t imagine what it would feel like to have flesh or a muscle tear, but it almost felt like there 
was some sort of tear that took place, kind of, between my shoulder blades.  Maybe just a hair 
higher than that.  And from that point on, I just kept having this pain across the top of my 
shoulders.  And it just kept getting more and more intense.  And eventually, it started to radiate 
down my arms”.  Another participant also used the term excruciating to describe her pain that 
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involved the shoulder.  “I was having pains that would start in my back and shoulder and then 
just run down my right leg; excruciating…I remember it almost like clockwork.  I would get to a 
certain part of the afternoon, and then I would – I could feel it starting, like below my shoulder 
blades…and then…it was just going to travel through my body down my right leg; and I would 
just be in constant pain.  It was very uncomfortable”.  Another participant described her pain in a 
similar fashion.  The pain “was emanating from the base of my spine, the very bottom.  And 
probably, by this time, I was feeling pain down both legs – shooting pain down both legs…[on] a 
scale to 10…I would say [my pain was a] nine…I went back to bed and I was really writhing, 
just rolling around on the bed”.   
Participants also described feelings of fatigue.  One participant said “it would take too 
much effort for me to cut my food and eat it.  So my mom would cut my food, and they would 
basically just feed it to me.  Because it took all my effort to, basically, chew; and then after I 
would eat, I would be exhausted”.  Another participant said “Just that tiredness level of whatever 
my muscles were doing, they just couldn’t do it.  Which was interesting.  And I still have 
fatigue”.  She acknowledged the staffs’ awareness of her fatigue when she stated “But they were 
very conscientious of working with me, knowing that I was extremely tired, extremely fatigued”.   
Other participants indicated that staff were not aware of the fatigue in Guillain-Barre’ syndrome 
and subsequently pushed them too hard in therapy.  One participant who went to inpatient 
rehabilitation stated “the people are very nice, but they were, sort of, of a no pain no gain 
philosophy.  And I would tell them:  That's not what works with Guillain-Barre.  And they were 
in charge.  They didn't believe me.  So I just told the doctors I wanted to get out of there.  I felt 
like I could do better at home”.  She further stated “I would say, you know, I'm exhausted by 
this.  I need to quit.  [Rehab was then] like:  Oh, just a few more steps”.     Another participant 
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said “And I was tired.  My energy level.  Actually, my energy level got worse as the time went 
by, the weeks afterwards”.  One participant also indicated that his fatigue progressively 
worsened over the course of the day.  He stated “And then as the -- like I said, the day went on 
like, you know, [I became] weaker and weaker”.  Another participant stated “I mean, I was 
really, really weak”.  A participant reflected on his fatigue during vacation before he knew that 
he would become ill with Guillain-Barre’.  He stated “I just felt a little fatigued and had to sit 
down.  That first part, when we were on vacation, usually it's [my wife] that does it.  This time it 
was me”.  One participant called this issue “the tired factor”.   
Theme 2:  Attitudes and Emotions 
The second theme centered around the attitudes and emotions that participants 
experienced during their course of illness encompasses four subthemes.   This theme illustrates 
the wide range of emotions that participants encountered; how having a positive attitude 
impacted mental well-being and was a useful coping strategy, how independence was desired, 
and how participants experiencing significant levels of personal disability had concern for their 
loved ones.  The four subthemes included:  (a) The “Emotional Rollercoaster”, (b) “Attitude is 
Everything”, (c) Seeking Independence, and (d) Concern for Others.  
“The Emotional Rollercoaster”. 
Participants described many emotions as a result of being diagnosed with GBS and the 
subsequent care that was required.  One particular participant stated in reference to the emotions 
that she encountered, “there were so many.  Frustration that I couldn’t figure out what was wrong 
with me.  Guilt because I was taking so many drugs.  There was…a not knowing what was 
wrong with me was, um, just heartbreaking.  A frustration when I fell at work, I laid in the 
doorway of my job, and I just cried”.  Another participant experienced fear when she was told 
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about her diagnosis of GBS.  She said “I had no idea what it might be.  I was scared.  I was told I 
was faking it…I felt like – honestly, I was 16 at the time, and I felt like my life was over.  I was a 
cheerleader, and I knew that was going to be over now.  And just all of the stuff was happening 
at once within a few days, and it was terrifying”.  This participant went on to say “it was just 
strong emotions through the whole thing.  I felt like for almost a year my life was an emotional 
rollercoaster because of it.  First, it was just scared, confused, mad, just really angry that this is 
happening to me.  And then in a bit there when I started, sort of, taking my first steps and doing a 
little bit more progress, it was determined and hopeful.  The fact that it happened so fast.  There 
was no warning.  It just happened.  And the fact that it was so dramatic, It was, like, the sky was 
falling all of a sudden”.   Participants also experienced fear.  “The biggest challenge was fear.  
Fear.  What’s happened to me?  Am I going to be okay?  I didn’t think I might die, but I just – 
you know, I’ve been an active person [and] I was afraid that I wouldn’t be able to do those things 
again.  Or just immediately, I was afraid I couldn’t even stand up on my own two feet, you 
know…I think that was it.  Just the fear and worry about the future”.  This participant also 
described a wide range of emotions.  “The first day as those little things were happening, I was 
just…dismayed, I guess.  You know, what’s going on?...then the emotion of fear when it 
knocked my legs out from under me.  I never had anything similar to that in my entire life.  You 
know, to be that disabled, that, or very rapidly.  Frustration.  Just because I couldn’t do…do what 
I wanted to do.  I couldn’t make my legs…motivate”.  Another participant described the wide 
range of emotions that she experienced.  She said “when I got to the hospital, [I felt] more 
curious.  What’s going on? What’s causing this?  Glad that I’d arrived someplace where 
somebody could help me.  Relieved a little bit.   I guess when I was admitted to the hospital that 
they were glad they didn’t send me home…and after the ICU experiences, I began to awake and 
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learn more about what I had.  Then, I was scared.  You know?  How was I going to earn a living?  
How was I going to…what was I going to do with myself?  You know? What if I was crippled or 
paralyzed?...those were legitimate worries.  Those were all reasonable things to be scared about”.  
Another participant also experienced a range of emotions including “initially…frightened, 
obviously.  You have no idea what is happening to you…And, so fear of the unknown.  A little 
frustrated that you can’t overcome it.  I like to work my way through things, and there’s no 
working your way through that one…Elation, I guess.  When you’re finally going to get out of 
the hospital…Anger over the care at rehab.  And anger with the doctors not being able to 
listen…doctors are amazingly poor listeners.  And gratitude.  I mean, geez.  I don’t know.  You 
know, it’s one of those times where thanks is not adequate, but it’s all you got”.  One participant 
described being upset with staff regarding the use of a fall alert monitor.  She revealed that “my 
worst experience about this was having the alarm on my bed.  And you know hearing the voice 
that come over the intercom saying:  Do not get out of bed! And to be yelled at.  I mean that’s 
the only way I can put it.  You know they weren’t really mean, but you know, being told, ‘Don’t 
get out of bed’, you know, all of the time just kind of ticked me off a little”.  A participant also 
described periods of being agitated.  She stated “I’d have a little temper tantrum—I’d call it.  Not 
seriously, but I would just in my – you know, I’d just grit my teeth and clench my fist and 
go…why did this happen to me?  I’m so tired of this! I’m so tired of this!  So, you know a little 
self-pity”.  Another participant described her emotional response that occurred secondary to the 
care that was provided to her.  She stated “when I could still walk they bathed me in the shower, 
which I thought was horribly traumatizing.  Because, you know, I was 25.  And being bathed by 
someone was, like, extremely embarrassing.  So that was, I think, the first day of, like, my 
traumatic – when I say my traumatic experience.  When I started crying like every day.  That was 
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the first day…maybe a day or two later is when I couldn’t walk.  So then they came in and gave 
me a sponge bath.  So I ranked that as even worse.  It’s just very – It felt very demeaning 
because, you know, I was still young and somebody here bathing me on my bed.  I thought it was 
terrible”.  One participant commented “Emotionally…I will always feel impaired.  I will 
always…remember who I used to be”.  This participant felt like her psychosocial needs mere not 
met.  She went on to say “the mental process of going through this illness was never addressed, 
really, except by me”. 
“Attitude is Everything”. 
Many participants discussed how maintaining a positive attitude helped them maneuver 
through the significant emotional challenges of this illness.  One participant stated “Your life 
isn’t over.  And I know it seems like it but it’s not.  It’s going to get better but your attitude is 
everything.  Your attitude will make or break this thing for you”.  Another participant stated 
“I’ve always maintained a positive outlook somehow.  I don’t know.  What else could I do?  I 
mean, all I could do was do what I could do today. And hope that tomorrow was better.  You 
know?  And I…I didn’t cry or anything, and I didn’t get depressed; I wouldn’t say that I ever 
really got depressed…I had one child, a daughter, [who] died [from a heart condition with] no 
warning…no hope.  Gone within five minutes of keeling over.  In that perspective, this wasn’t 
worse.  Guillain-Barre’ was not worse than losing my only child.  And I grieve…[having GBS] 
is grief of another kind”.  Another participant said “know that there’s a light at the end of the 
tunnel.  Another participant stated “I was depressed but I worked through that.  I likened my 
former healthy self to be a 7-foot ladder, and GBS had made me …I was now a 5-foot ladder.  I 
remembered what I used to do with those two feet that I’d lost.  All my functionality that I lost 
was in that two feet of the ladder.  That’s the best way I can express it in the fewest number of 
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words.  But my 5-foot was now normal.  Whatever’s left will be enough to have a good life”.  
Another participant said “It may not be the light that you’re hoping to see, but at least, you know 
there’s light”.    
Seeking Independence. 
 Many participants described their need for increased control and independence.  One 
participant said “I finally – I decided in my mind that I needed to create a deadline, or I needed 
to – I needed to take charge over something I obviously had not control over.  But I remember 
pushing myself up, putting my arms on the bed, and saying:  Listen, we’ve been here for, you 
know, 27 hours.  We came here looking for health care, and all you have done is talk.  I said:  If 
you don’t give me some treatment within the next three hours, we’re going to leave.   How I 
thought I was going to make good on a threat, I have no idea.  But I – I decided that was all I 
could do was give them a deadline”.  Another participant stated “occupational therapy helped me 
a lot because…it was nice to learn how to adapt, to even where I could – I could do some stuff 
by myself when I was In the hospital…being able to get into the wheelchair and brush my teeth 
in the morning was a big deal”.  Another participant stated “Well, little by little, you know things 
got better.  I mean, I can remember being so excited at home when I had to – I could actually get 
myself a cup of coffee and walk across the room without a walker…with a cane…and sit down 
in a chair, and do that all by myself.  I thought that was just …a major feat”.   
Concern for Others. 
 Several participants expressed concern for their loved ones while they were hospitalized 
with GBS.  A participant stated “But I do remember…there was – the type of beds they had for 
parents – because my mom stayed 24/7 – and I really liked the fact that she had somewhere to 
stay.  Made me feel a little bit better.  Like, almost like I wasn’t being selfish because I asked her 
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to stay.  Because she was going to be okay, too”.  Another participant was concerned for her 
husband.  She stated “I didn’t go to sleep when I first came to the hospital because my husband 
had to go to work, and I said:  No. I’m fine…I’m in the perfect place.  I said:  Go home.  There’s 
nothing you can do.”  This participant later shared “Your sisters are coming.  They’re going to 
take care of you.  That made me feel really good.  My goodness that hit a nerve [participant was 
sobbing].  I knew – they could take – they would come in there – I said:  They’re going to feed; 
they’re going to cook; they’re going to clean.  I said:  you are not going to have to do anything.  
They were doing what I couldn’t do”.  A participant also expressed concern for her husband’s 
well-being.  She stated “I was worried about my husband too, I guess.  That was a part of it.  All 
my family – I’m from a big family, but everybody lives someplace else…But as I got better, I 
worried about him and, you know, where he was getting support. 
Theme 3:  Knowledge and Awareness 
The third theme concerns the knowledge level of participants at the beginning of their 
illness and the desire that they had for additional information from caregivers and other 
resources.  The analysis of data related to knowledge and awareness of Guillain-Barre’ syndrome 
resulted in two subthemes including (a) “no earthly idea what GBS was”, and (b) a desire for 
more knowledge.      
“No earthly idea what GBS was”. 
All participants revealed that they had no knowledge of Guillain-Barre’ syndrome prior 
to their illness.   One participant stated “Nothing.  Before they came in and said the words GBS, 
Guillain-Barre’, I had never heard of it”.  One participant stated “Zero.  I’m sure that I had been 
asked every time I got a flu shot if I’d ever had it, and I said no because I probably didn’t even 
know how to pronounce it.  In fact, I had to have people write it down for me.  I remember when 
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I was in ICU, just so I knew what I had”.  Another participant stated “I mean, absolutely nothing.  
I didn’t even know that it had existed, and…and even when she told me on that Monday that’s 
what they thought it was, I still thought:  No.  I don’t think that could be it.”  Another participant 
recognized the name Guillain-Barre’ syndrome but still did not have knowledge regarding what 
occurred as a result of this illness.  One participant revealed that “I think that I had heard about it 
when they talked about it sometimes in relationship to flu shots.  But that was – I had no earthly 
idea what it was”.  Another participant stated that when she heard Guillain-Barre’ syndrome that 
that was “Greek to [her]” and that it sounded like “gobble-de-goop to [her] at the time…[she 
had] never heard of it [before]”.  Another participant was a retired registered nurse.  She stated “I 
had not worked in a hospital for a number of years.  And I had never taken care of a patient with 
Guillain-Barre’…I didn’t know anything about it”.   Another participant revealed that she did not 
have an awareness of GBS and the impact that it could have on her physical function.  She stated 
“Absolutely nothing” when asked about what she knew about GBS before her diagnosis.  She 
went on further to say “And honestly, the neurologists that were filtering in during those first six 
days I was in the hospital, I wasn’t taking it too seriously”.  Another participant revealed that “I 
didn’t know a thing about Guillain-Barre’, and really we were scared of what it was.  Like I said, 
I thought, maybe, it was ALS.  And I had no idea that it was – you know that it might be 
Guillain-Barre’.  I didn’t even know what Guillain-Barre’ was”.    
A Desire for more Knowledge. 
Participants used a variety of ways to learn what Guillain-Barre’ syndrome was and what 
to expect in terms of the prognosis for this illness.  Information regarding strategies that 
participants used to increase their knowledge and awareness of Guillain-Barre’ syndrome was 
gleaned from the interview guide question where participants responded to the question, tell me 
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about how you learned about GBS after you were diagnosed with the illness.  Participants also 
commented on the value of this knowledge in terms of the outlook for the future.  One 
participant stated that she would have liked “someone who might’ve brought me or my husband 
some information about it.  Somebody who – maybe the neurologists to have taken five minutes 
to give us a little rundown on what this was…help me understand what’s happening to me.  Help 
me understand what I can expect.  Or not.”.  Another participant stated “The duty nurse – one of 
the duty nurses at …the hospital told my wife about the Guillain-Barre’ Society.  And she went 
online and requested the information.  They sent the information out”.  Another participant’s 
family helped to collect information to assist the participant and the family better understand the 
illness.  This participant’s “parents had come to stay with [her] to help [her], and [her] 
dad…contacted the CDC – Centers for Disease – and that’s where he got the 
information…and…[her] parents got [her] the book…”No Laughing Matter, “ that Joseph Heller 
had written…and my mom would read it to [her]”.  A participant’s mother also assisted her with 
researching the illness.  She stated “my mom mostly.  Because most of my – most of the 
beginning of the hospital stay, I was pretty out of it on pain medication…So, I didn’t look up 
anything.  My mom researched a bunch of stuff and tried to use that to help me to help explain 
what was going on, and to help, you know, comfort me about it”.          
Many participants commented on their use, as well as their families use, of internet based 
resources to learn about Guillain-Barre’ syndrome.  One participant stated “the Internet.  I had 
my iPad with me and my iPhone with me…my husband went home and did some research on it 
and came back and told me.  But I don’t think I was told very much by the people in the hospital.  
I don’t remember that being the place where I learned – I learned anything more than what the 
diagnosis was…I think there’s something good on Wikipedia.  I think the CDC had a good 
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explanation on their website”.  One participant stated “after I got home, of course, I got on the 
Internet, and I looked it all up.  I learned how to spell it and pronounce it and a lot about it.  And 
at one – at one point, I found a list of 25 possible causes, and it included Lyme’s Disease, and I 
don’t remember all.  But for every single one, there was a no for me”.   Another participant also 
stated that my research, “It was all online”.  Another participant stated “my daughters – my three 
daughters flew in, and they were there with my wife.  And, uh, they are all very techy, so they 
were looking up everything they could find on the Internet about it at the time”.  
Some participants did not find the information on the Internet to be helpful.  One 
participant stated “I started looking things up.  And basically, everything that we saw online was 
very negative.  So, we were just trying – I was just trying to push it aside and say this is not what 
I had.  And then all the horribly negative stuff I found online.  So it was not a very positive 
learning experience, I would say.  I really wish that there was something that just, kind of…was 
a little bit more helpful…It’s very difficult to, kind of, look forward and be like:  Oh I’m going 
to be okay”.  This participant was not opposed to utilizing the Internet for research purposes 
related to this illness but would have found it more beneficial if the information found online was 
more balanced. 
Several participants were not aware of the Guillain-Barre’ syndrome/Chronic 
Inflammatory Demyelinating Polyneuropathy Foundation International or the educational and 
advocacy resources that they have available.  One participant stated “I only learned about the 
foundation about two, or maybe three years ago through another person…who had a GBS 
diagnosis…and it was through them – they had brochures and such”.  Another participant 
discussed the value of the resources provided by the GBS/CIDP Foundation International.  She 
stated my daughter “contacted the national organization…and they must have sent [the books 
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out] fast because they sent a couple of books…and as soon as I did wake up enough to know, 
you know, who I was, she would set there and read that stuff to me out of the book.  So, that’s 
how I learned about it was from my daughter.  And what I thought, I guess, was a saving factor 
was, you know, almost everybody gets over it”.     
Many participants expressed the desire to have more information about their illness.  In 
addition, participants commented on the value of this knowledge and the impact that it had in 
terms of their future outlook.  When asked, are there things that you know now that you wished 
you would have known when you were diagnosed with GBS, one participant responded “well, 
certainly more information.  You know, what is it?  What does it do to you? And what are the – 
what’s the prognosis?  More like that”.  Another participant stated “once I had a name to what 
was going on, it was a little bit better because I could hear that you have a chance of getting 
better, you probably will get better, and it will be okay, it will all be over soon”.   
Theme 4:  The Value of Peer Contact 
The fourth theme reveals the importance of peer contact.  Participants commented on the 
value of being able to talk with an individual who had also been ill with Guillain-Barre’ 
syndrome.  This provided the participants with hope about recovery and the future.  Participants 
described that information coming from an individual who had been through the illness would 
have been perceived differently than the information coming from staff.  Information from 
individuals who had experienced GBS would have been more impactful.  A participant stated 
“I’d had a friend who she actually has been through GBS as well, and the chances of it – because 
I went to a very small school were so rare – and so she helped me a lot because she was up 
walking again”.  Another participant was actually visited by a surgeon who had been personally 
impacted by GBS and he described the benefit of this interaction and stated “I think most of the 
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information I got was from a surgeon at [the hospital] who he, himself, had Guillain-Barre’ and 
was no longer able to do surgery because of lost finger dexterity; but he was able to maintain a 
regular medical practice”.  Another participant stated “I realize now that that can be very 
beneficial to have someone who – who might’ve gone through something similar”.  Another 
participant agreed and furthered her comments by suggesting a process that would be developed 
to alert peer counselors as you would alert any other adjunctive therapy personnel.  She stated 
“wouldn’t it be nice if it would – if it was just as possible for them to have a peer counselor come 
in, or somebody like me – somebody who has had Guillain-Barre’ or has had a family member 
whose had it who could come in and give some reassurance.  I don’t think it would be possible 
for health – you know, for nursing staff necessarily to – I mean, they can’t say there should be a 
nurse in every hospital that’s had Guillain-Barre.  That would be kind of goofy. But I think a 
peer counselor ought to be offered just as readily as they’d offer Reiki or aroma therapy.  It’s 
seen as an alternative kind of health care intervention that could be really beneficial to a patient.  
I think it ought to be just – especially for a rare disorder.  And if it wasn’t readily available, I 
guess that would be just a dream, but I think it is.   I think all somebody would have to do is call 
the Guillain-Barre Foundation.  And they would have found [another GBS patient], who is [in 
my state/area]…or they would have found somebody that’s on their registry in this list and call 
them up.  Say:  Are you willing to go see somebody in the hospital?  That ought to be 
routine…peer counseling, I think, is incredibly important for something that’s a rare disorder”.  
Another participant shared similar sentiments.  He stated “If you ever have anybody in here, in 
this condition…I’d be happy to come over, and I’ll shoot the breeze for a little while.  And tell 
them, you know, you can get better, you know?  And I think if I would have heard something 
like that from somebody who had been through it, rather than a caregiver giving it to me, I think 
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it would have had a lot more impact on how I would have perceived everything.  I really do.  The 
issue [with hearing it from a caregiver] was probably a lack of credibility on my part”.  Another 
participant stated “And just trying to find out from other people’s experiences because like I said, 
the doctors, obviously, can’t tell me:  Oh.  In three weeks you’ll be fine.  Because they don’t 
know.  So we were just trying to find things – more of other people’s experiences and how 
quickly they recovered or what they did to help them recover”.  One participant had 
conversations with two GBS peers and also used online resources to connect with others who 
had had GBS.  She states “There were two people who had GBS…One was this man.  He had 
GBS and now he was working and he was back at work and we related and talked.  And the 
other one was Miss L…She still calls me every now and then.  Just came by to talk and visit with 
me.  And that was very nice, and that was – and they told me a lot about…recovery, I guess.  
Recovery was possible, you know.  That was very helpful…And it was sort of an affirmation that 
things should get better”.  This participant went on to say “And there was some sort of GBS web 
page.  I used to get on that a lot, where you could talk to other people and ask questions and hear 
what other people’s experiences were.  That was nice.  That was helpful”.  
Theme 5:  Care Concepts 
The last theme that emerged from the data was titled care concepts.  This theme reveals 
that impact that the lack of staff knowledge had on participants.  In addition, this theme presents 
information related to the concept of personalized patient centered care and communication with 
caregivers.  Finally, this theme illustrates the positive impact that accomplishing achievements 
has on participants.  The care concepts theme resulted in four subthemes including (a) staff 
knowledge and availability of information was “remarkably absent”, (b) personalized patient 
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centered care and interactions with staff, (c) communication with caregivers, and (d) impact of 
achievements. 
Staff knowledge and availability of information was “remarkably absent”.     
The majority of participants discussed the knowledge level of physicians and clinical 
staff when responding to how they learned about Guillain-Barre Syndrome.  The participants 
indicated that physicians and staff, for the most part, were not knowledgeable about this 
syndrome.  In addition, participants expected that physicians and staff would have educated them 
more on the disorder.  Some participants felt that the physician should know more than the 
nursing staff and should provide the education.  A lack of provider and staff knowledge did 
cause an uncomfortable feeling for participants.  One participant stated “You know, he’s my GP 
internist.  He’d just get the big ol’ book out, and he said:  We’ll just look for this together.  He 
was never, you know, afraid of telling you that it was something I don’t know, but I know where 
I can look”.  Another participant said “And so they [the nurses] didn’t know very much about 
Guillain-Barre’, and I remember when they gave [the IVIG] to me, they had some questions, you 
know, on how to – what, I guess the procedure was…the nurses that would always come in and 
not really understand how…to, um, administer it.  So it would have been a little bit nicer, maybe, 
if they had reviewed what to do because they got a little bit confusing”.  One participant stated 
“Well, I had a conversation with the lady that was in charge of the rehab center…And I told her, 
you know…you can’t believe when someone is in the state of mind that you are in when you’re 
in rehab.  And people come in and are going to be your caregiver for that particular shift.  And 
they know so little about your condition…I mean, if you’re going to have people dealing with 
people, they ought to have a little bit of knowledge.  So, somebody that can really speak the 
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language and somebody who can relate and connect with the patient.  I think it would be 
worthwhile…it would have certainly been a comfort to me”.   
Physicians and staff not having a working knowledge of Guillain-Barre’ syndrome was 
not comforting to other participants as well.  Another participant stated “I just wish that, um, that 
the people who were treating me had known more about it,  You know, it’s not comforting when, 
you know, a nurse walks in and said:  I didn’t know anything about it, so I had to Google it.  You 
know, I didn’t find that comforting.  And there were – there was more than one person that – that 
said they had never really heard of it”.  Another participant stated “just the knowledge.  You 
know?  The lack of knowledge.  The lack of information.  The feeling, so desperately alone and, 
and…Nobody really giving me any comfort of along the lines of what might happen or might not 
happen.  So…That I think, was remarkably absent”.   Another participant shared similar feelings 
regarding staffs’ lack of knowledge.  She stated “Doctors – you know, my biggest complaint 
about all of it is that they just that nobody knew very much about my illness.  And that, you 
know, that made me not that confident?  Whether it was – I didn’t really expect the nurses to 
know a lot.  I expected the doctors to know a little more than they did”.  She went on further to 
say “And I’d gotten to the point, you know, with even physical therapists and – if they haven’t 
seen somebody with Guillain-Barre, they don’t make an effort to do some research about it.  And 
I’m not that interested in seeing them.  You know?  I don’t think they’re that helpful…they could 
know more about Guillain-Barre, and that would have made it better for me.  And the ones that 
made an effort to do that, I particularly appreciated”.   
Other participants also indicated that it appeared that if providers knew information about 
the illness, that they still didn’t have time to share the knowledge with the participant.  One 
participant stated “I mean, the doctors – honestly, I understand that, you know, you’re doctors.  
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You’re busy in a big hospital.  But they don’t have time to sit down with you and explain exactly 
everything that is going on.   It’s just:  This is what you have.  This is sort of how it works:  And 
here’s your prognosis”.     
Despite an apparent lack of knowledge and experience dealing with Guillain-Barre’ 
patients, several participants commented that staff addressed their care needs that were related to 
the physical function impairments.  One participant stated “my hunch is that they probably didn’t 
have a lot of experience with it….they might not have been prepared…but as far as dealing with 
my disabilities, they were great.  Even if they didn’t understand what caused it themselves.  But, 
you know, to help me do the necessities”.       
Personalized patient centered care and interactions with staff. 
 Several participants identified care concerns related to the provision of care that was not 
personalized to the patient experiencing Guillain-Barre’ syndrome nor was the care patient 
centered.  One participant discussed her experience with staff regarding the use of a bedpan 
versus the bedside commode.  She revealed “I will take the bedside commode, but I will not do 
the bedpan.  So that’s really when they started telling me they were not going to move me.  
There were some [staff] during the day, and I knew who to ask for to help me do that during the 
day.  But in the evening, they basically told me they were not going to help me.  That I weighed 
too much”.  Another participant shared “The fact that my legs were so sensitive, and it felt like 
my legs were always either hot or cold; and that’s not their fault, but there weren’t enough nurses 
to keep ice packs and heating packs coming…So just limited staff…And that really saved me 
was when I get an ice pack, I felt like everything was going to be okay”.  Another participant 
also had an experience where limited staff impacted that personalized attention that he needed.  
He stated “after I got in rehab that was a totally different situation…the nursing staff was really 
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quite nice, quite professional, and very, you know, attentive; but the problem was they were 
stretched so thin.  There were so few nurses on the floor, they would hire…these nurse’s aides, 
and they couldn’t speak English; so if you wanted anything you would have to communicate 
with them through sign language mostly…and so that was a problem…[and] they would come in 
and tell me to clean my teeth, and they would set the things down in front of me, and I couldn’t 
move my arms…it was just awful”.  Another participant discussed rehabilitation concerns that 
occurred on the weekends.  She stated “I think it’s the system.  The weekends.  The long 
weekends of just waiting for the weekend to be over, and nothing really happening, in terms of 
rehab.  Not being able to…being confined to the hospital, not being able to get out in fresh air at 
all was – made me crazy.  You know, just wanted…to break out”.  Another participant reflected 
on her experience with rehabilitation and them not having an understanding of her limitations 
related to fatigue.  She revealed “I remember one day they had me riding on a bicycle…[and] a 
physical therapists [should] not push, push, pushing somebody to the point of exhaustion.  That’s 
the only mistake – I wouldn’t even say mistake.  But you know what I mean.  It’s the only big 
thing…I just think it’s set up for a different kind of rehab than what I needed”. 
 Participants also provided positive feedback regarding the care that they received from 
staff and how the care was personalized to their needs.  One participant, when discussing the 
kind of care that you need when you have GBS, described it as “It’s, kind of, like your wife 
taking care of you.   That level of attention.  That level of care”.  This participant also had 
positive comments regarding the nursing care that he received at the second hospital where he 
was transferred.  He stated “the nursing care was just absolutely unbelievably good.  I mean, I’ve 
been in a number of – I mean, I’ve never been a patient in a hospital before, but I have been, you 
know, where I’ve visited numerous people; and I had never in my life seen anything even 
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remotely approached the level of care that I got at [this second hospital].  It was fantastic – and 
the same way with the doctors, the staff, they were unbelievable.  I had the one doctor who was 
like – kind of, like my personal physician”.  This participant indicated that this physician would 
check in on him every morning and every evening before leaving the hospital.  Another 
participant stated “most of my care was ice packs and heating packs, pain medication; for the 
first day I needed help going to the restroom, but after that I wore diapers because I couldn’t get 
up.  So it was…it was a lot of helping me be a human being still…and helping me do what I 
needed to do”.  This participant went on further to say “It’s those little things the nurses do.  And 
I’m sure they do it for everyone.  But they bring you juice first thing when you wake up because 
when you’ve been their patient for three nights in a row now, and they know you like that.  
And…and when you need them, they’re there, as far as nurses go.  Another participant described 
how a nursing aide provided assistance with activities of daily living by being creative and 
efficient.  She stated “I still remember, when I am getting myself dressed, there was an aid…and 
she was the one that would help me get dressed.  So she, you know would, I’d want to put my 
undies on and pull them up, and I’d want to put my pants on and pull them up.  And she 
said…we’re going to do this a better way.  We’re going to put those undies on and the pants on, 
then we’re going to pull up one time.  And I thought:  Great idea!”.  Another participant also 
commented on the kind things that staff did.  She said “She never seemed to be bothered by 
anything we asked.  You know, I didn’t want to ask her to, like, give me a sponge bath.  She was, 
like:  Yeah, no problem.  I’ll be right back.  And then:  Oh let me warm up the bottle for you so 
that the lotion is not so – so cold.  You know, stuff like that, the small stuff, because she really 
enjoyed what she was doing”.   
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Communication with caregivers. 
 Participants experienced unsupportive communication with care providers.  One 
participant had been to the Emergency Department several times seeking relief from the back 
pain that she was encountering.  On a subsequent encounter to the emergency department “I had 
this doctor that, I swear if I could kick her, I would…you know, I’d been into the emergency 
rooms three of four times with my back pain, and she walks in and she – this is all she said to me 
was:  Well, what do you expect me to do for you?...I never saw her again after that.  That was the 
only exchange I had with her”.  Another participant described communication with a nurse.  She 
stated “An episode that happened we had one nurse – before I went into the ICU – and I actually 
asked her, I said:  Have I done something to offend you?  Are you mad at me?  She was surly.  
And she didn’t really give me an answer.  And I mentioned it later to another nurse.  And she 
said:  Well, you should report her to her supervisor.  She’ll fire her immediately.  I said:  Well, 
why don’t you do it?  [the other nurse said] It would be better coming from you.  And I thought:  
Me, in bed, unable to do anything, I’m going to make a nurse mad at me?  No way in hell I’m 
going to do that...I was not going to aggravate somebody who could – basically paranoid wise – 
come back and retaliate if she wished to.  I was in a very vulnerable position”.  One participant 
said “it seemed that everyone who came into my room [said] ‘You’re so lucky’…I heard that 
over and over again…And nobody explained what they meant by that.  And I thought:  That’s a 
cruelty joke to say that this [having GBS] is good fortune.  You know?”.  Another participant 
had a similar experience related to not finding value in being told that he would get better 
without any additional information provided.  He stated “you know, you still don’t really know 
what the name of that truck was that hit you [and] they said:  Oh don’t worry.  You’ll get better.  
Well, you know, when you’re laying there, and you can’t even scratch your nose, and you have 
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this severe pain in your arms…it’s hard to believe when somebody says – with no more 
information than that – that you’re going to be better.  I was sure they were blowing smoke at 
me.  I really was”.  Yet another participant recalled an exchange with a physician.  The physician 
had performed a nerve conduction test and he said “he did believe it was Guillain-Barre’ 
syndrome” so the participant said “So what, you know, what’s going to happen?  And he said:  
Well, you know, you might get better.  I mean he was very cavalier.  I just looked at him as just 
being – just, kind of, trying to be cute with me…This guy was just like:  Well, how long does it 
take nerves to heal?  I don’t know.  Could be this.  Could be that.  You know?  But just in not a 
very kind way, I don’t think. I really resented that”.   
 Other participants recall more positive and supportive communication that enhanced the 
participant experience.  One participant revealed that the staff “were all so sweet and 
understanding about it; and they were all willing to say:  I know it’s scary, but come on.  I’m 
going to help you”.  Another participant stated “I remember one nurse that I actually had 
conversations with.  You know?  Just everyday kind of conversations.  It wasn’t necessarily 
about GBS, but you know, just about everything in general.  And I enjoyed that.  Because I am a 
people person.  I like to talk to people, so that part I remember”.  Another participant stated, “I 
have no complaints about their demeanor or the way they approached me”.  
Impact of Achievements. 
 Participants described key milestones and achievements that they recognized as being 
significant.  Accomplishing these achievements were motivating to these participants.  One 
participant stated “getting the diagnosis to me was the – was the hallelujah part for me…and 
being able to walk again was…great.  Being able to go back to work.  That was a really great 
achievement.  The fact that, um, I could walk again -- on my own – was just amazing to me”.  
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Another participant reflected on her major achievements and recalled “When I got out of ICU 
and stayed out for an entire day…my first step on a parallel bar.  Being vertical for the first 
time…being out of the hospital…going home.  And [then] my first unassisted step in outpatient 
therapy.  It was such a big deal and I cried.  I finally realized it was going to be okay…this little 
glimmer”.  One participant stated, “learning how to swallow again.  Being able to eat without 
being afraid that I was going to, you know, kill myself.  After that…[the] first steps with your 
walker…[then] using the machine that [helped me] walk.  That was a big day...[then after a few 
days]…taken 30 steps or something like that.  So that was pretty momentous”.   Another 
participant stated, “I like the successes when we have a goal in PT and I finally was able to stand 
unassisted.  That was huge…So, succeeding in something was a feel good moment”.     
Summary 
Data were collected from a demographic questionnaire and through qualitative interviews 
with 14 participants.  These participants ranged in age from 19 to 79 and represented eight states 
most of which were southeastern states (n=10).   
Five themes with a total of 14 subthemes were identified during the data analysis process 
including (a) physical manifestations of GBS, (b) attitudes and emotions, (c) knowledge and 
awareness, (d) the value of peer contact, and (e) care concepts.  Discussion of these findings 
follows in Chapter 5. 
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Chapter Five:  Conclusions and Recommendations 
 The purpose of this study was to gain a richer understanding of the patient’s recalled 
experience of an acute episode of moderate to severe Guillain-Barre’ syndrome.  Orem’s self-
care deficit theory of nursing informed the study.  This chapter discusses the findings including 
the resulting themes and subthemes, as well as the implications for practice, healthcare provider 
education, healthcare policy, and research.  Strengths and limitations also are reviewed.  
 The sample was comprised of 14 participants.  The most recent studies indicate that the 
average age at onset of GBS is 40 years of age (Schub & Schiebel, 2014).  Individuals in this 
study had an average age of 49.2 years (range 16 – 76) indicating that this sample of patients 
were older than the average patient diagnosed with GBS.  In addition, there were more females 
than males in this study.  Some studies found in the literature suggest that males and females are 
impacted nearly equally while other research indicates that males are affected at a higher rate of 
3:2 (Schub & Schiebel, 2014).  Onset of GBS for several participants followed an antecedent 
infection which is consistent with the literature.  Of other interest, seven of the participants 
indicated that they had received an immunization in the six month period preceding their illness.  
Since the increase in the number of GBS cases in the mid 1970’s related to the influenza vaccine, 
it has been determined that there is an extremely low chance of a link between immunization and 
the development of GBS.  Schub and Schiebel (2014) report that the approximate risk of 
becoming ill with GBS after an immunization is extremely low (two cases per million).  
Participants were asked about the six months prior to becoming ill with GBS and were not asked 
about the exact date of the immunization.       
This study sought to answer three research questions:   
1. What are patients recalled experiences of care and caregiver interactions during an 
episode of moderate to severe Guillain-Barre' syndrome? 
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2. What do patients recall about the characteristics and environmental conditions of the 
clinical area(s) where they received care? 
3. How do patients describe their change in knowledge of GBS over time from pre-
diagnosis to current time?  
Research questions were addressed through description of five themes and 14 subthemes.  The 
five major themes were: (a) physical manifestations of Guillain-Barre’ syndrome, (b) attitudes 
and emotions, (c) knowledge and awareness, (d) the value of peer contact, and (e) care concepts.  
Table 14 identifies the themes and associated subthemes. Appendix J provides a table that links 
research questions, interview guide questions, and resulting themes.  The discussion includes 
information related to: (a) enhancing care of participants’ physical and psychosocial issues 
(including both acute and rehabilitative care needs); (b) implications for education including 
nursing staff, interprofessional staff, and patient education; and (c) additional implications 
including peer counseling and organizational support resources.   
Discussion 
 Providing care to individuals with a rare disease presents numerous challenges for both 
the patient and the healthcare team.  Nurses are particularly impacted because they have so much 
contact with the patient.  This study accessed the participants’ perspective so that care for GBS 
patients could be informed and enhanced.  Further discussion is organized by each of the five 
themes.    
Theme 1:  Physical Manifestations of Guillain-Barre’ Syndrome 
  Theme 1 identifies how participants described the physical manifestations of Guillain-
Barre’ syndrome, how participants initially managed these symptoms, and the symptom and 
illness progression with particular attention to pain and fatigue.  This theme addresses the first 
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research question which relates to the participants recalled experience of care and caregiver 
interactions.  Descriptions of the symptoms are similar to what is found in the literature and 
demonstrates that the clinical presentation can be varied; however, similarities exist between 
participants’ descriptions of their initial symptoms.  Despite symptom onset and variation, 
participants utilized descriptors such as strange and odd sensations as well as peculiar feelings to 
describe how they felt when symptoms first became apparent before entry into the healthcare 
system.  Participants described times when there was an increased sensitivity to touch.  Atkinson 
et al. (2006) reported similar results.  This increased sensitivity to touch often worsened pain-
related symptoms.  Participants further described tingling sensations throughout the body and 
commented that their feet felt like they were “asleep” and their legs cramped and felt weird.  
These symptoms impacted participants’ ability to sleep.   
Some described that their feet and legs would not work properly and they had to 
accommodate this by sliding their feet.  Others also described the impact on their ability to 
ambulate and described the sensation as walking “six inches off the floor”.  Another indicated 
that that their legs and feet felt like heavy blocks.  Symptoms, and their resulting impact on 
ambulation, did contribute to falls through various stages of the illness including prior to 
diagnosis at participant’s place of employment, during hospitalization, and after discharge.  
Participants also commented on the impact of symptoms on their work responsibilities.  One 
participant, employed in the healthcare field, commented on how strange her hands felt and this 
impacted her work.  It was difficult for the individual to complete her work when trying to place 
her initials on all of the related documents that required her initials.  Others experienced upper 
extremity complaints including inability to use hands and fingers to open containers.  Another 
participant also described the sensation of bugs crawling all over her.  
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These descriptions are similar to what is found in previous research.  Forsberg et al. 
(2008) described symptoms as strange sensations that included tingling, numbness, and increased 
sensitivity of touch.  Participants in that study found their symptoms equally puzzling (Forsberg 
et al. 2008).  Similar to participants in the current study, a participant described one of the 
sensations like the thickening of the soles off the feet.  This was a similar symptom as described 
by participants in the current study.  Like this study, the participants in Forsberg et al. (2008) 
study reported that these sensations impacted their ability to sleep.  Additionally, individuals in 
the Forsberg et al. (2008) study also commented that their extremities, particularly the feet, felt 
as if they were asleep.  As with prior research (Forsberg et al., 2008), this study also revealed 
that participants experienced balance issues including falling.  
When participants experienced these strange and odd sensations, many of them attempted 
to explain away the symptoms by relating them to normal everyday activities and/or occurrences.  
Participants thought that perhaps these activities and/or occurrences could have precipitated the 
manifestation of symptoms.  The activities and occurrences included minor illnesses and very 
active busy days.  In addition, because symptoms appeared at or around the time of minor illness, 
participants approached these strange sensations without much caution.  The reason for lack of 
caution was because participants related the symptoms to the commonly known minor illness, 
such as sinusitis or ear infection, that generally would not have long-term negative sequelae.  
One participant related her symptoms to possible effects of durable medical equipment.  
Forsberg et al. (2008) found similar results where participants either ignored their symptoms or 
related the symptoms to overworking or being tired.  Unlike previous studies, there was not 
mention in the literature that participants related symptoms to a preceding illness or to any 
durable medical equipment.   
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Participants remarked on the pace as well as the level of progression of symptoms.  All 
participants experienced a progression of symptoms eventually requiring healthcare that moved 
from these strange and odd sensations up to and including the need for mechanical ventilatory 
support.  However, participants experienced differences in the pace of this progression.  Some 
had symptoms that worsened over several days before requiring healthcare whereas some 
progressed over hours requiring emergent health care.  One participant referenced this as “the 
downward spiral”.  This was also identified in prior research.  According to Forsberg et al. 
(2008), two themes were found regarding the onset of illness including (a) a slower more 
prolonged progressive onset versus and (b) a rapid frightening presentation.  These findings of 
variable symptom progression were consistent with this current study. 
Most participants experienced pain and fatigue throughout the course of the illness and 
into recovery.  Some of the participants had pain prior to hospitalization while others 
experienced their pain after being hospitalized.  Participants described their pain as significant 
using such descriptors as horrible and excruciating.  Another descriptor that participants used 
was a burning sensation and one stated that it felt like her feet “were on fire”.  Pain was so severe 
in some cases, that one participant, for example, returned to the emergency department.  Prior to 
hospitalization, participants commented that the pain felt like muscles tearing.  Many participants 
remarked on the need for polypharmacy to reduce the pain during and after hospitalization.  
Several participants described the pain as starting in the shoulders and radiating down the arms.  
Others described pain that started in back and radiated down legs.  Participants remarked that the 
pain did impact their ability to achieve restful sleep.  While some mentioned polypharmacy as a 
strategy to reduce pain, even this was not always effective.  Participants described various 
strategies that were provided by staff to help them with their pain.  Some remarked that hot 
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packs, ice packs, and arm massages were helpful; however, others could not be touched due to 
the resultant worsening of pain.  Participants were familiar with the pain scale and one rated her 
pain as a nine on a 10 point scale.  Regardless of pain management strategies and their 
effectiveness, pain was a significant complication for most participants.  Understanding the 
unique individualized pain that GBS patients encounter is important for the healthcare team and 
impacts assessment and planning of care.  Participants reported that there were times when 
nurses did not administer medications on a schedule that best ameliorated the pain.   
Pain was also discussed in prior studies (Eisendrath et al., 1983, Forsberg et al., 2008) 
and revealed similar pain descriptions and severities.  In the study by Eisendrath et al. (1983), a 
participant also described the pain as muscles being pulled on with chains.  Many individuals in 
this study remarked on the need for improvement in pain management (Eisendrath et al., 1983). 
Generally, for those who encounter severe pain, polypharmacy will be required (Hughes et al., 
2005).  This study also reveals that multiple medications were required for pain and 
improvement in pain management strategies is needed. 
Participants also described fatigue that resulted from their illness with Guillain-Barre’ 
syndrome.  Many used the terms like low energy, feeling weak, and exhausted when describing 
their fatigue.  One participant referred to her fatigue as “the tired factor”.  Participants 
contributed their fatigue to several things including the effects of the illness itself, the resultant 
immobility, and overworking in rehabilitation, just to name a few.  Many participants noted that 
the fatigue was progressive and remarked that it continued into recovery.  Participants noted that 
their muscles just couldn’t perform and that fatigue impacted functional abilities, like eating.   
Fatigue in GBS has been reported by others (Gregory, 2003).  Fatigue is a persistent issue in 
individuals and doesn’t seem to be related to their age, the length of time that they were ill with 
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GBS, or the illness’ initial severity level (Hughes et al., 2005).  Participants reported that there 
were times when members of the healthcare team did not identify that fatigue was an issue for 
the participant.  Additionally, participants indicated that the healthcare team did not recognize 
the need to alter the plan of care related to fatigue management in GBS patients.        
Theme 2:  Attitudes and Emotions 
Theme 2 reveals the attitudes and emotions that participants experienced during their 
course of illness.  This theme addresses all three research questions related to the participants 
recalled experience of care and caregiver interactions, environmental conditions, and knowledge 
level.   Care and caregiving interactions influenced their attitudes and emotions.  Some 
interactions positively contributed to participants emotions while other did not.  Participants also 
remarked on the impact of environmental conditions and knowledge, or lack of, on their attitudes 
and emotions.  
Participants encountered a wide range of emotions as a result of being diagnosed with 
Guillain-Barre’ and the subsequent care that was required.  Participants commented that the 
emotions were strong and utilized the following terms to describe the array of emotions:  
agitation, anger, anxiety, bewilderment, confusion, curiosity, demeaning, determined, dismay, 
embarrassing, fear, frustration, guilt, hopeful, mad, scared, terrifying, traumatizing, and worry.  
Participants described being agitated about how staff communicated with them about what they 
were not allowed to do.  Participants described being angry at why this (having Guillain-Barre’ 
syndrome) was happening to them.  In addition to anger, several other emotions such as 
confusion, were experienced related to why GBS was happening.  One participant related how 
she responded to the anger like that of a temper tantrum.  She commented on how she would just 
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yell out asking “why was this happening?”.  Participants also expressed anger over care 
concerns.   
Many participants discussed experiencing fear which was multifactorial.  Participants 
encountered fear as a result of not knowing what Guillain-Barre’ syndrome was and what impact 
it was going to have on their lives; they were essentially fearful of the unknown.  A source of 
fear for participants was related to their questioning of future wage earning capabilities, as well 
as impact on other life activities, in the event that they had long term limitations in function 
related to the illness.  Participants were fearful and worried about the future.  One participant 
seemed to want to justify her emotions.  She discussed that her questions about GBS and the 
impact that it was going to have on her were “legitimate worries” and cause for being scared.   
Participants described other feelings including guilt and embarrassment.  Participants felt 
guilt over the amount of pain medication they required.  Participants also expressed guilt when 
thinking about the effect that their illness was having on family member’s well-being.   
Other participants described being embarrassed by having to have certain care, 
particularly bathing and the provision of perineal care after incontinence, that were provided.  
Participants indicated that this experience was demeaning and traumatizing.  Concepts of patient-
centered care would support developing individualized plans to support both patient 
independence and privacy.     
The emotions that were encountered in this study have been described in part previously.  
Forsberg et al. (2008) discussed the concept of fear.  There are many similarities between the 
participants’ descriptions of fear in this study as compared to previous research.  Fear is 
experienced by individuals for many reasons including:  lack of knowledge about the illness, 
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pain, communication issues related to paralysis or ventilation, and becoming dependent, just to 
name a few (Atkinson et al., 2006). 
Participants did describe how healthcare team members provided information about their 
illness and how this made them feel.  Essentially, providers advised the participant that recovery 
was most likely but didn’t provide supporting information regarding how this improvement 
would happen or the anticipated timeframe.  Participants felt like providers sharing that they 
would improve, but not substantiating this with additional information, negatively impacted their 
attitudes and emotions.  
Emotional challenges also were apparent secondary to a loss of independence.  All 
severities of Guillain-Barre’ syndrome impact an individual’s physical functioning.  Naturally, 
the more severe the case of GBS, the more physical functioning is impaired.  Participants 
described a need for increased control and independence.  Individuals desired the need to control 
their bodies and/or their environment and were excited and motivated when this was possible. 
According to Weiss et al. (2002), individuals with GBS express emotional distress.  This 
distress manifests itself in different ways.  Participants in the previous research experienced 
anxiety, stress, depression, hopelessness, and insecurities (Weiss et al, 2002).  Participants in this 
study indicated the value of positive staff interaction in impacting their outlook.     
However, many participants in this study also expressed positive feelings such as 
determination, elation, and hopefulness.  The feeling of being determined and being hopeful was 
experienced by participants who had started to see improvements in the functional abilities or 
those that began to accomplish goals and achieve milestones.  Many participants were excited to 
be leaving the hospital and one described it as a feeling of “elation”.  More than one participant 
indicated that GBS had changed their lives making them appreciate the small things in life.  One 
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even stated that GBS had “been a good thing for” her.  The impact of Guillain-Barre’ syndrome 
is dramatic and because of the pace of new onset functional impairment, individuals will 
experience a flood of emotions.  The positive feelings experienced by patients with GBS have 
not been fully presented in the literature.      
Considering the vast emotional component of this illness, participants described coping 
strategies.  Many participants used the power of a positive attitude to manage their emotions.  
Participants recognized that maintaining a positive attitude helped them maneuver through the 
emotional challenges of the illness.  Maintaining a positive attitude is an important and helpful 
coping strategy.  A positive attitude allowed participants to have hope and believe that the next 
day would be better.  Participants shared that a positive attitude allowed them to see that there 
was “light at the end of the tunnel” and that despite having Guillain-Barre’ syndrome and any of 
the potential long-term functional impairment, “a good life” was possible.  The participants who 
described having positive attitudes did this independently and there was no mention of mental 
health professionals being part of the care received.   
 Despite the significant emotional and physical burden of moderate to severe GBS, several 
participants expressed a concern for their spouses or parents while they were hospitalized.   This 
concern was in relation to the comfort of the family member in the hospital room as well as 
where family was receiving support since the patient was not able to provide it.  In addition to 
participants expressing concern for their loved ones, many of them also expressed appreciation 
for their family’s presence while they were hospitalized.  For many, GBS and hospitalization 
resulted in families being close by and care came from family as well.  There was also an 
appreciation for the family members serving in an advocacy role for the participant.  This was a 
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unique result of this study.  Previous research did not discuss the participants’ concerns for their 
support systems.      
 The psychosocial impact of this illness on the patient and the family as identified in this 
was significant yet little information is available about how to effectively address the 
psychosocial aspects of Guillain-Barre’ syndrome.  Care strategies outlined in the literature as 
summarized in Table 7 are generally related to the physical care requirements of the immobilized 
or paralyzed patient.  More direction is needed on how nursing staff can effectively manage the 
specific psychosocial needs of the GBS patient.  
Theme 3:  Knowledge and Awareness 
 This theme specifically relates to the third research question about the participants’ initial 
knowledge level of GBS and how this knowledge changed.  No participant had knowledge of 
Guillain-Barre’ syndrome prior to his/her illness.  Most indicated that they had never heard of the 
disorder.  A couple of participants indicated that they may have heard of GBS in relationship to 
influenza vaccination; however, they knew nothing about it.  The lack of knowledge resulted in 
some participants minimizing the potential impacts of the illness, where others were scared by it.  
Prior studies have also highlighted that participants experience a knowledge deficit regarding 
GBS (Eisendrath et al., 1983). 
 Most participants desired more knowledge about GBS.  Because of this, participants and 
their families used a variety of strategies to retrieve information including:  asking questions of 
physicians, accessing educational resources through the GBS/CIDP Foundation International, 
contact with the Center for Disease Control, books written by individuals who had previously 
encountered GBS, and the Internet.  The Internet was the most commonly mentioned strategy for 
obtaining information related to this illness.  Participants were not satisfied with the amount of 
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information and education that was shared with them from physicians and staff about their 
illness.  Participants’ desire for additional information has been documented.  In this and other 
studies, participants utilized the Internet, medical books, and information from physicians to 
increase their knowledge level (Forsberg et al., 2008; Gregory, 2003).  There was no discussion 
in the prior research related to lack of education from physicians and hospital staff. 
When participants received information, most commented on the value of this increased 
knowledge regarding GBS and their outlook for the future.  Many were encouraged that 
significant improvement, up to and including full recovery, was probable.  There were 
exceptions with some participants expressing concern about the information that was available 
on the Internet, such as on blogs, and found that the information was generally negative rather 
than being a more balanced message regarding what the future may hold.   
One participant mentioned concern related to the information that she received when she 
was diagnosed.  This particular participant encountered minimal symptoms in the early stages of 
her illness.  She was provided a brochure, by the neurologist, regarding GBS.  While she 
appreciated the information, there was a lack of discussion between the neurologist and the 
participant about the contents of the brochure.  Considering her initial minor symptoms, she was 
scared to learn that total paralysis, and other limitations, was possible.  In addition to the 
brochure, she desired communication with the physician concerning the information provided.  
This also was mentioned in prior research.  When participants, in earlier study, were provided 
with a comprehensive discussion of potential residual functional impairments, they were 
doubtful that they would improve (Forsberg et al., 2008).  Only a few participants mentioned 
having knowledge of, and accessing all of the available resources at, the GBS/CIDP Foundation 
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International.  This should be an area of focus for the Foundation and healthcare providers who 
care for these patients.  
Theme 4:  The Value of Peer Contact 
 Many participants recognized and discussed the importance and value of having access to 
communication with individuals who have previously had GBS.  A primary outcome of these 
conversations reported by participants was creation of hope about recovery and the future.     
Having access to peer counselors was noted to be extremely important for GBS participants, 
especially considering its classification as a rare disorder.  Participants expressed interest in 
learning from peer counselors through their stories of the path to recovery as well as the 
strategies that they utilized to help gain improvements.  Participants felt that hearing information 
from an individual who had encountered GBS would be perceived differently than when 
compared to communication coming from hospital staff.  Some participants indicated that they 
had or would be willing to volunteer as peer counselors.  One participant also mentioned that 
they had utilized an online discussion forum with peer counselors, that was available through the 
GBS/CIDP Foundation International website.  The value of peer communication was described 
previously (Gregory, 2003).  In addition, another valuable resource for individuals was GBS 
support groups (Gregory, 2003).  Support groups were not mentioned in the current study.  
According to Gregory (2003), the technique used to communicate with a peer counselor, such as 
in-person meetings, phone contact, or other electronic mechanisms, was not as important as the 
connection itself. 
Theme 5:  Care Concepts 
 Participants were queried regarding their recollection of any memorable care moments.  
Most of the participants identified both positive and negative care encounters.  The theme care 
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concepts involves the positive impacts of patient-centered care, good communication, and the 
accomplishment of milestones.  It also involves the impact of the lack of staff knowledge.   
The first component of this theme relates to the issue of staff’s lack of knowledge and the 
scarcity of information that was available to participants.  Of those participants who commented 
on physician and staff knowledge of GBS, all indicated that physicians (with the exception of 
neurologists and some of the emergency department physicians that were encountered) and staff 
were not knowledgeable about this illness.  This lack of knowledge caused participants to have 
an uncomfortable feeling and impacted their level of confidence in their care providers for 
example related to nursing procedures such as administration of intravenous immunoglobulin 
(IVIG).  Other participants mentioned that multiple caregivers, including physicians and 
interprofessional team members, indicated that they knew nothing about Guillain-Barre 
syndrome.  Another participant mentioned that a caregiver proclaimed that they knew nothing 
about the illness and had “Googled it”.  The participant commented that it was not comforting to 
know that the nurse had to “Google” the condition in order to care for her.  Many participants 
reflected on the lack of patient-centered personalized care providing examples of care related 
concerns.  Participants provided negative examples such as limited staffing, week-end issues, 
and care that lacked sensitivity to patient needs.    
In addition to the issues that were identified as concerns, participants commented on the 
positive care moments as well.  One participant related the kind of care he needed, because of his 
total dependence, to that that his wife would provide.  The care required of a totally dependent 
patient is an intimate experience.  Participants provided compliments to caregivers and used 
words like unbelievably good and fantastic to describe the care.  Participants also commented 
that staff helped them do what they needed to do which was helping them basically being human 
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still.  Participants were reflecting on the essentials that staff provided such as assistance with 
feeding, providing care after incontinence, and ensuring a secure airway.  Several participants 
also commented on and appreciated that staff were creative when caring for them including 
helping with assistive devices to make tasks easier.   
Communication between participants and caregivers was also important with participants 
describing both positive and negative communication encounters, ranging from verbal 
encounters with emergency room physicians to exchanges with nursing staff.  Of the five 
individuals who required mechanical ventilation, all commented on communication.  Participants 
indicated that they utilized communication boards, lip-reading, and specialty nurse call lights in 
order to communicate with staff.  Most of the ventilated participants indicated that 
communication was adequate but was a challenge.  One ventilated patient’s daughter created an 
effective communication board that the participant found to be very helpful in communicating 
with staff.  Current literature is replete in discussing the value of effective communication for all 
patients.  It would seem much more so, with patients with rare disorders such as GBS. 
Participants described how achieving key milestones resulted in motivation to keep 
working to improve.  Achieving key milestones and making improvements ranged in scope 
based on each individual and included:  getting the diagnosis, staying out of intensive care for 24 
hours, being able to breathe without the ventilator, learning how to swallow again, being able to 
take a step on the parallel bars, being vertical for the first time, being able to walk, being out of 
the hospital, the first unassisted step in outpatient therapy, and being able to go back to work.  
Achieving these successes was described as momentous and this made participants feel good.    
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Implications for Practice and Education 
 The following discussion includes information related to enhancing care of participants’ 
physical and psychosocial issues, including both acute and rehabilitative care needs; implications 
for education including nursing staff, interprofessional staff, and patient education; and 
additional implications including peer counseling and organizational support resources.   
Provision of nursing care for the Guillain-Barre’ syndrome patient population is 
challenging.  Individuals who experience a diagnosis of moderate to severe Guillain-Barre 
syndrome will require significant support from nurses as well as other members of the 
interdisciplinary care team during hospitalization.  The need for nursing care becomes apparent 
because individuals with GBS will encounter physical symptoms and functional impairments 
that prevent them from performing self-care activities.  Orem’s Self-care Deficit Theory supports 
this idea.  Nursing care is needed when an individual cannot perform self-care activities to meet 
their own needs (Hudson & Macdonald, 2010).  While participants generally share positive 
feedback regarding routine nursing care, the lack of the nursing team’s knowledge negatively 
impacts the GBS patient’s overall care experience.  Orem indicates that one of the 
responsibilities of the nurse is to use supportive-educative systems to assist the patient in 
obtaining requisite knowledge (Hudson & Macdonald, 2010).  Because of the rarity of this 
illness, and nurses’ limited exposure to this patient population on a regular basis, the use of the 
supportive-educative system for these individuals impacted with GBS was not evident in this 
study.  The nursing team should educate themselves on the symptoms to assess for in early GBS 
as well as the special needs of GBS patients to enhance the overall level of nursing care 
provided.   
111 
 
There are nearly 7000 recognized rare diseases in the United States (Griggs et al., 2009).  
It is not reasonable to expect nurses to have a comprehensive working knowledge of all of these 
illnesses.  However, nursing team members need to know how to access resources regarding rare 
illnesses to improve their own as well as their patient’s knowledge regarding their illness when a 
patient with a rare disease presents.  Nurses and other healthcare team members also need to 
learn more about how to communicate balanced information with GBS patients so that fear and 
anxiety can be mitigated. 
This study supports previous research demonstrating that GBS is an emotionally 
impactful illness.  A wide range of emotions are experienced and psychosocial support is 
necessary.  It is important for nurses to assess, recognize, and discuss their patients’ emotional 
symptoms with the individual themselves, their physician, and other healthcare team members to 
ensure that these psychosocial needs are part of the patient’s care plan.  Mental health clinicians 
can be utilized as a resource in this patient population to assist with the many emotions that the 
patient will experience.  In addition, it is important for patients to be linked to the GBS/CIDP 
Foundation so that a peer counselor can be identified if desired.  Many of the participants in this 
current study identified the importance of this strategy.  Being able to connect with an individual 
who has previously had GBS and recovered was particularly important for these patients.      
Pain management is another critical element in the care of the GBS population.  Twelve 
participants described having pain that is consistent with prior studies which reports that 89% of 
GBS patients experience pain.  In many cases, patient’s pain levels were not well controlled.  
Nurses need to have a working knowledge of pain management concepts in order to make 
recommendations to physicians on the patient’s behalf.  Nurses also can use their assessment 
skills to identify what strategies work for the patient.  This is important as GBS patients 
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experience pain in different ways and pharmacologic and non-pharmacologic strategies work 
differently in different individuals.  Some strategies, like massage, that are beneficial for some 
individuals cause excruciating pain for others.  Considering that GBS patients experience 
symptoms variably, nurses will need to use assessment and planning strategies to develop a 
unique personalized patient centered plan of care.  
There are a host of other care strategies that are important for physicians and nurses to 
order and implement for the GBS patient:  intravenous immunoglobulin or plasmapheresis based 
on certain clinical information; airway management, if applicable; working with rehabilitation on 
mobility; monitoring for signs and symptoms of infection, evaluating and protecting skin 
integrity, and working with dietitians regarding nutrition (Bowyer & Glover, 2010).  The plan of 
care for GBS patients will be complex and require multidisciplinary collaboration and 
communication in order to provide the patient with the best care experience possible.     
Patients with moderate to severe Guillain-Barre’ will need rehabilitation services (Hughes et al., 
2005).  Despite this need, long-term outcome studies that are related to rehab services with GBS 
participants do not exist nor do studies comparing different rehab models (Hughes et al., 2005).  
As with other neuromuscular illnesses, overworking a particular motor unit in a GBS patient can 
cause fatigue that can negatively impact recovery (Hughes et al., 2005).  Participants in this 
study commented on being overworked in rehab therapy.  Participants also described feeling that 
the model of rehab that they were exposed to was more for orthopedic illnesses versus 
neuromuscular ones.  Additional research is needed in the area of neuromuscular rehab plans.  
This work has started in Brazil where new rehab models for neurological patients are being 
studied (Jorge et al., 2015).     
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While it would not be reasonable to expect healthcare academic programs to expose 
students to the nearly 7,000 rare diseases, students ought to be introduced to resources regarding 
rare diseases and how to access these resources in the future.  This would allow for practitioners 
to search for and obtain information about rare diseases in the event that they were called to 
provide care to one of the 30 million Americans who currently have a rare condition (Rubinstein 
et al., 2010).    
 Healthcare system education departments also need to investigate how they can support 
the bedside caregiver when a patient with a rare diagnosis is admitted.  With the increase use of 
point of care technologies, an electronic strategy is feasible.  The creation of on-demand video 
educational sessions (or podcasts) for both caregivers and patients would be beneficial. These 
on–demand educational videos could educate healthcare providers as to the standard of care for 
rare disorders.  This would also meet The Joint Commission’s requirement that healthcare staff 
should have competencies for low volume high risk illnesses and treatments that they may 
encounter.         
Implications for Healthcare Policy 
There is a need for a rare disease patient registry.  The idea of an international registry for 
patients with rare diseases was discussed at a 2010 meeting sponsored by the Office of Rare 
Diseases Research (Rubinstein et al., 2010).  Numerous challenges were identified with a 
registry of this magnitude; however, extreme excitement regarding the impact that this could 
have was expressed (Rubinstein et al., 2010).  It seems if there was one database that rare disease 
information could be housed, and with a patient’s ability to opt-in with informed consent, that 
this would be a good way to potentially connect people to create a peer counseling network.   
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Additionally, it would also be advantageous to both the lay public and the healthcare 
professional team if there was a standard nomenclature and organizational structure when 
searching for rare disease information.  For example, in some places where individuals would 
search the Internet, you would find Guillain-Barre’ syndrome listed as GBS, GBS/CIDP, 
Guillain-Barre’ syndrome.  In most cases, items are listed on the webpages in alphabetical order 
making finding these illnesses a challenge if they are not named and organized the same way for 
each illness.  Having a standardized nomenclature and organizational methodology would allow 
for ease in searching and locating information related to these rare diseases.  With the time 
challenges that the healthcare team of today faces, efficiency in locating evidence-based 
standards of care is essential.  This standard approach would also assist the lay public in more 
quickly identifying information that may be helpful.      
Implications for Research 
 There are limited previous studies regarding the experiences of individuals’ who have 
required hospitalization, secondary to having GBS.  More research is needed with additional 
participants.  Additional research studies utilizing mixed methods designs where participants 
could be further segregated into more homogenous cohorts such as age categories, GBS 
disability scores, year of onset to determine if this impacts recall, issues encountered during the 
recovery phase, impact of residual deficits could provide greater detail regarding certain 
segments of the GBS population.  Future research should also explore the relationship between 
GBS related pain and fatigue and how these symptoms impact the individual’s ability to obtain 
adequate periods of restful sleep.  More research on both the emotional and physical impact of 
GBS and how best to support patients is indicated.  Additional research also is needed with 
family members of GBS patients in order to understand better the impact that this illness has on 
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them individually but also on the family unit.  Research is needed with healthcare professionals 
who have had the opportunity to care for GBS patients to understand their challenges with 
managing this patient population.  Additional research with healthcare professionals who have 
not cared for an individual with a rare disease and what strategies would they employ to care for 
an individual who presented with a rare disease could also prove useful if such a population 
could be identified.   
Individuals who expressed an interest in participating in this study, but were advised that 
enough participants had already been recruited, were queried about interest in future studies.  Of 
the 75 additional individuals, many responded affirmatively that they would have interest in 
being contacted in the future for other GBS related research studies.  This researcher plans to 
continue a program of research in GBS.   
Strengths and Limitations of the Study 
 This study has several strengths including the qualitative approach; the maximum 
variation in several demographic indicators for the participants; one researcher collected all of 
the data; and the use of two interview strategies, in-person face-to-face and electronic face-to-
face.  While there were two strategies of interviewing, all were face-to-face.  This is a strength 
for this study because of the researcher’s ability to visually observe the participants reaction and 
response to questions.  The qualitative descriptive design allowed for the study of a human 
problem (a diagnosis with GBS and subsequent hospitalization) from the participant’s view 
(Creswell, 2009).  This design provided for a rich description of the participants’ experience with 
GBS using their own words (Neergaard et al., 2009).  The sample for this study was purposively 
selected and maximum variation of participants was observed.  Variation existed in terms of 
participant age at time of illness onset (age range 16 to 76), geographic location with participants 
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residing in eight different states, days hospitalized (less than 10 to greater than 365 days), and 
time from illness onset to time of interview (six participants’ illness occurred within the last five 
years, four between 2000 – 2010, and one participant in the 1970s).  Another study strength was 
the primary researcher performed all of the interviews that allowed for consistency in the 
interviewing process and with data collection.   
Study limitations include the number of women in the sample, racial demographic, 
geographic locale, the time between GBS diagnosis and interview, and the fact that participants 
self-selected to participant in this study.  In this study, there were 10 female participants and four 
male participants.  Past research demonstrated that GBS affected men and women nearly equally; 
however, the most recent research indicates a 3:2 ratio of men to women in terms of disease 
prevalence (Schub & Schiebel, 2014).  Another limitation for this study was that 12 of the 
participants identified as Caucasian or White.  While considered a strength because of the 
number of states represented (eight), this is also a limitation for this study.  Ten of the 
participants were from states located in the southeastern part of the United States.  This could be 
considered a limitation related to transferability of study results to individuals in other parts of 
the country.  Another limitation relates to the time between GBS diagnosis and participation in 
this research study.  Appendix K includes a table that demonstrates the year that the participant 
was diagnosed with GBS compared to date of research interview.  Participants for this study self-
selected to participate.  Some of the participants who participated in the study are or have been 
involved and serving as liaisons for the Guillain-Barre’ syndrome/Chronic Inflammatory 
Demyelinating Polyneuropathy Foundation International.  Individuals who self-selected may or 
may not have a similar characteristics to those who did not volunteer to participate.         
 
117 
 
Conclusion 
 Guillain-Barre’ syndrome (GBS) is a rare disease that impacts the peripheral nervous 
system.  GBS is now the leading cause of flaccid paralysis in the United States (Chalela, 2001; 
Napgal et al., 1999).  GBS is a term that is used to describe several variants of this illness.  
Moderate to severe cases of GBS can result in significant functional impairment in patients, 
sometimes temporary and other times permanent (Frenzen, 2008).  Patients encountering a 
moderate to severe case of GBS will require nursing care, whether wholly compensatory, partly 
compensatory, and/or supportive and educative.  GBS patients are unlike other patients (DeCort, 
2011).  GBS causes considerable mortality and morbidity (Hartung et al., 2001).  This 
neuromuscular illness is a challenge to manage for the healthcare team, especially nurses 
(Haldeman & Zulkosky, 2005; Murray, 1993; Sulton, 2002; Walsh, 2006).  Patients have 
described that nursing care for GBS patients has been inconsistent (DeCort, 2011).  In part, this 
has been because nurses are not aware of the special needs of the GBS patient which results in 
unnecessary discomfort and stress (DeCort, 2011).  According to Murray (2010), Guillain-Barre’ 
syndrome is simply not well understood by nurses. 
 The results for this study lead to the development of five themes and 14 subthemes.  The 
first theme was physical manifestations of Guillain-Barre’ syndrome which includes four 
subthemes:  “a strange sensation”, a rationalizing of symptoms, “the downward spiral”, and pain 
and fatigue.  The second theme was attitudes and emotions and includes four subthemes:  the 
“emotional rollercoaster”, “attitude is everything”, seeking independence, and concerns for 
others.  The third theme was knowledge and awareness and includes two subthemes:  “no earthly 
idea what GBS was”, and a desire for more knowledge.  The fourth theme was the value of peer 
contact.  The fifth theme was related to care concepts and includes four subthemes:  staff 
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knowledge and available information was “remarkably absent”, personalized patient centered 
care, communication with caregivers, and impact of achievements.  These themes and subthemes 
would suggest that healthcare team members, including nurses, do not have a complete 
understanding of the special needs of Guillain-Barre’ syndrome patients.  Additional work and 
research is needed to enhance the patient’s experience with moderate to severe Guillain-Barre’ 
syndrome.   
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Appendix A 
Guillain-Barre’ Syndrome Treatment Options 
Treatment utilizing Corticosteroids 
 Researchers have studied the use of corticosteroids in the treatment of Guillain-Barre’ 
syndrome.  The use of corticosteroids preceded the use of the other treatment options (Atkinson 
et al., 2006).  Despite the early use of corticosteroid therapy, there was not an absolute 
understanding of corticosteroid effect on the pathophysiology of Guillain-Barre’ syndrome 
(Atkinson et al., 2006).  The rationale for the use of anti-inflammatory agents in Guillain-Barre’ 
was secondary to the inflammation of the nerves that was associated with the autoimmune 
component of this disorder (NORD Hughes, 2011; Atkinson et al., 2006).  Additional support for 
corticosteroid use included evidence that corticosteroid therapy had been shown to be 
advantageous in the management of other demyelinating illnesses with presentations similar to 
Guillain-Barre’ syndrome (Atkinson et al., 2006).   
The route of corticosteroid therapy, as well as its combined use with others therapies, has 
been studied in patients affected by Guillain-Barre’ syndrome (Atkinson et al., 2006).  Clinical 
studies have reviewed the use of corticosteroids that were ordered and administered in the 
following ways:  (1) 500mg of methylprednisolone intravenously for five days daily versus a 
placebo; (2) 40mg of prednisolone orally administered daily for 14 days versus a placebo; (3) 
prednisone and plasma exchange concurrently versus supportive care only; and (4) intravenous 
methylprednisolone and IVIg concurrently versus IVIg alone (Atkinson et al., 2006).  Atkinson 
et al. (2006) presented the results of a meta-analysis that was performed which reviewed the use 
of corticosteroids in the medical management of Guillain-Barre’ syndrome.  The clinical studies 
outlined and the meta-analysis revealed that corticosteroid use in the Guillain-Barre’ syndrome 
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patient as first-line primary therapy was not beneficial (Atkinson et al., 2006; Khan, 2004).  The 
lack of efficacy of corticosteroid use was also discussed by other authors as well (Dimachkie & 
Barohn, 2013; Galloway, 2006; Meena et al., 2011; National Organization for Rare Disorders, 
2011; Pritchard, 2008; Rajabally & Uncini, 2012).    
Treatment utilizing Cerebrospinal Fluid Filtration 
 Another therapy that has been minimally utilized in the treatment of Guillain-Barre’ 
syndrome is cerebrospinal fluid filtration.  Cerebrospinal fluid filtration is considered a 
potentially new therapy for this syndrome but additional study is warranted (Atkinson et al., 
2006).  Cerebrospinal fluid filtration originated in Germany in the later part of the 1980s and has 
been utilized to treat bacterial meningitis and other autoimmune diseases (Tzabar & White, 
1999).  The purpose of filtering the cerebrospinal fluid is to eliminate any substances that could 
possibly lead to Guillain-Barre’ syndrome (Tzabar & White, 1999).  Since the exact cause of 
Guillain-Barre’ syndrome is unknown, the filtration process is not focused on the removal of any 
one substance (Tzabar & White, 1999).  Filters are “designed to eliminate cells, bacteria, 
endotoxins, immunoglobulins, and inflammatory mediators” (Atkinson et al., 2006, p. 259).  
Electron microscopy results from filtered cerebrospinal fluid samples found “cells, cellular 
debris, immune complexes and other proteins” on the filters (Tzabar & White, 1999, p. 916).        
 The cerebrospinal fluid filtration process requires the placement of an epidural catheter 
into the subarachnoid space (Tzabar & White, 1999).  Once the catheter is in proper position, the 
catheter is connected to a cerebrospinal filtration system.  The cerebrospinal filtration system 
includes a 0.2mm polyester matrix filter, a bypass equipped with a one-way valve, a 50ml 
syringe, and a bidirectional syringe pump (Tzabar & White, 1999).  In the cerebrospinal fluid 
filtration process, 20 to 50 ml of cerebrospinal fluid is removed at a rate of 1.5 to 2.0 ml/min 
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through the bypass valve by way of the syringe pump (Tzabar & White, 1999).  The 
cerebrospinal fluid is then re-instilled via the syringe pump at a rate of 2.0 to 4.0 ml/min (Tzabar 
& White, 1999).  Tzabar and White (1999) reveal that when the cerebrospinal fluid is returned to 
the subarachnoid space it passes through the filter.   Cerebrospinal fluid is filtered ten times daily 
for five days and then repeated for three weeks (Tzabar & White, 1999).  In one study, 37 
randomized Guillain-Barre’ syndrome patients received either cerebrospinal fluid filtration or 
plasma exchange (Wollinsky et al., 2001).  Results of the study revealed that the cerebrospinal 
fluid filtration therapy was as effective as plasma exchange (Atkinson et al., 2006).  Because of 
the number of patients in this study, Hughes, Pritchard, and Hadden (2013) suggest an inability 
to “confirm or refute benefit or harm in acute” Guillain-Barre’ syndrome patients (p. 2).  
Additional study utilizing this treatment is needed to evaluate efficacy in a larger cohort of 
patients.   
Treatment utilizing Immunotherapy 
Because of the strong evidence supporting the autoimmune component of Guillain-Barre’ 
syndrome, treatment is generally focused on immunotherapy.  There are two commonly utilized 
immunotherapy medical treatments:  (1) plasmapheresis (or plasma exchange, PE) and (2) the 
administration of intravenous immunoglobulin G (IVIg).  Both plasmapheresis and intravenous 
immunoglobulin administration have been shown to be effective in the treatment of Guillain-
Barre’ syndrome patients (Asbury, 2000; Burns, 2008). 
Plasmapheresis.   
Plasmapheresis was the first effective treatment for Guillain-Barre’ syndrome patients to 
be identified in two randomized controlled trials in the mid-1980s (Dimachkie & Barohn, 2013).  
One of the studies was performed in North America in 1985 and was known as the Guillain-
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Barre’ Syndrome Study Group (n=245) and the other was performed in 1987 and was a French 
study known as the French Cooperative Group (n=220) (Dimachkie & Barohn, 2013).  In these 
studies, plasma exchange was performed within two weeks of initial symptoms (Dimachkie & 
Barohn, 2013).  Reductions in time to wean from mechanical ventilatory support and to walk 
unassisted were shown to be statistically significant in the treatment group as compared to the 
control group (Dimachkie & Barohn, 2013).  In addition, the number of patients requiring 
assisted ventilation in the treatment group was less than in the control group and there was a 
reduction in the amount of time needed to see motor recovery comparing the treatment group 
with the control group (Dimachkie & Barohn, 2013).      
Plasmapheresis is the process of separating plasma from whole blood using 
centrifugation or filtration and removing substances that can contribute to an illness, in this case 
Guillain-Barre’ syndrome (Atkinson et al., 2006).  These substances can include “autoantibodies, 
immune complexes, complement, cytokines, and other nonspecific inflammatory mediators” 
(Dimachkie & Barohn, 2013, p. 500). Once the substances are removed from the plasma, the 
plasma is administered back to the patient.  In some cases, the patient’s plasma is not returned 
and is rather replaced with normal plasma or albumin (Atkinson et al., 2006).  The plasma 
exchange treatment volume is well established (Dimachkie & Barohn, 2013).  Fifty milligrams 
per kilogram (50 mL/kg) of plasma is generally administered, either daily or every other day, for 
a five to ten day period yielding a total volume of 250 mL/kg (Dimachkie & Barohn, 2013).  
Dimachkie and Barohn (2013) reveal that plasma exchange volumes that exceed the normally 
prescribed amount do not result in improved outcomes. The French Cooperative Group study 
revealed that patients admitted with a mild case of Guillain-Barre’ syndrome should receive two 
plasma exchange regimens and those admitted with a moderate case of Guillain-Barre’ syndrome 
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should receive four plasma exchange regimens (Dimachkie & Barohn, 2013).  The French 
Cooperative Group study also revealed that patients admitted with a severe case of Guillain-
Barre’ syndrome did not benefit from more than four plasma exchange regimens (Dimachkie & 
Barohn, 2013).  Plasma exchange is performed in specialized units, requires a double-lumen 
catheter, can be accompanied by numerous potential complications, and requires close 
monitoring of vital signs and laboratory data (Dimachkie & Barohn, 2013).  These circumstances 
should be considered and discussed with the patient prior to initiation of therapy. 
Intravenous Immunoglobulin. 
 The efficacy of intravenous immunoglobulin was established in 1992 in a large study, the 
Dutch Guillain-Barre’ Study Group (n=147), and subsequently in the 1997 Plasma Exchange and 
Sandoglobulin Guillain-Barre’ Syndrome Trial Group (Dimachkie & Barohn, 2013).  The Dutch 
study compared the benefits of plasma exchange versus intravenous immunoglobulin 
(Dimachkie & Barohn, 2013).  The Sandoglobulin Guillain-Barre’ Syndrome Trial evaluated 
plasmapheresis alone, intravenous immunoglobulin alone, and plasma exchange followed by 
intravenous immunoglobulin (Dimachkie & Barohn, 2013).  The outcomes from both of these 
studies revealed that patients treated with intravenous immunoglobulin had similar positive 
benefits as those patients treated with plasmapheresis (Dimachkie & Barohn, 2013).  There was 
no statistically significant benefit in terms of improved patient outcomes when both therapies 
were used together (Dimachkie & Barohn, 2013).  
 The normal total dosing for intravenous immunoglobulin is generally 2g/kg administered 
over two to five days (Dimachkie & Barohn, 2013).  Patients should be monitored closely to 
observe for any potential reactions or side effects.  Side effects can include mild, moderate, and 
severe reactions.  Mild reactions are rare and can include:  “headache, nausea, chills, myalgia, 
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chest discomfort, [and] back pain” (Dimachkie & Barohn, 2013, p. 502).  Moderate reactions can 
include:  chemical meningitis, neutropenia, desquamation of palms, trunk, and soles of feet 
(Dimachkie & Barohn, 2013).    Severe reactions are also rare and can include:  “anaphylaxis, 
stoke, myocardial infarction, [and] pulmonary emboli caused by hyperviscosity syndrome” 
(Dimachkie & Barohn, 2013, p. 502).  Dimachkie & Barohn (2013) reveal that infusions should 
start slowly at a rate of 25 to 50 mL/hr and then increasing the rate by 50mL/hr every 15 to 20 
minutes until the rate has reached 150 to 200 mL/hr.  Starting infusions slowly and then slowly 
increasing the volume administered per hour decreases the potential for side effects and enhances 
patient tolerance of the treatment (Dimachkie & Barohn, 2013).  Table A1 summarizes treatment 
options and associated efficacies of these treatments.    
Other Potential Treatments 
 Hughes et al. (2013) performed an analysis of all available randomized controlled trials to 
review medical interventions other than corticosteroid therapy, plasmapheresis, and intravenous 
immunoglobulin.  The initial analysis was performed in 2011 and updated in 2013.  The analysis 
resulted in four studies, all of which were of low quality,   outlining medical therapies including:  
(1) interferon beta-1a (used in treatment of multiple sclerosis) versus placebo (n=13), (2) brain-
derived neurotrophic factor (a nerve growth factor) versus placebo (n=10), (3) cerebrospinal 
fluid filtration versus plasma exchange (n=37) (presented in previous section), and (4) 
tripterygium polyglycoside, a Chinese herbal medicine, versus corticosteroid therapy (n=20) 
(Hughes et al., 2013).  Because of the number of subjects in these studies, drawing conclusions 
regarding “benefit or harm” of these therapies could not be confirmed or refuted (Hughes et al., 
2013, p. 2).  Additional treatment options are needed in the acute Guillain-Barre’ syndrome 
patient population.    
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Table A1 
Guillain-Barre’ Syndrome Treatment Options and Associated Efficacy      
Treatment Option Treatment Efficacy 
Treatment utilizing Corticosteroids: 
Intravenous, oral, steroid + PE, steroid + IVIg 
Not effective as first-line primary therapy 
 
Treatment utilizing Cerebrospinal Fluid 
Filtration 
 
Considered a “new” therapy; more research is 
needed particularly of stronger scientific 
merit 
 
 
Treatment utilizing Immunotherapy: 
Plasmapheresis (plasma exchange, PE) 
 
 
 
 
Effective if initiated early in the course of the 
illness 
Treatment utilizing Immunotherapy: 
Intravenous Immunoglobulin (IVIg) 
 
Equally as effective as plasmapheresis; 
however, is easier to administer  
 
Treatment utilizing Plasmapheresis followed 
by Intravenous Immunoglobulin (PE + IVIg) 
 
No statistically significant benefit 
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Appendix B 
Guillain-Barre’ Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy 
Foundation International Letter of Support 
 
 
J. Dwayne Hooks Jr., MN, RN, FNP-BC, FACHE 
1123 Newpark View Place 
Mableton, Ga 30126 
 
RE: Dissertation Research 
 
Dear Mr. Hooks, 
 
As Executive Director of the Guillain-Barre’ Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy 
Foundation International, I am pleased to write this letter to demonstrate our support of your dissertation research 
regarding patients’ recall of their experience during an acute illness with Guillain-Barre’ Syndrome.  
 
The Guillain-Barre’ Syndrome Foundation International’s mission is to improve quality of life for individuals and 
families worldwide affected by GBS, CIDP and related syndromes, and variants.  Tactics that we employ that 
contribute to the Foundation’s achievement of this mission include providing a network for individuals impacted by 
GBS, providing educational programs, engaging in patient advocacy, and by sponsoring research.  We believe that 
achieving our mission will lead to us being able to ensure that every person afflicted with Guillain-Barré Syndrome 
(GBS), Chronic Inflammatory Demyelinating Polyneuropathy, or GBS variants has convenient access to early and 
accurate diagnosis, appropriate and affordable treatments, and dependable support services. 
 
Your research has the potential to impact quality of life for those who have suffered from GBS.  Ensuring that 
nurses and other clinicians have information from patients that can guide their care is essential.  Your research could 
provide nurses and other clinicians with information from the patient’s perspective regarding their experience with 
GBS.  In order to support your work, the Foundation will email GBS/CIDP Foundation International members to 
advise them of your important research and to ascertain their interest in participating.  The email will notify them of 
the study and ask them to contact you directly at the contact information that you provide if they have interest in 
participating in your qualitative descriptive research.  Potential participants will be educated that the study will 
include an interview and possibly a follow-up discussion to clarify any information obtained during the interview.  
In addition, the potential participants will be notified that their participation will remain anonymous, that any 
identifying information will not be disclosed, and that their participation is voluntary. 
 
If you have any questions or need any additional information, please do not hesitate to reach out to me.  I look 
forward to working with you further once you have received all appropriate approvals for your research proposal.  I 
am excited about the potential impact of your research.  
  
Sincerely, 
 
Ken Singleton  
Executive Director  
GBS/CIDP Foundation International 
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Appendix C 
Participant Recruitment Notice to Guillain-Barre’ Syndrome/Chronic Inflammatory 
Demyelinating Polyneuropathy Foundation International Membership 
Notice of Research Study 
 Nursing Researchers from the University of Kansas School of Nursing are performing a 
research study with participants who have had a moderate to severe case of Guillain-Barre’ 
syndrome.  This research will look to better understand what the patient recalls about the period 
of time that they were hospitalized with moderate to severe Guillain-Barre’ syndrome.  What is 
learned from this research can be shared with nurses and other clinicians to enhance the care 
provided to those individuals affected by this illness.        
Patients who have been diagnosed with moderate Guillain-Barre’ syndrome have had 
paralysis of their legs (lower extremities) that affected their ability to walk (ambulate) when they 
were hospitalized with their illness.  Patients who have been diagnosed with severe Guillain-
Barre’ syndrome have had paralysis of the respiratory muscles (the muscles that help in 
breathing) that affected their ability to breathe on their own.  Patients with severe cases of 
Guillain-Barre’ syndrome typically need help breathing with a ventilator when they were 
hospitalized with their illness.   
You are receiving this notice because you have registered with the Guillain-Barre’ 
Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy Foundation International and 
may qualify to participate in this study.  Criteria to participate in this voluntary research study 
include:  (1) adults 18 years of age and older, (2) a prior self-identified diagnosis of moderate to 
severe Guillain-Barre syndrome, (3) alert and oriented, (4) able to respond to interview 
questions, (5) English as a primary or secondary language, and (5) able to give informed consent.   
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If you meet participation criteria and decide to participate, you will be interviewed by a 
nursing researcher for approximately 60 to 90 minutes.  The interview will be recorded with a 
digital recorder.  A second telephone interview may be requested if the researcher needs to 
clarify any of your responses and/or to obtain any additional needed information. The primary 
researcher anticipates that you will not directly benefit from participating in this research study.  
Researchers hope that the information obtained during this research study may be useful in 
enhancing the care and treatment for patients who will be diagnosed with moderate to severe 
Guillain-Barre’ syndrome in the future.  
 For more information, or if you have questions, regarding this research study, please 
contact  J. Dwayne Hooks Jr., MN, RN, FNP-BC at jhooks2@kumc.edu or by mobile 706-231-
0840.  Alternately you may contact Dr. Wanda Bonnel PhD, APRN at wbonnel@kumc.edu or 
913-588-3363. 
     
 
 
 
 
 
 
 
 
 
Guillain-Barre Syndrome:  A Qualitative Descriptive Study Protocol # 00001986 
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Appendix D 
Sample Snowballing Referral Letter 
Dear [Mr. / Ms. Participant’s LAST NAME], 
Thank you for your interest and participation in Guillain-Barre Syndrome:  A Qualitative 
Descriptive Study.  I am providing you with this letter to ask you to pass along the enclosed 
information to individuals that you know who may also be interested in learning about, and 
possibly participating, in this research study.  You are under no obligation to share this 
information and whether or not you share this information will not affect your relationship with 
the staff at the University of Kansas Medical Center (KUMC).  Potential participants should be 
18 years of age or older and thought to have had a previous diagnosis of moderate to severe 
Guillain-Barre’ syndrome.  If you or anyone you know has questions regarding this study or how 
to participate, researchers can be reached by email at jhooks2@kumc.edu or  
wbonnel@kumc.edu or by calling or texting the number listed below.  
Thank you for your time and consideration. 
Sincerely, 
 
J. Dwayne Hooks Jr., MN, RN, FNP-BC, FACHE 
Email:  jhooks2@kumc.edu 
Mobile Number:  706-231-0840 
Enclosure(s): 
Research Consent Form 
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Appendix E 
Additional Recruitment Strategies 
Table E1 
Summary of Additional Participant Recruitment Strategies 
Strategy Timing of strategy 
Announcement of study using Appendix B Recruitment 
Notice to Guillain-Barre’ syndrome support group leaders in 
Georgia (four support groups in Georgia including Atlanta, 
Central Georgia, Macon, and West Central Georgia chapters) 
and in North Carolina (four support groups in North Carolina 
including Charlotte, Durham, Raleigh, and Winston-Salem 
chapters) 
Approximately one month 
after study initiated if 
informational redundancy not 
achieved 
 
The additional recruitment strategy that will be employed in the event that informational 
redundancy is not achieved with the primary recruitment methods includes:  announcement of 
the study through the nationwide network of Guillain-Barre’ syndrome support groups with 
focus on the four support group chapters in Georgia and the four support group chapters in North 
Carolina.  Table E1 outlines when the timing of this strategy would have been deployed if 
needed.   
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Appendix F 
Demographic Questionnaire 
Guillain-Barre Syndrome:  A Qualitative Descriptive Study 
Identifier:_________________________________________________________________ 
Gender:     Male Female 
Race:  ____________________________________________________________________ 
Marital Status at onset of GBS illness:  Single     Married/Domestic Partner     Divorced  
Highest level of education:  ___________________________________________________  
Date of Birth and Current Age:_________________________________________________ 
Age at onset of GBS illness:___________________________________________________ 
Year GBS was diagnosed: ____________________________________________________ 
Were you told that Campylobacter jejuni preceded your illness:      Yes No Unknown 
Were you told about any other illness that may have preceded your GBS:  Yes   No  Unknown 
 If yes, what was the illness:  ____________________________________________ 
Did you have any immunizations within the 6 months prior to your GBS:  Yes   No    Unknown 
If yes, what immunization did you have and what was the approximate time prior to your 
diagnosis of GBS:  
____________________________________________________________________ 
Have you received this immunization since your diagnosis with GBS:    Yes       No  
Have you received any other immunizations since your diagnosis with GBS:  Yes    No 
Has anyone in your family ever been diagnosed with GBS:     Yes     No 
 If yes, then what was their relationship to you:  ______________________________ 
Were you admitted to the hospital because of your GBS diagnosis:     Yes    No 
 If yes, were you admitted emergently:     Yes No 
Approximately how many days did you remain in the hospital:  _______________________ 
 Admit Date (if known):  ___________  Discharge Date (if known):  ______________ 
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While in the hospital, was any of your care provided in an Intensive Care Unit:     Yes       No 
Were you able to walk (ambulate) during the most severe time of your illness?    Yes   No 
Were your legs (lower extremities) paralyzed during the most severe time of your illness?  
Yes    No   
Did you need mechanical ventilatory support (ventilator or breathing machine)?    Yes     No    
Were you told that your GBS was moderate or severe:      Yes  No 
Did you receive care in a hospital or a specialty unit designated as a GBS Center of Excellence? 
Yes      No      Unknown 
 
How did you hear about this study:   (1)  Email from GBS Foundation 
(circle the appropriate response) 
(2)  Ad on the GBS Website (Latest News Section) 
 
(3)  GBS FaceBook Posting 
 
(4)  From an individual who told me about the study 
 
(5)  Other:  ________________________________ 
 
 
 
 
 
 
 
 
 
 
 
143 
 
Appendix G 
Interview Guide 
1.  Tell me about when you were first diagnosed with Guillain-Barre syndrome (GBS).  
 P1.1  What made you go to the doctor or hospital?   
P1.2  Tell me about your symptoms at the beginning (onset) of your illness. 
P1.3  Tell me how you felt at the beginning (onset) of your illness. 
 
2.  Tell me what you knew about GBS before you were diagnosed with the illness? 
3.  Tell me about how you learned about GBS after you were diagnosed with the illness. 
 P3.1 Where did you get the information? 
 P3.2  Are there things that you know now that you would have liked to have known when 
you were first diagnosed with GBS? 
 
4.  Tell me about the care you got while you were in the hospital when you were diagnosed with 
GBS.    
 
P4.1  Did you have any problems with communication?  If so, how did you communicate 
with hospital staff (nonverbally, verbally, special communication devices)?   
 P4.2  Describe any special communication techniques or devices that were 
 utilized during  your care?  Tell me how those things worked. 
 P4.3  Describe how your needs were met during the most severe time of your 
illness? 
 P4.4  Tell me about any needs you felt were not met during your illness. 
 
5.  Tell me about the place(s) where you got your care when you were in the hospital (Intensive 
Care Unit patient room, Nursing Unit patient room, etc.).  
  
P5.1  Were there any care moments that were particularly good or bad? 
 
6.  Tell me about the biggest challenge(s) that you faced during the most severe time of your 
illness?   
 
P6.1  What made this better? 
P6.2  What made this worse? 
 
7.  What were important or key achievements (events, milestones, etc.) during your illness? 
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8.  What did nurses (or other caregivers) do that helped you deal with your illness? 
 P8.1  What could nurses (or other caregivers) have done to make the care better? 
9.  Tell me about your emotions during this time (if participant is unsure of time will clarify by 
adding “the emotions that you experienced or encountered during your illness”). 
 
P9.1  Some other people who have had GBS have told me they felt scared or anxious or 
depressed - did you feel any of these things?  Can you tell me more about this?  
How did you deal with this (will use this only if not previously addressed by the 
participant)? 
 P9.2  What other emotions or feelings did you experience? 
 
10.  What words of wisdom would you have for another person who was just diagnosed with 
GBS? 
 
11.  Is there anything else that you think would be important for me to know about your 
experiences with GBS?  
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Appendix H 
Research Consent Form 
Title:  Guillain-Barre Syndrome:  A Qualitative Descriptive Study 
Study Protocol # 00001986 
You are being asked to join a research study.  You are being asked to take part in this study 
because you have had a previous diagnosis of moderate to severe Guillain-Barre’ syndrome.  
Patients who have been diagnosed with moderate Guillain-Barre’ syndrome have had paralysis 
of their legs (lower extremities) that affected their ability to walk (ambulate) when they were 
hospitalized with their illness.  Patients who have been diagnosed with severe Guillain-Barre’ 
syndrome have had paralysis of the respiratory muscles (the muscles that help in breathing) that 
affected their ability to breathe on their own.  Patients with severe cases of Guillain-Barre’ 
syndrome typically need help breathing with a ventilator when they were hospitalized with their 
illness.   
 
You do not have to participate in this research study.  The main purpose of research is to create 
new knowledge for the benefit of future patients and society in general.  Research studies may or 
may not benefit the people who participate.   
 
Research is voluntary, and you may change your mind at any time.  There will be no penalty to 
you if you decide not to participate, or if you start the study and decide to stop early.  Either way, 
you can still get medical care and services at the University of Kansas Medical Center (KUMC).    
 
This consent form explains what you have to do if you are in the study.  It also describes the 
possible risks and benefits.   Please read the form carefully and ask as many questions as you 
need to, before deciding about this research.   
 
You can ask questions now or anytime during the study.  The researchers will tell you if they 
receive any new information that might cause you to change your mind about participating.   
 
This research study will take place at the University of Kansas Medical Center (KUMC) with 
Wanda Bonnel, PhD and Sandra Bergquist-Beringer, PhD as the principle investigators and J. 
Dwayne Hooks Jr., MN, RN, FNP-BC as the primary researcher.  This research is a requirement 
for completion of the PhD in Nursing degree for the primary researcher.  A total of about 10 to 
12 people will be in the study at geographic locations across the United States. 
 
BACKGROUND  
Guillain-Barre’ syndrome is considered a rare disease.  No research exists regarding the patients’ 
recalled experience (memories) of care during a hospital stay caused by Guillain-Barre’ 
syndrome.  This syndrome can cause patients to rely on a ventilator (breathing machine) to assist 
with breathing secondary to the paralysis that is caused by this illness.  This illness impacts 
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communication and can cause fear and anxiety in patients.  Research is needed in this area to 
better understand what the patient experiences when they have a moderate to severe case of 
Guillain-Barre’ syndrome.  
 
PURPOSE 
By doing this study, researchers hope to learn more about the experiences that patients have 
during an acute illness and hospitalization with moderate to severe Guillain-Barre’ syndrome.  
Guillain-Barre’ syndrome is a disabling disorder that has multiple implications for patients.  
These implications include physical limitations, financial hardship, psychological effects, and 
impacts on support systems and family.  Many of these implications, particularly during an acute 
illness and hospitalization, have not been fully studied.  This research will look to better 
understand what the patient recalls about encounters during the acute illness and hospitalization 
with moderate to severe Guillain-Barre syndrome and what learnings can be shared with 
clinicians to enhance the care provided to patients affected by this illness.     
  
PROCEDURES 
If you are eligible and decide to participate in this study, your participation will last 
approximately 90 to 120 minutes.  Your participation will involve: 
 
 The completion of a demographic questionnaire to obtain key information about you and 
also about your experience(s) with moderate to severe Guillain-Barre syndrome.  The 
questions on the demographic questionnaire include, but are not limited to:  age, gender, 
marital status, race, information about the illness, questions about events prior to your 
illness with Guillain-Barre’ syndrome, etc.  Your name will not be recorded on this form.  
You will select an identifier to record on the questionnaire which will be cross referenced 
with a participant list.  Your identity will be confidential and you will choose a 
pseudonym that will be utilized during the interview.  Only the primary researcher and 
the research team will know your identity.     
 
 The completion of an interview with the primary researcher, asking open ended questions 
about your experience during your illness with moderate to severe Guillain-Barre 
syndrome.  The interview will be conducted in a public space, such as a library or healthcare 
setting conference room meeting your need for convenience.  Or if you  are unable to leave 
your home, or are prohibited by distance from meeting face to face, you can be 
interviewed by phone or with online technology.  The interview is expected to last 60 to 
90 minutes and will be recorded with a digital recorder.  The digital recording and the 
exact (verbatim) transcriptions of these interviews will be securely stored by the primary 
researcher for a period of fifteen (15) years as required by the Institutional Review Board 
 
 After the primary researcher, and other members of the research team, have reviewed 
your responses to the questions from the initial interview (during the data analysis phase 
of the research study), a second interview may be requested to clarify any of your 
responses and/or to obtain any additional needed information.  This second interview can 
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be a telephone interview and should last no more than 30 minutes.      
 
 
 You also may be asked to share information about the potential for study participation 
with someone else you think may be interested in the study. 
 
RISKS 
You may feel uncomfortable by some of the questions the researcher asks you or the questions 
may cause you to recall an event or events that may have been unpleasant or embarrassing during 
your illness with moderate to severe Guillain-Barre’ syndrome.  You are free at any point not to 
answer a question or questions and you may stop participating in the study all together.   
 
In order to reduce the risks of disclosure if information is released, the information you provide 
will be treated as confidential (see Procedures section) and will not have the participants’ given 
name on written transcriptsYou are free to give only the information you choose.   
 
There may be other risks of the study that are not yet known.   
 
NEW FINDINGS STATEMENT 
You will be told about anything new that might change your decision to be in this study. You 
may be asked to sign a new consent form if this occurs.   
 
BENEFITS 
The primary researcher anticipates that you will not directly benefit from participating in this 
research study.  Researchers hope that the information obtained during this research study may 
be useful in enhancing the care and treatment provided by clinicians to patients who will be 
diagnosed with moderate to severe Guillain-Barre’ syndrome.  
 
ALTERNATIVES 
Participation in this study is voluntary.  Deciding not to participate will have no effect on the 
care or services you receive at the University of Kansas Medical Center.   
COSTS       
There is no cost for being in the study.   
PAYMENT TO SUBJECTS 
There is no payment for this study.    
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INSTITUTIONAL DISCLAIMER STATEMENT 
If you think you have been harmed as a result of participating in research at the University of 
Kansas Medical Center (KUMC), you should contact the Director, Human Research Protection 
Program, Mail Stop #1032, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas 
City, KS 66160.  Under certain conditions, Kansas state law or the Kansas Tort Claims Act may 
allow for payment to persons who are injured in research at KUMC.    
 
CONFIDENTIALITY AND PRIVACY AUTHORIZATION 
The researchers will protect your information, as required by law. Your health information is 
protected by a federal privacy law called HIPAA. By signing this consent form, you are giving 
permission for KUMC to use and share your health information for the purposes of this study. If 
you decide not to sign the form, you cannot be in the study. The researchers will only use and 
share information that is needed for the study. Absolute confidentiality cannot be guaranteed, but 
in order to minimize any risks procedures described in this document will be adhered to.   The 
researchers may publish the results of the study.  If they do, they will only discuss group results.  
Your name will not be used in any publication or presentation about the study.   
 
QUESTIONS 
Before you sign this form, or give verbal consent,  J. Dwayne Hooks Jr., MN, RN, FNP-BC 
(jhooks2@kumc.edu),Wanda Bonnel, PhD (wbonnel@kumc.edu), or  Sandra Bergquist-
Beringer, PhD (sbergquist-beringer@kumc.edu) members of the study team should answer all 
your questions.  You can talk to the researchers if you have any more questions, suggestions, 
concerns or complaints after signing this form.  If you have any questions about your rights as a 
research subject, or if you want to talk with someone who is not involved in the study, you may 
call the Human Subjects Committee at (913) 588-1240.  You may also write the Human Subjects 
Committee at Mail Stop #1032, University of Kansas Medical Center, 3901 Rainbow Blvd., 
Kansas City, KS 66160. 
 
SUBJECT RIGHTS AND WITHDRAWAL FROM THE STUDY 
You may stop being in the study at any time.  Your decision to stop will not prevent you from 
getting treatment or services at KUMC.  The entire study may be discontinued for any reason 
without your consent by the investigator conducting the study.   
 
CONSENT 
Either J. Dwayne Hooks Jr., MN, RN, FNP-BC, Wanda Bonnel, PhD, or Sandra Bergquist-
Beringer,PhD, member of the research team has given you information about this research study.  
They have explained what will be done and how long it will take.  They explained any 
inconvenience, discomfort or risks that may be experienced during this study.   
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By signing this form, or providing verbal agreement,  you say that you freely and voluntarily 
consent to participate in this research study.  You have read the information and had your 
questions answered.   
 
You will be given a copy of the consent form to keep for your records. 
 
____________________________________    
Print Participant’s Name       
 
____________________________________ _______ __________________ 
Signature of Participant      Time  Date 
 
____________________________________ 
Print Name of Person Obtaining Consent 
 
____________________________________   __________________ 
Signature of Person Obtaining Consent    Date 
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Appendix I 
Participant Recruitment Notice for Social Media Sites 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESEARCH STUDY 
 
GUILLAIN-BARRE’ SYNDROME 
Have you had a prior diagnosis of moderate to severe Guillain-Barre’ syndrome? 
 
Nursing Researchers from the University of Kansas School of Nursing are performing a 
research study with participants who have had a moderate to severe case of Guillain-
Barre’ syndrome.    
This voluntary research study will look to better understand what the patient recalls 
about encounters during the acute illness and hospitalization with moderate to severe 
Guillain-Barre syndrome and what learnings can be shared with nurses and other 
clinicians to enhance the care provided to patients affected by this illness.    
For more information, contact J. Dwayne Hooks Jr. at 706-231-0840  
or by email at jhooks2@kumc.edu.  You may alternately contact  
Wanda Bonnel, PhD, ARNP at wbonnel@kumc.edu or 913-588-3363. 
 
 
Guillain-Barre’ Syndrome:  A Qualitative Descriptive Study Protocol # 00001986 
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Appendix J 
Table J1 
Relationship between research questions, interview guide questions, and resulting themes 
Research Question 
Number 
Research Question 
Text 
Interview Guide 
corresponding question 
Resulting Theme 
1 What are patients 
recalled experiences 
of care and caregiver 
interactions during an 
episode of moderate 
to severe Guillain-
Barre’ syndrome? 
4, 5.1, 6, 7, 8, 9 1, 2, 5 
 
2 
 
 
What do patients 
recall about 
characteristics and 
environmental 
conditions of the 
clinical area(s) where 
they receive care? 
 
5, 6, 7, 9 
 
1, 2 
 
3 
 
 
How do patients 
describe their change 
in knowledge of GBS 
over time from pre 
diagnosis to current 
time? 
 
2, 3, 10 
 
2, 3, 4, 5 
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Appendix K 
Table K1 
Year of Diagnosis with Guillain-Barre’ Syndrome 
Decade Number of participants whose GBS was 
diagnosed in the corresponding decade 
1970 - 1979 1 
1980 - 1989 2 
1990 - 1999 1 
2000 - 2009 4 
2010 - current 6 
 
